Computational Methods for Improved Peptide and Protein Identification in Proteomics by Meyer-Arendt, Karen
University of Colorado, Boulder
CU Scholar
Chemistry & Biochemistry Graduate Theses &
Dissertations Chemistry & Biochemistry
Spring 1-1-2011
Computational Methods for Improved Peptide and
Protein Identification in Proteomics
Karen Meyer-Arendt
University of Colorado at Boulder, karen@nippos.com
Follow this and additional works at: http://scholar.colorado.edu/chem_gradetds
Part of the Bioinformatics Commons
This Dissertation is brought to you for free and open access by Chemistry & Biochemistry at CU Scholar. It has been accepted for inclusion in
Chemistry & Biochemistry Graduate Theses & Dissertations by an authorized administrator of CU Scholar. For more information, please contact
cuscholaradmin@colorado.edu.
Recommended Citation
Meyer-Arendt, Karen, "Computational Methods for Improved Peptide and Protein Identification in Proteomics" (2011). Chemistry &
Biochemistry Graduate Theses & Dissertations. Paper 33.
  
 
 
COMPUTATIONAL METHODS FOR IMPROVED PEPTIDE AND PROTEIN 
IDENTIFICATION IN PROTEOMICS 
by 
KAREN MEYER-ARENDT 
B.A., Reed College, 1981 
M.S., Oregon State University, 1987 
 
 
 
 
 
A thesis submitted to the 
Faculty of the Graduate School of the 
University of Colorado in partial fulfillment 
of the requirement for the degree of 
Doctor of Philosophy 
Department of Chemistry and Biochemistry 
2011 
 
 This thesis entitled: 
Computational Methods for Improved Peptide and Protein Identification in Proteomics 
written by Karen Meyer-Arendt 
has been approved for the Department of Chemistry and Biochemistry 
 
 
 
________________________________ 
Natalie G. Ahn 
 
 
________________________________ 
William M. Old 
 
 
Date____________ 
 
 
The final copy of this thesis has been examined by the 
signatories, and we find that both the content and the form 
meet acceptable presentation standards of scholarly work in 
the above mentioned discipline. 
ABSTRACT 
 
Meyer-Arendt, Karen (Ph.D., Biochemistry) 
Computational Methods for Improved Peptide and Protein Identification in Proteomics 
Thesis directed by Professor Natalie G. Ahn 
 
Shotgun proteomics is an analytical method used to identify proteins from complex 
mixtures such as a whole-cell lysates. This method utilizes high-resolution mass spectrometers, 
proteolysis, and fractionation techniques in order to maximize the number and quantities of 
proteins being detected.  Knowing the identity and abundance of proteins in a cell provides 
insights into cell functioning, and how cells respond to external stimuli.  Our lab uses proteomics 
to further understanding of signaling networks and how these are dysregulated during melanoma 
progression. 
Computer algorithms are an essential aspect of shotgun proteomics in order to match 
hundreds of thousands of spectra to the peptide sequences from which they came.  The most 
productive peptide identification methods search databases of protein sequences, looking for the 
best peptide spectrum matches, but these methods can be plagued by false positives and false 
negatives.  I designed and implemented MSPlus, software which increases sensitivity and 
specificity in peptide identification by using physicochemical filters and consensus scoring 
between multiple database search programs, approaches which are now commonly in use. 
After peptides are identified, they must be mapped back to the proteins from which they 
derive, a non-trivial task in the human proteome with its extensive alternative splicing, gene 
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duplication, and post-translational processing.  I designed and implemented IsoformResolver, 
software which accurately and efficiently infers proteins from peptides using a pre-calculated 
peptide-centric reformatted protein database.  Proteins are reported in the context of protein 
groups, a concise representation which allows experimentalists to see the most likely proteins in 
the context of all possible proteins for which there is mass spectrometry evidence.  This novel 
representation minimizes the protein volatility inherent to the more common protein-centric 
output. 
Finally I examine the capabilities and limits of shotgun proteomics.  I introduce a tier-
based representation of protein abundances, and investigate how the abundances vary by protein 
class and at different sampling depths.  I compare proteomics and transcriptomics results, and 
investigate to what extent proteomics can be used to identify members which distinguish cell 
states. 
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CHAPTER I 
 
INTRODUCTION 
 
Overview of Proteomics  
Since the completed sequencing of the human genome (Lander et al, 2001; Venter et al 
2001), a great deal of effort has been taken to make sense of the function of each of the 
approximately 20,000 genes (Clamp et al, 2007).  One rich source of information comes from 
transcriptomics, a high-throughput method which attempts to enumerate and quantify all mRNA 
transcripts from a cell lysate using microarray analysis.  This method has been used successfully 
in numerous studies, and has led to the identification of biomarkers used in diagnosis 
(Bhattacharjee et al, 2001; van't Veer et al, 2002).  But the majority of cellular activity is at the 
protein rather than the mRNA level, so proteomics analysis – a high-throughput, discovery-based 
method which looks at the identity and abundances of protein in a cell – may be even more 
promising.  Looking at proteins directly will shed light on protein abundances (which do not 
always correlate with mRNA abundances), provide information about splice variants, truncation 
products, and cellular localization that microarray chips may not assay and, perhaps most 
importantly, provide information about post-translational protein modifications essential to the 
signaling networks which drive much of cell function.   
There are many approaches one can take in proteomics (Aebersold and Mann, 2003; Zhu 
et al, 2001), but by far the most successful has been shotgun proteomics.  Also known as 
multidimensional protein identification technology (MudPIT), shotgun proteomics is a large-
scale method which uses multiple types of chromatographic fractionation and proteolysis to 
analyze protein mixtures as complex as an entire cell lysate (Washburn et al, 2001; Kislinger et 
al, 2006).  In our lab we have identified over 10,000 proteins from human cell lines, a number 
which approaches the total number of proteins expected from most human cell types.   
The heart of shotgun proteomics are mass spectrometers which use different types of ion sources 
including matrix-assisted laser desorption ionization (MALDI)  and electrospray ionization  
(ESI)  (Yates, 1998).  In ESI, biological sample enters the mass spectrometer in liquid form 
through a nebulizer needle (Figure 1.1).  Incoming peptides are ionized (usually by adding 
protons in positive mode or removing protons in negative mode), enabling them to be 
manipulated by radiofrequency fields to be separated by molecular weight to charge (m/z) ratio, 
and their intensities recorded by a detector.  Peptide ions are then selected for fragmentation and 
the intensities and m/z of the resultant charged fragment ions recorded in an MS/MS spectrum.  
Because peptides typically fragment along the peptide backbone, it is possible to read off the 
amino acid sequences of the peptides as shown in Figure 1.2.    
 
 Figure 1.1  Diagram of a mass spectrometer 
(http://masspec.scripps.edu/information/intro/index.html) 
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 Figure 1.2  Peptide fragmentation 
(http://www.protein.sdu.dk/bm131/download/tandemMS.doc)   
 Good separation is key to large-scale proteomics experiments, since often only the most 
intense peptide ions are selected for fragmentation.  Chromatographic separation can occur at the 
protein and peptide level.   Protein separations often involve reverse phase, size exclusion or ion 
exchange chromatography.  While some labs analyze intact proteins, analysis of peptides is more 
efficient because of their smaller size, thus proteins are often proteolyzed after separation, using 
trypsin or other proteases.  Once proteolyzed, peptides are further resolved, for instance, by one-
dimensional reverse phase (RP) HPLC directly coupled to the ESI, or by two-dimensional strong 
cation exchange (SCX) separation followed by RP-HPLC.  A final optional “gas phase 
fractionation” can be carried out by repetitive runs of the same sample, each scanning a narrow 
mass range.  Thus, multiple levels of fractionation ensure that a complex sample is simplified 
well enough to capture even low abundance proteins.  However, another consequence of 
fractionation is that it produces many spectra, sometimes upward of one million or more, 
requiring automated computational methods for analysis.  A diagram of the overall protocol is 
shown in Figure 1.3.  
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 Figure 1.3  Shotgun proteomics protocol.  This figure shows an example proteomics 
protocol from cells to a list of proteins inferred to be in the cells.  Proteins are 
optionally fractionated, then proteolyzed.  Peptides are fractionated in one or two 
dimensions, including HPLC which elutes directly into the mass spectrometer.  Peptide 
ions are isolated by mass and charge and fragmented, and their fragmentation patterns 
output to a computer.  Software programs then identify peptides and infer proteins. 
 
 
 
 
 
Peptide Identification  
Matching large numbers of spectra to peptide sequences in an automated manner requires 
having a database of all possible peptide sequences available for lookup.  The first protein 
databases that were made freely accessible were the Protein Identification Resource (PIR), 
established in 1984 (Sidman et al, 1988), and Swiss-Prot, established in 1986 (Bairoch and 
Boeckmann, 1991).  In 1993, an algorithm was described which compared amino acid sequences 
from a protein database to the fragmentation patterns from MS/MS (Mann et al, 1993), and the 
field of automated peptide identification began.  The principle behind the use of protein 
databases is that the protein sequences can be cleaved in silico at the peptide bond, allowing for 
missed cleavages, and that the computed mass of the in silico peptides will match that of the 
biological peptides.  From the peptide sequences it is, furthermore, possible to predict where the 
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peptides will be charged, fragmented, and post-translationally modified, which helps match 
possible peptides to the information on observed peptides contained in the spectra.   
Two peptide identification programs which were implemented in the 1990s are still the 
most commonly used today.  Sequest was the first to create a predicted pattern of MS/MS spectra 
for a given peptide, and compared this simplified spectra to observed MS/MS using a cross-
correlation algorithm (Eng et al, 1994).  In addition to the cross-correlation score (XCorr), 
Sequest also reported other useful scores, including rank of score per peptide (RSP), and the 
percent of ions matched.   A second program, called Mascot, evaluates the probability that a 
particular peptide sequence could have produced fragment ion m/z values observed in an MS/MS 
spectra, based on all fragment ions predicted from all peptides in the database (Perkins et al, 
1999).  Other approaches to peptide identification have been reported and new methods continue 
to be developed (many are described in Sadygov et al, 2004), but Sequest and Mascot are still 
the most popular.   
It has become commonplace for peptide identification software to report a single score as 
a measure of the quality of the peptide spectrum match.  A single score is intuitively a good idea 
because it simplifies the analysis, but since the scores from all MS/MS typically lie along a 
continuum, this requires drawing a threshold to separate identifications which are believed to be 
correct from those believed to be incorrect. The most common way to determine this threshold is 
to repeat the search of the MS/MS against a database of peptide sequences which are derived 
from randomized or inverted protein sequences, and where all peptide sequences are incorrect 
(Moore et al, 2002), the presumption being that a peptide identified with a score higher than the 
highest randomly found match will be correct.  However, as shown in Figure 1.4 (with closed 
symbols), the distribution of scores is almost always bimodal, regardless of the peptide 
5 
 
identification software used, make it difficult to draw a single threshold.  When the threshold is 
set too high, many correct identifications will be rejected (false negatives), while when setting 
the threshold too low, many incorrect identifications would be accepted (false positives).       
 
Figure 1.4   Distribution of peptide identification scores.  Sequest 
cross-correlation scores for MS/MS spectra are shown as produced when 
searched against a protein database (closed symbols) or against a 
sequence-inverted protein database (open symbols).  
 
 
PeptideProphet is a program developed for peptide validation which dealt with this bimodal 
distribution by using curve fitting software to identify the two peaks and converting each score into 
a probability by dividing the number of spectra under the positive peak by the total number of 
spectra at that score (Keller, 2002).  While this method worked well for large datasets and highly 
discriminant scoring methods, it could be imprecise when the peak representing the positive class 
was not well modeled (i.e., it extends further under the class negative peak than expected).   
Our lab dealt with the bimodal distribution using an alternative strategy, by filtering out 
peptide identifications that were clearly bad.  To do this, I implemented MSPlus, software which 
allowed users to specify a number of physical and chemical characteristics in order to assess the 
quality of each MS/MS spectrum, the peptide sequence, and the match between them.  Spectral 
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quality was assessed by computing the standard deviation of intensities of the spectral peaks, 
where spectra containing few product ions and high noise showed low standard deviations and 
were rejected.  Peptide sequences were also rejected when they consisted of few amino acid 
residues or were less than 8 amino acids in length, because very small peptides were more 
frequently misidentified.  A close look at peptides identified from numerous experiments led to 
the development of a missed cleavage filter (Yen et al, 2006), to remove peptides with 
improbable missed cleavages; this became integrated into MSPlus.  Finally, we assessed matches 
based on the physicochemical properties of peptides.  For instance, we required that peptide 
sequences contained the types and numbers of amino acid residues that would be consistent with 
the observed charge state reported for each ion.  We required a high percentage of observed 
fragment peaks in each spectrum to be accounted for by the expected fragmentation products of a 
matched peptide.  We also used information about the chromatographic separations to inform the 
peptide assignment.  If, for instance, a sample had been fractionated by SCX, then peptides were 
required to have a number of basic residues consistent with its elution in a particular region of 
the salt gradient.  Other filters evaluated hydrophobicity (eliminating those with amino acid 
composition inconsistent with the reverse phase elution), and protein mass in samples separated 
by size exclusion chromatography.  As shown in Figure 1.5, application of these filters decreased 
the number of false identifications. 
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Figure 1.5  MSPlus filters remove false positive assignments. Distribution 
of Sequest cross correlation (XCorr) scores for all identified MS/MS from a 
proteomics experiment.  The top curve shows scores as they were produced 
by Sequest.  All curves underneath show that as filters are applied, low 
scoring peptide spectrum matches are filtered out.    
 
 
In addition to removing poor peptide spectrum matches, MSPlus also aimed to recover 
false negative peptide identifications, which were correct but had scores below threshold and were 
initially rejected.  Because different peptide identification programs used complementary methods, 
we found that the likelihood that a peptide match was correct increased when they were identified 
by more than one program, even when the scores were low.  When there was no consensus 
between programs, we required high thresholds, but when consensus was reached, we accepted 
lower scores, which were established and validated using extensive manual analysis.  Using 
consensus between programs as a criterion for peptide identification was well received in the field 
(Kapp et al, 2005), and led to development of a commercial product (Searle et al, 2008).   
Perhaps the most promising improvement in peptide identification comes from the 
introduction of more accurate theoretical spectra.  Using a kinetic model for peptide fragmentation, 
it is possible to model the chemistry of collision induced dissociation in the gas phase, and from 
this construct theoretical spectra which predict fragment ion intensities as well as m/z (Zhang, 
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2004; Zhang 2005).  These theoretical spectra are vastly more informative than the simplified 
models used by Sequest which consider fewer fragment ions, and they allow for improved 
discrimination when compared to observed spectra.  Our lab used these more advanced theoretical 
spectra to score MS/MS matches, and used these scores within MSPlus to further validate Sequest 
and Mascot identifications (Sun et al, 2007).  Since then we have developed peptide identification 
software independent from Sequest and Mascot (Yen et al, 2011). 
Peptide identification is discussed in greater detail in Chapter 2, a published paper, in 
which my work on MSPlus is described. 
 
Protein Inference  
In the analysis of proteomics experiments, it is not enough to have confidently identified 
peptides, because matching peptides to proteins introduces ambiguities when a peptide sequence 
is found in more than one protein.  Different types of situations are shown in Figure 1.6, which 
uses real examples from a proteomics analysis of a human melanoma cell line.  Peptides LDL... 
and MNC... are proteolytic products derived from a single protein in the protein database 
(“Protein 1”), and there is no ambiguity that Protein 1 is present in the sample based on the 
peptide evidence (Figure 1.6a).  However, peptide IQD... can be proteolytically derived from two 
proteins, Protein 2 and Protein 3, therefore it is unclear from the peptide evidence whether only 
one protein or both proteins are present in the sample (Figure 1.6b).  Because peptide FTN... is 
only derivable from Protein 2, the simplest explanation is that only Protein 2 is present, because 
it accounts for both peptides IQD... and FTN....  However, it would be prudent to retain the 
information that Protein 3 may also be present, should a different dataset contain a peptide which 
uniquely specifies Protein 3.  The ambiguity of deciding which of many proteins should be 
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reported from a proteomics experiment is called the “protein inference problem” (Nesvizhskii 
and Aebersold, 2005).   
 
 
Figure 1.6  Distinct vs. shared peptides.  a. Peptides LDL... and MNC... are 
proteolytic products of a single protein in the database.  b. Peptide FTN... can only have 
come from one protein, but peptide IQD... could have derived from two proteins, and it 
is not clear which protein to report in the proteomics output.  
 
 
 
Shared peptides are very common in mammalian proteomes, accounting for nearly two-
thirds of validated peptides.  They exist because of splice variants, gene duplication events, and 
post-translational events such as proteolytic truncations.  They may also exist because of protein 
database errors, such as protein redundancy and sequencing errors.  How many shared peptides 
are possible depends on the allowable minimum peptide length.  The percent of shared peptides 
in the IPI protein database remains constant at about 50% when the allowable length is 8 amino 
acids or higher.  However, as peptides shorter than 8 amino acids are allowed, the percentage of 
shared peptides rapidly rises, up to 80% for peptides of length 4 amino acids.  
Initially, peptide identification programs just assigned proteins as an afterthought.  As 
result, proteins selected from among multiple possibilities were reported inconsistently, leading 
to an over-reporting of proteins.  As the problem was recognized, it became clear that by 
considering all of the identified peptides at the same time, it would be possible to come up with a 
minimum set of most likely proteins.  This led to the implementation of several protein inference 
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programs, some of which reported the proteins which accounted for the greatest number of 
peptides, such as DTASelect (Tabb et al, 2002) and DBParser (Yang et al, 2004), while others 
used probability based models such as ProteinProphet (Nesvizhskii et al, 2003) and IDPicker 
(Zhang et al, 2007).  These programs, and several others, reported what they deemed to be the 
most likely proteins to be present in a proteomics sample (“primary proteins”), in contrast to less 
likely proteins (“secondary proteins”) which were sometimes not even reported.    
We identified two major shortcomings in protein inference programs:  peptide 
redundancy and protein volatility, both of which arise from the protein-centric manner used by 
these programs.  A protein-centric strategy maps validated peptides against a protein database, 
and presents its output in terms of proteins identified (Figure 1.7a).  In the case where peptides 
are shared between two or more primary proteins, e.g., peptide_b and peptide_c, these peptides 
are redundantly copied to each protein from which they can derive.  We found this replication 
misleading in that it seemed to show more support for each protein than actually existed, proteins 
which were, furthermore, often found at vastly different locations within the protein profile 
output.  We realized that by grouping proteins together that had peptides in common, we were 
able to avoid redundant replication of peptides, and furthermore found that the proteins that were 
grouped in this way were nearly always related to each other.  We called this alternative 
presentation a “peptide-centric” strategy (Figure 1.7b).   
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Figure 1.7 Protein-centric vs. peptide-centric strategy.  a. In a conventional 
protein-centric approach, observed peptides are searched within a protein 
sequence database.  Protein-centric protein groups replicate peptides when those 
peptides are found in more than one protein.  b. In the peptide-centric approach, a 
database consisting of non-redundant peptide sequences is generated from a 
protein sequence database, where each peptide is matched to all proteins 
containing the peptide sequence.  Observed peptides are matched one-to-one 
against the list of non-redundant peptide sequences in the database.  This allows 
easy clustering of protein groups which share peptides in common.   
 
Our second frustration with existing protein inference programs came from protein 
volatility, the idea that inferred proteins are anything but stable.  Proteins are inferred by a set of 
peptides, and as the peptides vary, so do the proteins.  Because of the stochastic nature of data 
collection by mass spectrometers, it is common to find that identified peptides are not completely 
overlapping between technical replicates of the same sample.  Using datasets of technical 
replicates, we were able to see how small differences between identified peptides were 
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exacerbated into larger differences between proteins identified in the replicate runs, as shown in 
Figure 1.8. 
 
 
 
 
 
Figure 1.8  Protein volatility.  Technical replicate runs resulted in overlapping, but 
slightly different sets of peptides.  This, in turn, led to differences in proteins inferred 
for each replicate run. 
Our solution to the problem of protein volatility was to construct protein groups using all 
peptides derived from an in silico digest of a protein database, not only from the peptides which 
were detected from MS/MS.  We found that the MS/MS derived (MSD) protein groups were a 
strict subset of the in silico derived (ISD) protein groups, making it easy to map from unstable 
proteins (and MSD protein groups) to highly stable ISD protein groups.  By doing so, we were 
able to obtain a more reliable method by which to compare proteomics results between 
experiments.   
My Ph.D. research addressed and solved current problems in shotgun proteomics, in 
order to facilitate automated analysis of large scale LC-MS/MS datasets.  In Chapter 2 of this 
thesis, I will present the development of MSPlus, a computational algorithm to help solve the 
problem of evaluating the correctness of peptide sequence assignments based on peptide 
physicochemical properties, and the results of testing and validating the algorithm.  This work 
was published in 2004 in Analytical Chemistry.  In Chapter 3, I will describe IsoformResolver, a 
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computational algorithm to solve the protein inference problem using a novel peptide-centric 
database strategy, the results of my experiments evaluating main contributors to protein 
volatility, and metrics for IsoformResolver’s performance compared to other protein inference 
programs.  A manuscript on this study is under review after revision in the Journal of Proteome 
Research.  Finally, in Chapter 4, I will end the thesis with a summary of my thesis work and 
show how IsoformResolver can be used to answer important questions that remain for future 
investigations – are our proteomic methods going deep enough to provide a global view into the 
proteome, what are relative protein abundances in cells with regard to protein classes, are we 
close to identifying biomarkers – asking, in other words, what we can conclude about the results 
from large-scale proteomics experiments.  
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CHAPTER II 
 
IMPROVING REPRODUCIBILITY AND SENSITIVITY IN IDENTIFYING HUMAN 
PROTEINS BY SHOTGUN PROTEOMICS 
 
 
Published 2004 in Anal. Chem. 76, 3556-68.  Resing, K.A., Meyer-Arendt, K., Mendoza, A.M., Aveline-
Wolf, L.D., Jonscher, K.R., Pierce, K.G., Old, W.M., Cheung, H.T., Russell, S., Wattawa, J.L., Goehle, 
G.R., Knight, R.D., and Ahn, N.G.  
 
 
INTRODUCTION 
 
Profiling expressed proteins in a cell type (the proteome) is now possible through the 
convergence of genome sequencing, automated data acquisition by mass spectrometry (MS), and 
database search programs.  One approach, called shotgun proteomics, involves proteolysis of the 
proteins in a sample, then sequencing peptides by MS fragmentation (MS/MS)  (McCormack et 
al, 1997).  Charge competition between peptides during ionization and limitations in MS 
sensitivity, dynamic range, and data collection rate require prior peptide fractionation.  A major 
advance was the introduction of a multidimensional chromatography approach, where peptides 
are separated first by strong cation exchange (SCX) chromatography, then by reversed phase 
chromatography (Link et al, 1999), coupling the reverse phase column to a mass spectrometer 
(LC/MS), so that thousands of sequencing spectra can be collected in a few hours.  To identify 
peptides, each MS/MS spectrum is compared against theoretical spectra of candidate peptide 
sequences represented in a protein database, and a score is assigned to rank the most likely 
peptide assignments (Eng et al, 1994).  However, current scoring methods are poor at 
distinguishing correct from incorrect sequence assignments, leading to high false positive and 
false negative rates (MacCoss et al, 2002).  Consequently, protein identification is problematic 
when based on a small number of peptide assignments (Moore et al, 2002).  In such cases, 
peptide assignments are manually validated by visual inspection of each MS/MS spectrum.  This 
approach has been successful in characterizing the protein composition of organisms such as S. 
cerevisiae, where 25% of ORFs contained in the genome were observed (Washburn et al, 2001).   
Higher eukaryotes present a more difficult problem, because there are more proteins in 
their proteomes, the proteins are larger, and the protein concentration ranges are wider; 
consequently, more spectra must be collected to define the proteome composition.  Furthermore, 
because protein sequence databases are larger with more sequence redundancy, each spectrum 
must be compared against a larger number of candidates.  Manual analysis becomes a daunting 
task with substantial error; therefore, validation methods are needed that can be implemented 
computationally.  A robust solution to this problem has not been achieved, although recent 
reports used linear discriminant analysis (Keller et al, 2002) or machine learning algorithms 
(Anderson et al, 2003) to evaluate the scores generated by the Sequest search program, or used 
peptide properties other than the fragmentation pattern, such as exact mass measurements (Smith 
et al, 2002), to validate peptide assignments.  
Here we describe a novel programmatic approach to data analysis that significantly 
improves sensitivity and confidence in peptide assignments and protein representation.  Key 
features include (i) integrating results of two database search programs to increase detection 
sensitivity of correctly identified peptides, (ii) implementing new filtering criteria based on 
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peptide chemical properties to increase discrimination between correct vs. incorrect sequence 
assignments, (iii) focusing the search strategy to improve accuracy in sequence assignments, and 
(iv) developing a peptide-centric nomenclature for protein profiling to accurately report 
ambiguities in protein identification due to sequence redundancy in the database.   
 
METHODS 
 
Sample preparation   
The shotgun proteomics analyses were carried out on an extract of the erythroleukemia 
cell line K562 grown in suspension as previously described (Whalen et al, 1997). Cells were 
washed twice by centrifugation, and pellets were flash frozen in liquid nitrogen.  Cell pellets 
were suspended in lysis buffer (140 mM potassium phosphate, pH 7.4, 150 mM NaF, 1 mM 
Na3VO4, 6 mM EDTA, 6 mM EGTA, 250 mM NaCl, 4 mM DTT) containing  40 µg/ml 
leupeptin, 5 µg/ml pepstatin A, 4 mM benzamidine,  20 mM PMSF, and sonicated 4 x 15 s at 
4°C (Branson, microtip probe).  Lysates were centrifuged at 200,000 x g for 30 min at 4° C, and 
soluble proteins recovered in the supernatant.  Typically 108 cells yielded ~15 mg protein.  In 
this study, three different samples were analyzed (Table 2.1).  For Samples 1 and 2, proteins 
were alkylated with 14 mM iodoacetamide (Aldrich, Milwaukee, WI) for 30 min in the dark at 
room temperature.  Reactions were quenched by adding 3 mM DTT, and proteins were 
immediately desalted on a PD10 column (Amersham, Piscataway, NJ) equilibrated with 100 mM 
NH4HCO3, followed by trypsinization at 37° C with 3% (w/w) trypsin (Wako, Richmond, VA, 
Cat#20709891) added in 1% aliquots at t= 0, 4, and 12 h.  The NH4HCO3 was removed by 
repeated lyophilization and resuspension in water (usually 3 times) until the conductivity after  
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Table 2.1  Samples of soluble protein extracts from human K562 erythroleukemia cells. a
 
Sample 
and search method 
Number of 
DTAs b 
Number of 
peptides 
identified 
Number of 
unique 
peptides 
Number of 
proteins 
identified c 
Number of 
proteins identified 
by one peptide 
      
Sample 1:  16 SCX fractions of soluble lysates, analyzed with full mass range d
MSPlus, normal database e 2,117       856 (40%)          434          243          169 (69%) 
MSPlus, randomized database  2,117         33    
      
Sequest only, normal database f 2,117       680 (32%)          351          209          148 (71%) 
Sequest only, randomized database 2,117         22    
      
Mascot only, normal database g 2,117       702 (33%)          377          219          152 (69%) 
Mascot only, randomized database 2,117         27    
      
      
Sample 2:  11 SCX fractions, each analyzed in 10 gas phase fractions h
MSPlus, normal database e 47,598     8,190 (17%)        4,387       1,757          883 (50%) 
MSPlus, randomized database 47,598        259    
      
Sequest only, normal database f 47,598     5,804 (12%)        3,275       1,433          736 (51%) 
Sequest only, randomized database 47,598        181    
      
Mascot only, normal database g 47,598     5,173 (11%)        2,971       1,320          689 (52%) 
Mascot only, randomized database 47,598        162    
      
      
Sample 3:  7 gel filtration fractions  x 16 SCX fractions, each analyzed in 6 gas phase fractions i
MSPlus, normal database e 602,520   85,267 (14%)      20,675       5,130      2,323 (45%) 
Sequest only, normal database f 602,520   64,194 (11%)      15,217       4,120      1,790 (43%) 
Mascot only, normal database g 602,520   63,431 (11%)      16,006       3,971      1,683 (42%) 
  
a  Summary of samples described in this study, showing effects of varying sample fractionation by gel filtration and gas phase fractionation.   
b Number of MS/MS files with peptide mass between 900-4,800 Da. 
c Proteins counted after removing redundancies with Isoform Resolver (see text and Table 3). 
d  Soluble extracts (1 x 108 cells) were trypsinized and peptides separated into 16 fractions by SCX-HPLC.  6.3% of each fraction was analyzed by RP-LC/MS/MS, 
collecting data over a full ion mass range of 350-1,500.  Tables of validated peptide sequences and scores, and raw data files for Sample 1 are available upon request. 
e MSPlus protocol was carried out using the normal or randomized IPI database (April 10, 2003, 48,000 entries).  Acceptable assignments required peptide mass 
between 900 Da and 4,800 Da, up to two tryptic cleavages, no internal KK, KR, RR, or RK sequences, no covalent modifications, and either consensus between Sequest 
and Mascot or XCorr and Mowse scores above unequivocal thresholds (XCorr ≥2.55 (MH+1), 3.39 (MH2+2), and 3.78 (MH3+3); Mowse = 44 (MH+1), 49 (MH2+2), and 49 
(MH3+3)), ion ratio >25% (MH+1 or MH2+2) or >20% (MH3+3), RSP=1, and a number of basic residues consistent with the SCX fraction the peptide was in.   
f Sequest search protocol was carried out using the normal or randomized IPI database.  Acceptable assignments required XCorr values above a threshold that yielded 
the same ratio of the false positive assignments to the number of identified peptides (~3.4%) as MSPlus.  Sample 1:  XCorr = 2.56 (MH+1), 2.98 (MH2+2), and 3.0 
(MH3+3); Sample 2:  XCorr = 2.31 (MH+1), 2.75 (MH2+2), and 3.0 (MH3+3); Sample 3:  XCorr = 2.3 (MH+1), 2.7 (MH2+2), and 2.8 (MH3+3). 
  Mascot search protocol was carried out using the normal or randomized IPI database.  Acceptable assignments required XCorr values above a threshold that yielded the 
same ratio of the false positive assignments to the number of identified peptides (~3.4%) as MSPlus.  Sample 1: Mowse = 44 (MH+), 39.6 (MH2+2),  and 39.6 (MH3+3); 
Sample 2: Mowse = 44 (MH+), 47 (MH2+2), and 47 (MH3+3); Sample 3: Mowse = 44 (MH+), 44 (MH2+2), and 46 (MH3+3).
h  Soluble extracts (1 x 108 cells) were trypsinized and peptides separated into 11 fractions by SCX-HPLC.  7.5% of each fraction was used in separate RP-LC/MS/MS 
analyses of each of ten  overlapping narrow mass ranges:  300-558 Da, 550-678 Da, 670-798 Da, 790-918 Da, 910-1,038 Da, 1,030-1,158 Da, 1,150-1,278 Da, 1,270-
1,398 Da, 1,390-1,558 Da, 1,550-1,718 Da,  consuming 75% of the sample. 
i  Soluble extracts were separated by sizing gel exclusion chromatography into 13 fractions, with pool size based on UV profiles.  Nine of the gel filtration fractions (fx# 
1, 2, 3, 5, 7, 9, 11, 12, and 13) were trypsinized and peptides separated into 16 fractions by SCX-HPLC.  5% of each fraction was analyzed by RP-LC/MS/MS over a 
full mass range of 350-1,500 Da, and 15% of each fraction was analyzed over 6 overlapping mass ranges:  300-678, 670-798, 790-918, 910-1,038, 1,030-1,278, 1,270-
1,750. 
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dilution of 10 µl sample into 3 ml of water was less than 0.004 mho/cm.  Lyophilized peptides 
were dissolved in Buffer A (5 mM K2HPO4, 5% acetonitrile pH 4) and fractionated by HPLC 
using a SCX column (PolySulfoethyl A, 2.1 mm ID x 200 mm, Poly LC), equilibrated in Buffer 
A, and eluted using a gradient of increasing 0.5 M KCl in Buffer A.  For Sample 3, proteins were 
homogenized in lysis buffer on a gel filtration column (Sephacryl HR300 (26/60), Amersham) 
equilibrated in lysis buffer.  The column was run at 1.3 ml/min, collecting 8 mL fractions over 
the included volume.  Proteins in the pooled fractions were then alkylated with iodoacetamide, 
desalted into 100 mM NH4HCO3, digested, lyophilized and processed in the same manner as 
Samples 1 and 2.  Sample preparation was performed by Dr. Natalie Ahn. 
 
Data collection   
For Samples 1 and 2, aliquots of 5-20% of the total SCX fraction were loaded onto 250 
µm ID reversed-phase capillary columns fabricated in-house, using a frit made from a C18 
Empore Disk (3M, St. Paul, MN), inserting a 50 µm ID, 180 µm OD piece of tubing as an outlet, 
then joining the two pieces of tubing with epoxy glue (EPO-TEK; Epoxy Technology, Billerica, 
MA).  Columns were packed with Jupiter C18 resin (10 µm particle size; Phenomenex, Torrance, 
CA) using a bomb pressurized with helium gas at 100 – 400 psi.  A multi-stage gradient 
delivered by an Agilent 1100 Series HPLC (Agilent Technologies, Santa Clara, CA) was used to 
elute peptides into the electrospray ionization source of an LCQ Classic ion trap mass 
spectrometer (ThermoElectron, San Jose, CA).  Columns were loaded and washed in 0.1% 
formic acid (buffer A) at 10 µl/min.  For Sample 1, peptides were eluted with a gradient into 
Buffer B (70:30 acetonitrile:water + 0.1% formic acid) at 5 µl/min: 0 – 30% B in 30 min, 30 – 
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50% B in 10 min, 50 – 100% B in 10 min. For Samples 2 and 3, the gradient was 0 – 18% B in 
27 min, 18 – 27% B in 45 min, 27 – 50% B in 22 min, and 50 – 100% B in 7 min.   
The target value for the ion trap was 5 x 108 ions in full scan mode and 2 x 107 ions in 
MS/MS mode, and regularly reoptimized in concert with the electron multiplier voltage to 
enhance the mass spectrometer performance.  One full scan mass spectrum was acquired, then 
MS/MS spectra were acquired for the three most intense peaks in the MS spectrum, using a 
normalized collision energy of 34 units.  To ensure that the same high abundance ions were not 
continually analyzed, dynamic exclusion was set to exclude ion mass-to-charge ratios (m/z) from 
MS/MS after they were analyzed twice during a 90 s interval.  After 3 min, the m/z value was 
removed from the exclusion list.  The m/z scan range was either 350-1500 for full mass range, or 
a sequence of overlapping m/z ranges (gas phase fractionation) (Spahr et al, 2001; Yi et al, 
2002), as described in Table 2.1.  Data collection was performed by Lauren Aveline-Wolf and 
Kevin Pierce. 
  
Data collection  
DTA files were generated from the MS/MS spectra using TurboSequest, with intensity 
threshold=10,000, peptide mass tolerance=2.5 Da (average mass), allowed grouping of 1-5 
scans, and minimum ion count=35.  An in-house script concatenated DTA files into a Mascot 
Generic File for Mascot searches.  Mascot and Sequest searches were normally carried out 
allowing 2.5 Da (avg) peptide mass tolerance and 1.0 Da (avg) fragment ion mass tolerance.  
Static modification of Cys and tryptic cleavage were specified for the searches; because 
TurboSequest allows cleavages at KP or RP, the Pro cleavage trypsin setting was used for 
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Mascot.  One incomplete cleavage was allowed for TurboSequest and two incomplete cleavages 
for Mascot, using the IPI human protein database (http://www.ebi.ac.uk, version 2.18, updated 
April 10, 2003).  In analysis of oxidation or phosphorylation, database searches were carried out 
allowing variable modification of Met and Trp, or Ser, Thr, and Tyr, respectively.  The output 
files of Mascot were parsed into MYSQL using a modified version of DBParser (Yang et al, 
2003) (provided by Jeff Kowalak, NIH), then into an Oracle 9i database; Sequest results were 
parsed directly into the Oracle database using an in-house parser.  Workflow scripts were 
implemented by Alex Mendoza. 
Text files summarizing results were generated by SQL for input to in-house Perl scripts 
that applied filtering criteria (MSPlus), generated protein profiles (Isoform Resolver), and carried 
out spectral comparisons (CLASP).   MSPlus compares results of Sequest and Mascot searches, 
considering the two charge forms of multiply charged DTA files separately, and excludes or 
validates the assignments according to a set of rules.  The rules are applied in the following 
order:  (1) Exclude all assignments where (a) the observed MW is <900 Da, (b) the peptide 
length <8 amino acids long, (c) there is an internal KR, KK, RK, or RR sequence, (c) the number 
of basic residues is inconsistent with elution during SCX chromatography, or (d) the Sequest ion 
score is greater than or equal to 20% (+3) or 25% (+1 or +2).  (2) Validate any assignment 
scoring above threshold for Mowse or above threshold for XCorr where RSP=1 (we observed no 
cases in which Sequest and Mascot disagreed and both assignments were above threshold), as 
described in Results.  (3) Validate assignments scoring below thresholds when the following 
conditions are met: (a) Mascot and Sequest agree (peptide isoforms with 1 or 2 substitutions of 
K/Q/E, D/N/I/L, E/M, V/P, or V/T are considered identical by MSPlus; the choice of peptide 
isoform is made in Isoform Resolver, see below), (b) RSP=1, and (c) Sumscore is greater than or 
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equal to 3.5, where Sumscore = XCorr + Mowse/C [C is a normalization factor = 18 (+1), 15 
(+2), or 12 (+3), obtained by linear least squares fitting of XCorr vs. Mowse values for DTA files 
that have identical peptide assignments by Sequest and Mascot and at least one score above 
threshold].  (4) Resolve ambiguities regarding ion charge for DTA files (ambiguous multiply 
charged DTA files were searched assuming both +2 and +3 charge); in <2% of cases, both 
charge forms of a DTA were found in the validated list, and MSPlus chose the form with highest 
Sumscore. 
Isoform Resolver uses peptides validated by MSPlus to construct a protein profile.  For 
each peptide, protein accession numbers for all protein entries containing that peptide sequence 
replaces the accession number(s) assigned by the search program(s).  Then, peptides are grouped 
according to the protein variants in which they are present.  The minimum number of proteins 
that account for all peptides in each group are computed using a greedy algorithm.  Isoform 
Resolver also considers peptide isoforms containing one or two amino acid replacements that are 
often not distinguished by ion trap mass spectrometers (D/N/I/L, K/Q/E, E/M, V/T, or V/P).  If a 
peptide isoform is present which specifies more than one protein, all peptides are reported 
although only one protein is counted, favoring proteins that are supported by other peptide 
identifications; the other protein(s) and isoform peptides are reported in a separate list.   
CLASP performs a pairwise comparison of DTA files in order to identify those that are 
plausibly derived from identical or related peptide sequences.  First, DTA files are grouped by 
observed mass, normalized reverse phase elution time, and SCX elution (allowable ranges 
defined by user).   For each pair of DTA files, a similarity score is calculated as the percentage of 
fragment ions in common, using only the monoisotopic forms of each ion with mass tolerance of 
2.0 Da.  To reduce noise, CLASP only considers fragment ions with intensities greater than the 
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mean value of all fragment ion intensities plus 0.5 times the standard deviation.  The minimum 
acceptable similarity score is determined from cases in which one search program made an 
incorrect assignment due to distraction, while the other program made a correct assignment that 
scored below threshold, and therefore was not validated by MSPlus.  CLASP was used to 
identify cases of distraction (see Results), by comparing DTA assignments that MSPlus failed to 
validate, against DTA assignments that were validated by MSPlus.  DTA files of peptides that 
eluted within 90 scans of each other, eluted in the same or adjacent two SCX fractions, and had 
observed mass within 9 Da of predicted (to allow for error due to space charging) were scored 
for spectral similarity.  CLASP was also used to identify spectra of peptides that were modified 
by dehydration (-18 Da), deammoniation (-17 Da), Met/Trp oxidation (+16, +32 Da), or Met side 
chain β-elimination (-48 Da).  The nonvalidated spectra were compared against the validated 
spectra, allowing a mass difference appropriate to each case: –14 to –20 Da (dehydrated, 
deammoniated), +15 to +17 Da or +31 to +33 Da (Met/Trp oxidized), or –46 to –50 Da (Met β-
eliminated).  Sequences were checked to ensure the amino acid composition was appropriate for 
each modification.  A second search condition for oxidation used variable modification of Met or 
Trp, which allowed estimation of the number of cases in which the unmodified peptide was 
absent.  
Manual analysis was carried out by selecting a random subset of the data, and screened 
initially by an experienced analyst.  About one-third of spectra could be evaluated based on 
simple criteria as incorrectly assigned (more than three major ions were not identified) or 
correctly assigned (all ions with signal >10 times noise were identified, and chemically plausible 
cleavages C-terminal to Asp or N-terminal to Pro were observed, when present); the remainder 
were independently examined by a second analyst, who also evaluated internal fragment ions and 
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other types of fragment ions not considered by Mascot and Sequest, using Protein Prospector 
(http://prospector.ucsf.edu) to calculate the predicted ions.   Correct assignments required that 
the peptide sequence accounted for >95% of the fragment ion current above background.  Where 
necessary, the manual analysis includes a detailed assessment of chemical plausibility.  
Examples of manually analyzed spectra are shown in Appendix A.   
 
RESULTS AND DISCUSSION 
 
Characterizing the MS/MS dataset  
Experiments were carried out to determine the number of peptide assignments validated 
by conventional search methods.  Initial studies compared the effectiveness of two database 
search programs, Sequest (Eng et al, 1994) and Mascot (Perkins et al, 1999), in assigning 
sequences to MS/MS data collected on a tryptic digest of extracts from human K562 cells 
separated into 16 SCX fractions (Sample 1).  For searching, MS/MS data were summarized as 
text files (DTA files).  Two DTA files were generated for each multiply charged parent ion by 
assuming that the parent is either doubly or triply charged; in this discussion, these pairs are 
counted as one DTA file.  A commonly used approach for validation of search results is to accept 
all peptide assignments with scores above a certain threshold; this threshold is often determined 
by searching against a "randomized" protein database created by inverting each protein sequence 
contained in the normal database (Keller et al, 2002).  Fig. 2.1A shows the distributions of cross-
correlation (XCorr) scores for doubly charged ions of a dataset searched by Sequest against both 
the normal and randomized database.  When spectra are searched against randomized databases  
24 
 
I       II     III     IV I       II     III     IV I       II     III     IV
8
6
4
2
0
  I:  Randomized database
 II:  Normal database
III:  Protein standards
IV:  MSPlus method
B
C
charge:        +1                           +2                           +3
0 1 2 3 4 5
Number of repeats
100
80
60
40
20
0
120
TurboSequest
Mascot
MSPlus
0
50
100
200
250
300
0 1 2 3 4 5 6 7 8
    
A
                                                                        
XCorr
# 
D
TA
 fi
le
s
X
C
or
r
# 
pe
pt
id
e 
as
si
gn
m
en
ts
25
Figure 2.1.  Randomly determined peptide scores. Only half of peptide assignments have 
scores greater than randomly determined.  (A) Distribution of XCorr values for DTA files 
generated from Sample 1 illustrates the method used for determining thresholds from random-
ized database searches.  Shown are results of searching doubly charged ions (1,615 files) 
against a normal protein database (IPI version 2.18, April 10, 2003) (closed circles), or against a 
randomized database in which each protein sequence in the normal database was inverted (open 
symbols).  The highest score produced by chance in the randomized database search (XCorr = 
3.22, vertical line) indicates the threshold value for doubly charged ions, above which sequence 
assignments can be accepted with high confidence. The highest XCorr score in the normal 
search was 7.93. 
Figure 2.1. (continued) (B) Distribution of XCorr values for singly, doubly, and triply charged 
ions, searched using Sequest.  Box plots indicate median and quartile values (boxes), and 
highest and lowest scores (whiskers).  (I) DTA files from Sample 1 searched against the 
randomized database indicate thresholds of 2.56 (MH+), 3.22 (MH2+2) and 3.45 (MH3+3) 
(horizontal dotted lines).  (II) DTA files from Sample 1 searched against the normal IPI data-
base, where some assignments with scores below thresholds represent correct assignments.  (III) 
DTA files representing manually confirmed peptides from a set of 18 protein standards (Perkins 
et al, 1999) showed 46% of validated assignments with scores above thresholds from random-
ized searches.  (IV) DTA files from Sample 1 searched using MSPlus peptide sequences 
accepted as valid based on the combined method, showing improved discrimination from 
corresponding randomized database searches.  Thus, the validated peptides (set IV) are a subset 
of set I/II.  Parallel searches using Mascot indicated Mowse thresholds of 46 (MH+), 50 
(MH2+2), and 50 (MH3+3) for searches against a randomized database (not shown).  Manual 
analysis of a random subset of peptide assignments in (II) with scores above thresholds 
confirmed all Sequest and Mascot identifications as valid.  Similar improved discrimination was 
observed using MSPlus over the Mascot search alone with the normal database.  The number of 
DTA files in each experiment were: I and II (+1) 655, (+2) 1,462, (+3) 1,462;  III (+1) 66, (+2) 
201, (+3) 63;  IV (+1) 167, (+2) 589, (+3) 100.  (C) Repeated LC/MS/MS analyses of a single 
SCX fraction from Sample 3, searched with Sequest (circles) or Mascot (diamonds).  The 
number of unique peptide assignments with scores above thresholds determined from random-
ized searches (see Panel B) was determined for each of the five analyses.  The number of 
unique peptide assignments within 5 combinations of one dataset, 10 combinations of two 
datasets, 10 combinations of 3 datasets, 5 combinations of 4 datasets, and one combination of 5 
datasets is shown, where each data point represents one combination.  The results show that the 
number of unique peptide assignments when considering one dataset (57 for Sequest, 50 for 
Mascot) increases when considering all five datasets (109 for Sequest, 95 for Mascot), indicat-
ing that about twice as many peptides are identifiable in repeated experiments.  In contrast, the 
number of peptide assignments captured by MSPlus in each individual analysis (triangles) was 
comparable to the number seen in aggregate by Sequest or Mascot alone, demonstrating greater 
sensitivity in validating assignments.  Likewise, the number of proteins in each MSPlus analysis 
showed 92% overlap with proteins identified from 5 aggregate datasets by Sequest.
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with Sequest, the XCorr distribution peaks at low values and falls to zero at a threshold value 
that determines the highest scores obtained by chance.  In a normal search of similar database 
size, peptide assignments with scores above this threshold have a very high probability of being 
correct (MacCoss et al, 2002; Keller et al, 2002).  Threshold XCorr values of 2.56, 3.22, and 
3.45 for MH1+1, MH2+2, and MH3+3 ion charge states, respectively, were determined from 
searching a randomized IPI database using Sequest (Fig. 2.1B, Set I).  When searched by Sequest 
against a normal database (Fig. 2.1B, Set II), only 523 (25%) of 2,117 DTA files generated from 
Sample 1 showed XCorr values above these thresholds.  The presence of incorrect spectra in the 
normal searches is revealed by the large peak centered about XCorr ~2 (Fig. 2.1A).  Similar 
results were obtained using Mascot and evaluating Mowse score thresholds (data not shown).  
It is known that many valid peptide assignments yield scores below threshold (MacCoss 
et al, 2002; Keller et al, 2002); therefore, we next estimated the maximum number of peptides 
that should be identifiable in a given MS/MS dataset, regardless of score.  This was assessed in 
three ways.  First, 18 standard proteins (Keller et al, 2002) were digested using trypsin, and 
peptide spectra acquired during the LC/MS/MS analyses were manually validated to determine 
correct identifications.  Analyzed by Sequest, 54% of the validated peptide assignments for this 
set scored below the thresholds determined by the randomized database (Fig 2.1B, Set III).  
Applying this estimate from the standards to Sample 1, where there are 523 DTA files with 
XCorr scores above threshold, predicts that an additional ~614 DTA files with scores below 
threshold should be identifiable, and ~1,137 of the 2,117 DTA files should represent identifiable 
tryptic peptides in this dataset (class positive).  Thus, an estimated 980 DTA files cannot be 
identified by this search protocol (class negative).   
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A second way to estimate the number in the class positive is based on the understanding 
that shotgun proteomics involves population sampling and that stochastic processes lead to low 
scores and incorrect assignments.  Therefore, repeated analysis should eventually allow all of the 
identifiable peptides to score above threshold.  Indeed, in replicate analyses, the number of 
unique peptide assignments above threshold increased by 2-fold after extrapolating to an 
endpoint (Fig. 2.1C).  This approach predicted that at least 1,046 of the total DTA files should be 
assignable to tryptic peptides, similar to the 1,137 estimated by the first method.   
The third method estimated the number of class negative DTA files from combined 
results of several experiments, which showed that ~43% of DTA files in Sample 1 represented 
artifacts such as oxidation during sample handling, in-source fragmentation during MS, ions too 
weak for search programs to assign correctly, incorrectly made DTA files, or false positives (for 
more detailed discussion, see below).  Only 66 DTA files were not explained, and these may 
represent nonpeptide ions, salt adducts, or other peptide modifications.  This is further evidence 
that ~54% of DTA files would be expected as class positive.  Overall, the three approaches 
suggest that 50-60% of DTA files should be assignable to tryptic peptides in Sample 1.  Of these, 
less than half can be validated based on having scores above thresholds.  The rest are "hidden" 
due to their failure to be validated using a threshold approach.   
 
Combining Sequest and Mascot improves validation of peptide assignments  
We then looked for ways to identify and validate these low scoring peptide assignments.  
In studies comparing search programs, we found that a given peptide assignment might obtain a 
high score with one search program and a low score with another search program, presumably 
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due to variations in the scoring algorithm between programs (Fig. 2.2A).  We utilized parsers to 
capture Mascot and Sequest outputs into a database, and wrote a script (MSPlus) that allowed 
easy comparison of results from Sequest and Mascot programs.  Thus, in Sample 1, 7.5% of 
Sequest assignments with subthreshold XCorr scores were validated when Mascot assignments 
of the same DTA files showed Mowse scores above threshold.  Another important class included 
cases where both search programs made the same sequence assignment, although both XCorr 
and Mowse scores were below threshold.  However, manual analysis indicated that only half in 
this class were correctly assigned; therefore, a filtering protocol was implemented in MSPlus to 
discriminate between correct vs. incorrect assignments.  
Filters tested included the Sequest scores SP and RSP (preliminary score and ranked 
preliminary score, where SP is the sum of the matched b and y fragment ions together with 
adjustment factors for matching consecutive ions in a series), ion ratio (percent of theoretical 
fragment ions observed in a spectrum), and ΔCN (difference in XCorr between the first and 
second highest ranking sequence assignments) (Eng et al, 1994; Yates et al, 1995).  Examination 
of manually validated data revealed that 97% of correctly assigned sequences had RSP=1, all 
singly or doubly charged ions had ion ratio >25%, and 95% of triply charged ions had ion ratio 
>20%.  SP and ΔCN provided insufficient discrimination, possibly because of the large size and 
sequence redundancy of the human database, and were not used.  We also excluded peptides 
with mass less than 900 Da, because we found that the frequency of incorrect assignments due to 
distraction (see below) was greater with small peptides.  This was not a serious limitation, 
because peptides smaller than 9 amino acids were not generally useful for uniquely specifying 
proteins.  Also excluded were assignments with internal KR, RK, KK, or RR sequences, where 
trypsin would cleave efficiently.   
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Figure 2.2.  Combining Sequest and Mascot results to validate more DTA files.   (A)  Com-
parison of XCorr vs Mowse scores for DTA files in Sample 1, in which both Sequest and 
Mascot identified the same peptide sequence.  Thresholds for different charge states determined 
from randomized database searches (Fig. 1B) are indicated by lines.  The results show a signifi-
cant number of DTA files scoring above threshold for one program but not the other, which 
reveals that the two programs have overlapping but nonidentical scoring criteria. (B)  Summary 
of DTA file classifications from Sample 1.   The number of class positive assignments was 
estimated by extrapolating the number of DTA files for standard peptides above Sequest thresh-
olds (1,137 = 46% of 2,117); the number of class negatives (980) was obtained by subtracting 
class positives from the total number of DTA files (980 = 2,117-1,137).  The number of Sequest 
assignments scoring above threshold was 523.  The number of assignments made by MSPlus 
was 856 (Table 1), which included Sequest assignments scoring above threshold (Validated by 
Sequest = 523), and false positive assignments (FP = 33) estimated by searching against the 
randomized database.  
Figure 2.2.  (continued)  By difference, ~300 additional assignments were validated by MSPlus.  
False negative assignments (FN = 101) were estimated by manual analysis, as described in the 
text.   The distracted class (Distracted = 210) is estimated from DTA files that were incorrectly 
assigned by Sequest, but identifiable by CLASP, as described in the text.   Other classifications 
in Sample 1, estimated by direct counting, included: (i) 332 DTA files with weak ions or poor 
fragmentation (threshold defined by the lowest signal to noise for fragment ions in DTA files 
that were manually validated), (ii) 50 post-translationally modified peptides, e.g., containing 
oxidation products of methionine or tryptophan (47 DTA files), phosphate (3 DTA files), or 
incomplete cysteine alkylation (none observed), (iii) 395 fragment ions or nonspecific proteoly-
sis products, identified by searching without specifying protease cleavage and extrapolating for 
false negatives and distracted cases (276 DTA files), or dehydrated/deammoniated fragment 
ions of parents identified using CLASP (119 DTA files), and (iv) 104 DTA errors.  DTA errors 
included (a) 3.5% of DTA files (74) representing ions of charge greater than or equal to 4 
(estimated by analyzing results from data collected with high resolution scans in order to iden-
tify the charge), (b) 0.9% of DTA files (19) representing singly charged ions misassigned as 
multiply charged ions, due to noise peaks in the MS/MS at masses greater than the parent ion 
(identified by the dehydrated fragment ions of the parents in a small dataset), (c) 0.5% DTA 
files (11) which represent incorrect combinations of MS/MS that are actually derived from 
different peptide ions (identified by manual analysis of those DTA files where more than one 
MS/MS spectrum was summed in order to enhance signal to noise, and the peptides were 
validated by MSPlus, and at least 35% of the fragment ions were unidentified).  After summing 
all classes, 66 remained with unknown classification (Unk).
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 An important filter criterion insured that the number of basic residues in the assigned 
sequence was consistent with the SCX column elution.  A set of rules was delineated from the 
SCX behavior of the high scoring peptides.  For example, only peptides with 1 basic residue 
were allowed in SCX fraction 4 through 8, and only peptides with 1 or 2 basic residues were 
allowed in fraction 9 (Fig. 2.3A and legend).  These criteria were highly discriminatory; in 
analyses with the randomized database, the SCX filter removed half of the false positives 
observed among MSPlus-validated peptides generated without the filter.  Fig. 2.3B shows that 
the SCX filter preferentially removed incorrectly assigned spectra that were concentrated in the 
peak between XCorr 0.8 - 3.2.  This figure also shows the effect of further applying the RSP =1 
filter as well as the complete set of filtering criteria.  Although the filters removed a few 
validated assignments, most of these peptides were captured in other fractions or from other 
DTA files.   
MSPlus is a heuristic or expert program that implements a set of pass/fail rules using all 
these criteria for acceptance/rejection of peptide assignments, as described in Methods.  After 
filtering the combined results of Sequest and Mascot searches using these criteria, MSPlus 
validated 854 DTA files (40% of the total DTA files) in Sample 1 (Table 2.1, Fig. 2.2B).  A 
second script (Isoform Resolver) assembled these peptide sequences into a protein profile, 
applying an additional filter for false positives due to sequence isoforms in the database and 
reporting the minimum protein profile that will account for the peptide data (discussed in detail 
below and in Methods).  MSPlus and Isoform Resolver were applied to the five repeated LC/MS 
analyses described in Fig. 2.1C (right panel) and compared to results obtained by the Sequest 
threshold approach.  Analyses of each individual LC/MS by MSPlus/Isoform Resolver yielded  
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Figure 2.3. Using SCX chromatography as an MSPlus filtering criterion.   (A) The number 
of basic residues (BR: Lys, Arg, His) in peptide sequences for DTA files that passed all 
MSPlus filters (excluding the SCX filter) are plotted vs their SCX fraction number.  Early 
eluting fractions primarily contain peptides with one basic residue, while later fractions 
contain peptides with multiple basic residues.  Rules were developed for each SCX chromato-
graphic run, because small variations were observed with column lot number and chromato-
graphic conditions.  The data shown represent one sizing gel fraction from Sample 3, where 
the SCX filter allowed (1) 1BR in fr# 48, (2) 1 or 2 BR for fr# 9, (3) 2 BR for fraction 10, (4) 2 
or 3 BR for fr# 1114, (5) 2, 3, or 4 BR for fr# 1520.(B) The effect on the XCorr distribution of 
MSPlus-validated DTA files is shown after sequentially applying the SCX rules derived from 
Panel A, the RSP =1 filter, and the remaining MSPlus filters.  Each filter removes large num-
bers of incorrect assignments, without affecting the high confidence assignments with XCorr 
>3.5.  A few DTA files with correct assignments were lost, however many were captured in 
adjacent SCX fractions.  Importantly, applying the SCX filter had little effect on the protein 
profile.  Thus, the SCX filter removed only 4 proteins in Sample 1, which in all cases were 
supported by only one peptide. 
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an average of 53 proteins (S.D. 6), while combined analysis of the five datasets yielded 63 
proteins by the Sequest threshold.  Furthermore, an average of 92% (average 49, S.D. 2) of the 
proteins identified by MSPlus/Isoform Resolver in each dataset overlapped with the proteins 
identified by Sequest in the combined dataset.  This demonstrates that the MSPlus/Isoform 
Resolver algorithms greatly enhance data capture from complex datasets, improving sensitivity 
of protein detection similar to that seen by collecting repeated datasets on the same sample.  
 
False Positives 
The accuracy of the filtering approach was tested by assessing the frequency of false 
positives (FP = peptides validated by MSPlus, but judged incorrect by manual analysis).  First, 
540 peptide assignments were randomly selected for manual analysis from the Sample 1 output, 
half of which were accepted and the other half of which were rejected by the MSPlus script, then 
results were extrapolated to the full dataset.  The manual analysis indicated ~3.4% of the peptide 
assignments validated by MSPlus were incorrect.  Note that this frequency represents the 
percentage of false positives normalized to the number of MSPlus validated assignments, rather 
than the statistical false positive rate. 
Second, the number of false positives was estimated by searching datasets against the 
randomized database, where any identification is by definition incorrect.   These searches yielded 
false positive frequencies of 3.9%, 3.2%, and 3.9% for Sample 1, Sample 2, and a dataset of two 
gel filtration fractions from Sample 3, respectively.  (Samples are described in Methods and in 
Table 2.1.)  Thus, the independent measurements were in good agreement with results from 
manual analysis.  
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The randomized database does not survey false positives due to peptide isoforms.  For 
example, the presence of peptides with amino acid replacements that are often indistinguishable 
by ion trap mass spectrometers (D/N/I/L, K/Q/E, E/M, V/T, or V/P) may introduce false positive 
assignments.  Many of these were detected and removed by Isoform Resolver (see below), which 
ensures that the protein count is not inflated by the presence of peptide isoforms.  However, in 
the Sample 1 dataset, we did observe three cases in which two or more amino acid changes 
occurred that did not alter the peptide mass (such as QS to NT).  Therefore, we estimate that the 
peptide false positive frequency is approximately 4.2%.  This value is consistent with 
reproducibility studies discussed below. 
 
False negatives and incorrect assignments 
An important goal was to minimize the number of false negative validations (FN = 
peptides failing the MSPlus/Isoform Resolver filters, but presumably correctly assigned by 
Sequest).  We initially assumed 314 false negative assignments from the number of class 
positives (1,137) minus the number of MSPlus-validated DTA file assignments (856), excluding 
the false positives (33).  However, manual analysis of 540 spectra showed that 8% of DTA files 
that MSPlus rejected were correctly assigned.  This indicated that there were only ~101 false 
negative assignments out of the 1,261 DTA files that MSPlus rejected, leaving 213 of the class 
positives unaccounted for.  Therefore, we considered the possibility that many DTA files were 
identifiable, but incorrectly assigned by the search programs (referred to as “distracted”).  Such 
occurrences were clearly revealed in cases where Sequest and Mascot assigned different 
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sequences to a DTA file, only one of which was validated based on scoring and manual analysis 
(Table 2.2). 
To estimate the number of incorrect assignments due to distraction, a cluster analysis of 
spectra (CLASP) program was developed that directly compares MS/MS spectra, scoring for 
similarities in fragmentation patterns, parent ion mass, and reverse phase and SCX 
chromatographic behavior (Meyer-Arendt et al).  The 1,261 DTA files that failed the filtering 
criteria in Sample 1 were compared against the 856 DTA files that passed.  CLASP identified 
175 additional DTA assignments with spectral similarity to previously validated peptides.   Of 
these, 57 were correctly assigned, but failed the filtering criteria (false negatives), and 118 were 
incorrectly assigned by Sequest and/or Mascot.  These values represent underestimates, because 
some identifiable peptides failed the CLASP criteria, and because CLASP can only identify 
cases where a peptide is sequenced more than once (and at least one case is validated).  
Therefore, we extrapolated from the ratio of the number of validated peptides observed multiple 
times to the number of peptides observed once (1.27:1).  This ratio was measured by direct 
counting and was similar between three datasets of similar size taken on samples of similar 
complexity.  Correcting for the total peptide number yielded 103 FN assignments, comparable to 
the 101 FN determined independently from manual analysis.  From this, we estimated that ~311 
identifiable assignments failed the MSPlus criteria, which included ~101 false negative 
assignments and ~210 DTA files incorrectly assigned by Sequest (~176 incorrect assignments by 
Mascot; some were incorrectly assigned by both search programs).  The sum of all the 
identifiable peptides (excluding 33 false positives), distracted assignments, and false negatives 
was 1,134 (55%), in good agreement with our initial predictions of 1,046-1,137 (summarized in 
Fig 2.2B).   
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Table 2.2  Examples illustrating "distraction" by Sequest and Mascot, in which correct sequence assignments are 
replaced by incorrect assignments as the database size increases. a
Database Size First Sequest Assignment XCorr RSP First Mascot Assignment Mowse Second Mascot Assignment Mowse f
Example 1
Restricted database b AIGTEPDSDVLSEIMHSFAK 1.98 1 AIGTEPDSDVLSEIMHSFAK 39.5 VGLPPGKAAAKASESSSSEESR 6.3 
IPI database c AIGTEPDSDVLSEIMHSFAK 1.98 1 AIGTEPDSDVLSEIMHSFAK 39.5 DVKEFKPESSLTTLKAPEK 25.8 
IPI, No protease d AIGTEPDSDVLSEIMHSFAK 1.98 422 e TTIGAAGLPGRDGLPGPPGPPGPP g 40.0 AIGTEPDSDVLSEIMHSFAK 39.5 
Example 2
Restricted database b EGLELPEDEEEK 2.00 1 EGLELPEDEEEK 50.4 EQVNELKEKGNK 17.1 
IPI database c EGLELPEDEEEK 2.00 1 EGLELPEDEEEK 50.4 GDQGIAGFPGSPGEK 36.1 
IPI, No protease d EGIELLLNEGSEL g 2.23 2 EGLELPEDEEEK 50.4 EGNLKKFQPDLK 48.0 
Example 3
Restricted database b GDAMIMEETGK 0.74 1 GDAMIMEETGK 41.4 DGDKQRYLGK 10.8 
IPI database c YPILFLTQGK g 1.11 1 GDAMIMEETGK 41.4 TAPFFKQGRK 22.7 
IPI, No protease d AVYVEMLQIL g 1.34 12 GIMAIEMVEGE g 43.9 GDAMIMEETGK 41.4 
Example 4
Restricted database b DLSLEEIQK 1.15 1 DLSLEEIQK 25.2 EQEVAELKK 13.1 
IPI database c DLSLKEIQK 1.64 11 IDCEAPLKK  g 27.7 DSLKGGGALEK 25.7 
IPI, No protease d NSQVKELKQ g 1.53 243 ALASQSAGITGV g 31.5 ILTLDEGGSAP 31.4 
a  Datafiles were from Sample 1,  where correct sequence assignments were confirmed by manual inspection and are underlined.  286 out of 856 validated DTA files showed distraction in one or both search 
programs.  None of the distracted assignments shown here were caused by error in observed molecular mass.  The spectra and manual evaluations are shown in Supplementary Data, Fig. 1. 
b The normal search protocol was carried out using a restricted database of 644 proteins, containing the 243 proteins and possible variants observed in Sample 1.  
c The normal search protocol was carried out with the IPI database (47,306 entries), specifying peptide mass range 900-4,800 Da and up to two trypsin cleavages.   
d The normal search protocol was carried out with the IPI database, specifying peptide mass range 900-4,800 Da, and no protease cleavage specificity.  Removing protease specificity increased the effective 
database size by ~10-fold.   
e Note the very large increase in RSP value; ~20% of the peptides validated by the normal search failed the RSP filter of MSPlus when the database size was increased by removing protease specificity.  
f The scores for the second Mascot assignment showed a systematic increase with database size; this was also observed in scores resulting from searches against the IPI database randomized by sequence inversion.   
g Upon searching a larger database, the correct sequence assignment was replaced by an incorrect assignment with higher score, revealing distraction. 
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Note that the distracted class is false negative for the search program, but true negative 
for MSPlus.  Therefore, the correct class positive size for MSPlus is 101+300+523 = 924 (Fig. 
2.2B), so that the statistical FN rate is 10.9% (101/924); presumably, if distraction could be 
avoided, MSPlus could validate up to 89% of the ~210 incorrect, but identifiable assignments.  
When Sequest or Mascot thresholds were set to yield the same percentage of false positives as 
observed with MSPlus, their FN rates were 42% or 41%, respectively; thus, the 11% FN rate 
from MSPlus represents a significant improvement.   
We evaluated possible causes for incorrect assignments.  A major cause seems to be the 
presence of "extraneous" fragment ions not considered by the search programs; these will lower 
the XCorr or Mowse scores for the correct assignment and increase the probability of making an 
incorrect assignment.  These extraneous ions include sequence-specific a, b, or y ions not 
considered by the search programs (e.g., triply charged fragment ions) and internal fragment ions 
generated by multiple cleavages (for examples, see Appendix A).  Another source could be noise 
peaks that were not adequately removed from low intensity spectra by the search programs, and 
it might be thought that this is a major source of distraction.  However, comparison of the 
fragment ion intensities in distracted vs. validated spectra, showed that the distraction class was 
only slightly enriched for DTA files with weaker spectral intensities (Appendix B).  Most of the 
spectra with low intensities and/or poor fragmentation were classified as class negatives, and 
were not a significant cause of distraction, because neither the search programs nor CLASP had a 
strong chance of identifying them.   
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Effect of Database Size   
Another important class of distracted assignments were those where the peptide mass 
shows significant error, sometimes as high as 9 Da (depending on the charge state of the peptide 
ion), even after minimizing space charging effects by optimizing the number of ions allowed into 
the trap (Cleven et al, 1994).  Because the mass tolerance in our search strategy was initially 
narrow, we varied the mass tolerance during searching in order to examine the number of 
validated peptide sequence assignments (i.e., with high XCorr values).  From 1.0 to 3.0 Da 
(average mass), 25% more assignments were validated (Fig. 2.4A), but above 3.0 Da there was 
no further gain from increasing mass tolerance.  Furthermore, the score distribution shifted to 
higher XCorr values after searching the randomized database with higher mass tolerances (data 
not shown), resulting in an increased percentage of scores below threshold.  This suggested that 
the frequency of incorrect assignments due to distraction increased as the mass tolerance was set 
to higher values, which we ascribe to an effective increase in database size due to the increased 
number of peptides that must be queried as the mass tolerance is increased.   
To more clearly demonstrate the effect of database size on distraction, searches were 
carried out under other conditions that altered the effective database size.  We decreased the 
effective size by 75-fold upon restricting the MSPlus/Isoform Resolver search to a database 
consisting of only the proteins identified in Sample 1 (644 proteins, including all possible 
variants, vs. the full database of 48,000 proteins).  We saw no increase in percentage FP when 
searching the randomized version of this database.  Alternatively, we increased the effective size 
~20-fold by not designating protease specificity.  Table 2.2 shows examples in which both 
Sequest and Mascot programs replaced correct sequence assignments with incorrect assignments, 
as the database size increased from (i) the restricted set, to (ii) the normal IPI database with 
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tryptic sites specified, to (iii) the IPI database with no protease specified.  (The spectra in these 
examples are shown in Appendix A)   Likewise, a histogram of XCorr distributions for Sample 1 
revealed significant increases in threshold scores as the database size increased (Fig. 2.4B).  
These results demonstrate that for spectra with low scores, better discrimination between correct 
vs. incorrect peptide assignments can be achieved by searching against the smallest possible 
database.  
These analyses suggested search strategies that would minimize the database size, and 
thus minimize the distraction effect as well as computational cost.  First, only fully tryptic 
products were considered in the searches with Sample 1.  When nontryptic products were 
considered, 147 DTA files with correct assignments in the tryptic search were assigned incorrect 
sequences in the nontryptic search, while 209 DTA files with lower scores in the tryptic search 
gave high scoring nontryptic sequences.  Of the 209 spectra, 84 yielded no new information, 
because they represented ions that coeluted with larger peptides that contained the same ion; 
thus, many nontryptic peptides appear to be fragment ions derived from in-source cleavage.  
More important was the number of unique peptides captured (56% of validated peptides are 
sampled multiple times).  When unique peptide assignments were considered, more information 
was lost (95 unique peptide assignments) than gained (62 unique peptide assignments) in 
allowing nontryptic searches.  Second, peptide modifications were excluded from the search.  
When covalently modified peptides were examined by searching for specific mass increases, 
unmodified forms of the same peptides were almost always present elsewhere in the dataset.  
Therefore, accounting for peptide modifications did not significantly increase the numbers of 
peptides and proteins identified, and for the purposes of accurate protein identification, including 
modified forms in the search procedure did not justify the increased computational cost.   
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Figure 2.4.  Distraction increases with database size.  (A) Increasing peptide mass tolerance 
provided only a small number of additional peptide assignments.  The combined dataset of five 
LC/MS/MS runs shown in Fig. 1C were searched with increasing mass tolerance, using average 
parent masses.  The number of high scoring peptide assignments increased by 24%, when mass 
tolerance was increased from 1 to 3 Da.  No further increase in high scoring peptides was seen 
above 3 Da, although manual analysis identified many files with mass inaccuracies up to 9 Da.  
(B) Increasing the effective database size during the search increased the scoring thresholds for 
unequivocal assignments, providing an explanation for increased distraction.  (squares) Search of 
data in Sample 1 using the IPI database (~48,000 proteins);  (circles) search using a restricted 
database (644 proteins, including proteins and isoforms identified by MSPlus); (triangles) search 
using the IPI database without limiting protease specificity, which increases the effective data-
base size by about 10-fold. 
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In contrast, we considered incompletely digested peptides and found many examples of 
high scoring, incompletely digested peptides with missed cleavages at K or R that were 
immediately adjacent to E or D (29 of 409 unique peptides), within two residues of the N- or C-
terminus (25 peptides), or within highly acidic sequences (15 peptides).  All were consistent with 
the known proteolytic specificity of trypsin (Hill et al, 1965).  We compared the number of 
peptides validated allowing one, two or three missed cleavages.  Allowing three missed 
cleavages significantly decreased the number of validated peptides, but no difference in number 
of validated assignments was observed when comparing one or two missed cleavages, although 
specific differences were observed between these cases.  Allowing one or two missed cleavage 
with both search programs yielded 406 unique peptide assignments in all cases; 15 additional 
peptides were observed by specifying one missed cleavage, reflecting increased capture due to 
reduced distraction; 16 additional peptides were observed by specifying two missed cleavages, 
reflecting increased capture of incomplete proteolytic products.  Using different parameters for 
incomplete proteolysis in each search program should minimize distraction with one program, 
while capturing more incomplete proteolytic products with the other.  Allowing one missed 
cleavage for Sequest and two missed cleavages for Mascot validated the 406 peptides along with 
25 additional peptides, all of which were found in the 31 (= 15 + 16) assigned in the first two 
experiments (the other 6 assignments lacked consensus for capture by MSPlus).  The best results 
were obtained by minimizing the effective database size by requiring tryptic cleavages at both N- 
and C-termini and excluding covalent modifications, while allowing one or two incomplete 
products using Sequest or Mascot, respectively. 
It is important to note that the distraction is more important for the low scoring 
assignments than for assignments with high, unequivocal scores.  The probability of distraction 
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for peptide assignments increases as the score falls below threshold values, because the chance 
that an incorrect peptide sequence will score higher than the correct assignment increases.  
Furthermore, the effectiveness of MSPlus was greater when large datasets were analyzed.  
Comparison of the number of unique peptides identified in Sample 1 vs. Samples 2 and 3 showed 
that MSPlus validated 18-20% more unique peptides than Sequest or Mascot in Sample 1, and 
25-35% more peptides in Samples 2 and 3.  We assume this is because we are differentially 
sampling a population of ions with complex fragmentation or lower intensity ions in the gas 
phase extraction; as discussed above, these will generally have lower scores, and will be 
disproportionately represented as MSPlus-validated peptides vs. those validated by the threshold 
approach. 
 
Constructing an accurate protein profile from peptide sequence information 
Assembling a protein report from validated peptide assignments is complicated by the 
large number of protein database entries containing redundant sequences.  Furthermore, Sequest 
and Mascot search programs may choose different protein entries when assigning peptides to 
proteins with redundant sequences, without reporting that the proteins are actually 
indistinguishable from the supporting peptide assignments.  Minimizing these ambiguities is 
essential for an accurate protein profile; however, it also is important to retain information about 
possible alternative isoforms.  Therefore, we did not rely on Sequest/Mascot-designated protein 
accession numbers.  Instead we developed a peptide-centric database that catalogues all unique 
peptide sequences in the human protein database, and reports proteins that are redundantly 
associated with each peptide sequence.  An “Isoform Resolver” algorithm was developed that 
links each peptide in the sample dataset to all protein database entries containing that peptide, 
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clusters peptides that are linked to the same set of accession numbers, and groups the clusters 
that contain one or more accession numbers in common (Table 2.3).  Finally, the minimal 
number of protein variants required to account for the observed peptides is determined.  The 
resulting numbering scheme specifies all possible protein isoforms for each observed peptide, 
and accurately reports whether the observed peptide(s) support a single protein vs. a set of 
possible variants.  Consequently, closely related proteins are adjacent to each other in the final 
report, which is helpful for characterizing the relative contribution of isoforms in our samples.   
In addition, validated peptide variants that are similar in mass due to amino acid 
replacements within the mass tolerance of the ion trap (D/N/I/L, K/Q/E, E/M, V/P, V/T), were 
treated as potentially redundant.  If a peptide specifies a protein supported by only that peptide, 
and a related peptide variant specifies a different protein, only one protein is counted (favoring 
the protein supported by the largest number of peptides), although all are recorded in the output.  
Application of Isoform Resolver revealed that sequence redundancy caused substantial 
overestimation of protein counts using conventional methods; for example, Sequest predicted 
309 proteins from 856 validated peptides in Sample 1, whereas detection of protein and peptide 
variants by Isoform Resolver reduced the protein count by 24%, to 243 proteins.  This reduction 
was slightly larger with larger datasets.   
 
Enhancing protein detection 
Finally, the combined approaches of examining consensus between search engines, 
applying filtering criteria based on peptide chemistry, and applying Isoform Resolver were used 
to analyze larger datasets.  To evaluate effects of varying experimental conditions on peptide and  
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Table 2.3  Isoform Resolver specifies protein variants from observed peptide sequences a
Protein Accession Number, Annotation                              Highest scores              Number of peptides observed
                                       
Reference 
No.b                 Peptide Sequence  c                XCorr Mowse Total  +1  +2  +3 
Example 1:  Only one open reading frame detected: 
725 IPI00045914,  NUCLEAR RECEPTOR TRANSCRIPTION COFACTOR 
725 AAPTPTPAPVPVPVPLPAPAPAPHGEAR 4.0 43 1 1
725 GNSSETSHSVPEAK 3.2 43 1 1
725 HLWVGNLPENVR 3.4 47 2 2
725 TYHPPAQLTHTQFPAASSVGLPSR 2.8 23 1 1
725 VDATRPEATTEVGPQIGVK 4.0 81 1 1
725 VLQPANLGSTLTPHHPPALPSK 2.3 48 1 1
Example 2:  Two isoforms that cannot be distinguished: 
770* d IPI00014311,  CULLIN HOMOLOG 2 
770* IPI00180783,  CULLIN 2 
770* AVSTGLPHMIQELQNHIHDEGLR 4.9 67 4 2 2
770* FVQLINTVLNGDQHFMSALDK 2.4 30 1 1
770* KYLHPSSYTK 2.5 29 1 1
770* RLIHGLSMSMDSEEAMINK 1.7 30 1 1
770* VIHGVINSFVHVEQYK 5.2 102 4 2 2
770* YIDDKDVFQK 1.7 37 1 1
Example 3:  One protein isoform specified by one peptide; other peptides cannot distinguish isoforms: 
775 IPI00220502, BAI1-ASSOCIATED PROTEIN 2 ISOFORM 2 
a IPI00180292, BAI1-ASSOCIATED PROTEIN 2 ISOFORM 3 
b IPI00180972, SIMILAR TO BAI1-ASSOCIATED PROTEIN 2 
c IPI00185159, BAI1-ASSOCIATED PROTEIN 2 ISOFORM 1 
d IPI00186231, SIMILAR TO BAI1-ASSOCIATED PROTEIN 2 
e IPI00217925, SIMILAR TO INSULIN RECEPTOR SUBSTRATE 
775 NPFAHVQLKPTVTNDR 3.9 72 2 2
775_a_b_c_d_e EGDLITLLVPEAR 3.3 46 1 1
775_a_b_c_d_e LHMSLQQGK 2.0 45 1 1
775_a_b_c_d_e MSAQESTPIMNGVTGPDGEDYSPWADRK 2.4 37 1 1
775_a_b_c_d_e SNLVISDPIPGAKPLPVPPELAPFVGR 2.9 31 1 1
775_a_b_c_d_e SSSTGNLLDKDDLAIPPPDYGAASR 2.1 32 1 1
775_a_b_c_d_e YSDKELQYIDAISNK 2.9 28 1 1
775_a_b_c_e SFHNELLTQLEQK 4.1 71 3 1 2
Example 4:  Complex group with minimum of three proteins, including bridge peptidesf:
787 IPI00023860,  NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 1 
788* IPI00017763,  NUCLEOSOME ASSEMBLY PROTEIN 1-LIKE 4 
788* IPI00180912,  SIMILAR TO NAP1 
789 IPI00184769,  SIMILAR TO NAP1 
a IPI00185366,  SIMILAR TO NAP1 
787 EQSELDQDLDDVEEVEEEETGEETK 5.0 88 4 3 1
787 KYAVLYQPLFDK 4.0 74 8 3 5
787 KYAVLYQPLFDKR e   77 6 2 4
787 LDGLVETPTGYIESLPR 5.7 113 5 1 4 1
787 YAVLYQPLFDK 4.1 58 3 2
787 YAVLYQPLFDKR 2.7 51 3 3
787_a GIPEFWLTVFK 2.9 61 4 4
787_a NVDLLSDMVQEHDEPILK 6.4 109 3 2 1
787_788*_789 f FYEEVHDLER 3.8 49 18 4 9 5 
788* KYAALYQPLFDK 4.7 73 6 1 5
788* LDNVPHTPSSYIETLPK 4.9 66 4 1 3
788* QVPNESFFNFFNPLK 3.4 77 5 5
788* YAALYQPLFDK 2.6 64 3 1 2
788*_789 f GIPEFWFTIFR 3.0 60 3 3
789 AAATAEEPNPK 2.9 56 1 1
a  Proteins were identified from MSPlus-validated peptide sequences in Sample 1 using the Isoform Resolver script.  Observed peptides were matched against a 
peptide-centric database, which specifies proteins that share every unique peptide sequence in the IPI database. 
b  At the end of the analysis, Isoform Resolver assigns each protein a reference number or letter.  Proteins that can be distinguished based on the peptide sequence 
information are assigned different numbers, whereas proteins that cannot be uniquely distinguished are assigned identical numbers.   Those protein variants where 
unique peptides are identified are assigned numbers, which allow enumeration of the minimum number of proteins required to account for the peptides.  Proteins that 
represent variants in the database which also contain one or more of the peptides are assigned letters. 
c IPI protein accession numbers from Version 2.18 update. 
d Asterisks indicate examples where peptides are found in more than one protein isoform, with no unique peptide sequence observed that specifies a single isoform.   
In this example, all six observed peptide sequences are found in both IPI00014211 and IPI00180783 database entries. 
e This peptide was not identified by Sequest, because it contains two missed cleavages which were not allowed by Sequest (see Methods). 
f Peptides with sequences in common between two numbered proteins are italicized. 
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protein identification, experiments compared protein profiles from Sample 1 which was analyzed 
by SCX separation followed by RP-LC/MS/MS, Sample 2 which was analyzed with fewer SCX 
fractions but included gas phase fractionation, and Sample 3 which fractionated proteins by 
sizing gel exclusion prior to digestion, SCX chromatography, and RP-LC/MS/MS, combining 
results from full mass range and gas phase fractionation.  In order to assess the effects of gas 
phase fractionation, peptides in SCX fractions were analyzed over the full mass range or in ten 
narrow mass ranges (Table 2.1, Sample 1 vs. 2, MSPlus/Isoform Resolver).  Gas phase 
fractionation yielded a >20-fold larger dataset, increasing the number of proteins identified by 
>7-fold (from 243 to 1,757 proteins), and reducing the percentage of proteins specified by only 
one peptide from 70% to 50%.  However, gas phase fractionation also increased the number of 
fragment ions observed, which lowered the percentage of validated DTA files from 40% to 17% 
of the total dataset.  Resolving proteins by gel exclusion simplified the protein complexity prior 
to SCX chromatography and significantly increased peptide sampling (Table 2.1, Sample 3, 
MSPlus/Isoform Resolver).  In all, 5,130 proteins were identified in K562 soluble extracts, of 
which 55% were supported by two or more peptides.   
The number of false positive proteins was estimated from the false positive frequency for 
MSPlus-validated peptides (~ 4.2% of total peptides, see above).  This predicts that 4.2%, 
0.18%, and 0.007% of proteins supported by one, two, or three peptides, respectively, should 
represent false positive assignments (a peptide observed in more than one charge form is counted 
as only one peptide).  Therefore, in Samples 1, 2, and 3, the number of false positive protein 
assignments would be approximately 7 (2.9%), 38 (2.2%), and 100 (1.9%), respectively.  In 
Sample 3, a combination of MSPlus and Isoform Resolver identified more than 5,000 proteins 
from a single cell type in a single experiment.  In comparison, conventional analyses using 
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Sequest and Mascot which applied XCorr and Mowse thresholds and allowed ~4% false positive 
peptide validations, resulted in only 4,130 and 3,971 proteins, respectively (Table 2.1).    
As the number of peptides identified in each experiment increased between Samples 1, 2, 
and 3, the number of proteins increased by a lower percentage, suggesting saturability in protein 
detection.  Saturability was also indicated by the fact that a progressively lower percentage of 
proteins supported by only one peptide are observed as the total number of peptides sampled 
increases (Table 2.1).      
 
Reproducibility  
The low frequency of false positives suggested high accuracy; therefore, reproducibility 
should be high.  To test this, the lists of identified proteins were examined to assess the degree of 
overlap between different experiments.  In order to test reproducibility between identical 
experiments, proteins were fractionated by sizing gel exclusion, proteolyzed, and peptides were 
separated by SCX chromatography (Sample 3).  Each SCX fraction was analyzed by RP-
LC/MS/MS over a full mass range as well as six gas phase fractionation mass ranges (defined in 
Table 2.1).  Triplicate experiments performed on one sizing gel fraction from Sample 3, analyzed 
by SCX separation and gas phase fractionation, showed 70% (S.D. 5%) overlap in proteins 
identified between all six combinations of two repeats.  The nonoverlap of 30% reflects both the 
presence of false positives and incomplete sampling of the highly complex protein mixture.  
In order to minimize the impact of incomplete sampling, reproducibility also was assessed by 
comparing smaller datasets against larger datasets (the ratio of peptides sampled in the smaller 
vs. larger datasets was ~9).  The results showed that 227 of the 243 proteins (93%) identified in 
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Sample 1 (Table 2.1) were also found in Sample 2.  A second analysis compared two subsets of 
data from Sample 3, in which of 320 proteins identified by full mass range scanning of one size 
exclusion column fraction, 298 proteins (93%) were present in the larger dataset collected using 
gas phase fractionation.  In each experiment overlapping a smaller dataset onto a larger one, the 
~6-7% of proteins not reproducibly detected were supported by only one peptide, and could be 
accounted for by false positive assignments as well as incomplete sampling.  Finally, Sample 1 
was compared to the Sample 3 dataset, which is 100-fold larger.  Upon overlaying Sample 1 onto 
Sample 3, 234 of the 243 proteins were reproduced, 160 of which were supported by single 
peptides in Sample 1.  Of the 234 proteins, 224 were supported by 2 to 55 high quality peptides 
in the larger dataset, indicating that most of the proteins identified in the Sample 1 experiment 
were true positives, even if the majority were observed by only one peptide.  Significantly, only 
9 of Sample 1 proteins (4%) did not reproduce in Sample 3, consistent with our estimate of 4.2% 
peptide false positives.   
 
CONCLUSION 
 
This study demonstrates a novel programmatic approach for protein identification by the 
shotgun method, which primarily relies on peptide chemical properties, consensus between 
search programs, and parameters reflecting quality of the MS/MS spectra, rather than XCorr or 
Mowse probability threshold cutoffs for peptide validation.  In three independent experiments, 
the number of validated peptide assignments increased by 21 – 58% compared with threshold 
methods, when allowing the same ratio of false positives to identified peptides.  This represented 
a reduction in the false negative rate from 41% to 11%.  Several lines of evidence show that the 
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frequency of false positive peptide assignments is approximately 4.2% (FP/MSPlus-validated) in 
all three samples; thus, very few proteins are incorrectly identified, and reproducibility is high 
(within the limits of sampling in the system).  By minimizing not only the false positive rate, but 
also the false negative rate, we were able to achieve a high number of protein identifications with 
a minimum of SCX fractionation.   
A major finding of this study is that ~19% of identifiable DTA files are incorrectly 
assigned by the search programs through a "distraction" effect; this increases to 29% using a 
search strategy that specifies no protease.  Distraction has been noted previously (MacCoss et al, 
2002); however, our implementation of the CLASP algorithm allowed quantification of the 
effect.  We found that a major cause of distraction was increased database size, which led to 
increased statistical thresholds for validating Sequest and Mascot searches.  Effective database 
size was strongly affected by searching with increased mass tolerance, allowing nontryptic and 
missed tryptic cleavages, and allowing variable modifications (e.g., oxidation or 
phosphorylation).  Thus, when including these in the search strategy, results should be evaluated 
critically to determine if there is a significant improvement in protein identification or sequence 
coverage to justify the increased computational cost and reduced statistical discrimination.  
These results also suggest that carrying out several searches on the same dataset using different 
parameters may increase extraction of information from the data.  In addition, experiments 
investigating physiological covalent peptide modifications should be optimized by first 
identifying the proteins that are present, then searching for modified peptides against a limited 
set of observed proteins.   
An important result was that as the size of the datasets increased, the number of false 
positives measured by the randomized database search did not increase disproportionately.  
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Instead, the frequency of false positives normalized to class positives remained constant at ~4%, 
whereas the statistical false positive rates (FP normalized to class negatives) actually decreased 
from Sample 1 (2.6%) to Sample 2 (0.7%).  Furthermore, if the number of false positive peptide 
assignments increased disproportionately with the dataset size, we should have observed an 
increase in the percentage of proteins supported by only one peptide.  In fact, this percentage 
decreased from 69% to 45% between Sample 1 and Sample 3.  This suggests that the class 
positive DTA files are described by different sampling statistics than the class negative DTA 
files, when filtered by MSPlus/Isoform Resolver.  We hypothesize that the combined use of 
SCX, RSP and ion ratio filters by MSPlus allows partial evaluation of peptide chemical 
properties, and thus treats class positive vs. class negative sets differently.  Further studies are 
needed to clarify this issue.   
We also describe a novel protein profiling approach that eliminates peptide and protein 
sequence redundancy.  The removal of isoforms can also be carried out by DTA Select and 
Peptide Prophet programs (Keller et al, 2002; Tabb et al, 2002), but these do not allow filtering 
based on peptide chemical properties.  Furthermore, the MSPlus/Isoform Resolver approach 
makes use of a new nomenclature for reporting ambiguities due to protein variants.  This will 
facilitate comparative studies, where differential expression of specific variants may be 
important to understanding biological regulation.  Although the protein numbering and peptide 
nomenclature currently implemented in the Isoform Resolver are arbitrary, numbering can be 
adapted to report systematic relationships such as gene loci, functional classes, or evolutionary 
relationships.  Taken together, the analytical and computational methods described in this study 
provide a comprehensive set of tools for optimizing data analysis in shotgun proteomics, and 
demonstrate high coverage of the soluble components of a mammalian cell proteome. 
  
 
CHAPTER III 
 
ISOFORM RESOLVER: A PEPTIDE-CENTRIC ALGORITHM FOR PROTEIN 
INFERENCE 
 
Submitted 2011.  Meyer-Arendt, K., Old, W.M., Houel, S., Renganathan, K., Eichelberger, B., Resing, 
K.A., and Ahn, N.G.. Status: Revised manuscript under review.  
 
INTRODUCTION 
  
 An effective method for identifying proteins within complex samples involves 
multidimensional LC-MS/MS, where proteins are proteolyzed, and peptides are separated by 
reverse-phase liquid chromatography (RP-LC) and sequenced by mass spectrometry gas phase 
fragmentation (MS/MS).  Automated computer programs are used to analyze the tens of 
thousands of spectra that can be generated by a single experiment, by matching MS/MS spectra 
to peptide sequences in protein databases.  A significant problem is how to assemble the 
information contained in large numbers of peptide sequences into a final set of identified 
proteins.    
 The task of protein identification is straightforward when peptide sequences are found 
only within single protein database entries (which we will refer to throughout as “proteins”).  
However, when a peptide sequence is found in multiple entries, ambiguities arise about which 
proteins are truly present.  This problem is greatest with proteomes where paralogous genes and 
extensive alternative splicing produce many related proteins within a database (Rappsilber et al, 
2002).  For example, the estimated 20,488 distinct genes in the human genome (Clamp et al, 
2007) yield 89,486 proteins in the International Protein Index (v3.75, Aug. 2010) database 
(Kersey et al, 2004), which include splice variants, proteolytically processed proteins, and 
protein fragments.  Our analysis shows that of the 3.8 million fully tryptic peptides from this 
protein database (allowing ≥8 amino acids and up to 2 missed cleavages), over 2 million are 
shared between two or more proteins.  The prevalence of shared peptides creates a need for 
computational algorithms which infer the most likely protein assignments, a process called 
protein inference (Nesvizhskii et al, 2005).   
Often protein profiles do not report all possible proteins, but only the minimal list which 
best accounts for the observed peptides (Table 3.1).  The manner in which minimal list proteins are 
selected differs between protein inference programs.  DTASelect identifies proteins using a greedy 
algorithm (Tabb et al, 2002), and in ambiguous cases, shows all possible proteins, allowing users 
to manually decide between them.  ProteinProphet ranks proteins according to probabilities 
computed from the number of peptides, confidence in the peptide sequence, and the degree to 
which peptides are shared between multiple proteins (Nesvizhskii et al, 2003).  Proteins which are 
“indistinguishable” (i.e., represented by a set of identical peptides) are assigned equal probabilities.  
DBParser also uses a greedy algorithm to rank proteins according to those with the most peptides 
(Yang et al, 2004).  Phenyx selects a minimal list of proteins, ranked by the number of peptides 
identified and the protein sequence coverages (Allet et al, 2004), but differs from other programs 
by reporting only one protein entry and accession number (a representative “anchor” protein), even 
when two or more proteins are indistinguishable.  All of these programs use a “protein-centric”  
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Table 3.1 Terminology  
 All possible proteins The complete collection of proteins from which MS/MS observed peptides could be derived. 
 Minimal list proteins The smallest number of proteins from which MS/MS observed peptides could be derived.  
   
 In silico-derived (ISD) protein groups 
The set of all proteins in the protein database clustered by having 
one or more peptides from an in silico digest of that protein 
database in common. 
 MS/MS-derived (MSD) protein groups 
The set of all possible proteins clustered by having one or more 
observed peptides in common. 
   
 Primary protein Within an MSD protein group, a protein which has been inferred to be in the minimal list.  
 Secondary protein Within an MSD protein group, a protein which may be present, but which has been inferred to not be in the minimal list. 
   
 Shared peptide A peptide which matches two or more protein entries in a protein database. 
 Bridge peptide A peptide which matches two or more distinguishable primary proteins.   
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approach of matching peptides directly to protein database entries, and reporting peptides within 
the context of proteins (Fig. 3.1a). 
In 2004, we proposed an alternative strategy for protein inference, named IsoformResolver, 
which generates a list of non-redundant peptide sequences, and then matches each peptide to all 
protein entries which contain that sequence (Resing et al, 2004).  Thus, the approach is “peptide-
centric” because the observed peptides are directly referenced against a peptide database (Fig. 
3.1b). This strategy has the advantage of more readily assessing the ambiguity in matching 
peptides to proteins that share peptide sequences in common.  Peptides are output within the 
context of all possible proteins from which they can derive.   
In this study, we describe the IsoformResolver algorithm in detail for the first time, and 
demonstrate the advantages of using peptide-centric protein grouping methods to address problems 
in protein inference for large datasets.  We demonstrate that protein inference increases the 
variability of proteins between similar datasets (“volatility”), and show that protein inference 
methods yield significant volatility when reporting proteins separately, which is solved by peptide-
centric protein grouping.  A compare profile feature of IsoformResolver allows results from many 
protein profiling experiments to be analyzed, by first performing inference across all experiments 
pooled together, and then reporting spectral counts from individual experiments in an easily 
viewed format.  Finally, we compare IsoformResolver against other protein inference programs, 
and show that the most important factor influencing agreement between different programs is how 
they treat indistinguishable proteins.  Advantages of IsoformResolver are: (i) its protein grouping 
methods, which allow concise display of proteins including all possible candidates, (ii) its ability 
to display related proteins adjacently in a protein profile and compare proteomics datasets analyzed 
at different times and using different software, (iii) its facile integration of label-free quantification 
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Figure 3.1 IsoformResolver uses a peptide-centric strategy for protein inference.   a. In a 
conventional protein-centric approach, observed peptides are searched within a protein 
sequence database.  Protein-centric protein groups replicate peptides when those peptides are 
found in more than one protein.  b. In the peptide-centric approach, a database consisting of 
non-redundant peptide sequences is generated from a protein sequence database, where each 
peptide is matched to all proteins containing the peptide sequence.  Observed peptides are 
matched one-to-one against the list of non-redundant peptide sequences in the database.   This 
allows easy clustering of protein groups which share peptides in common.
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 by spectral counting into protein sets, and (iv) its ability to compare results from multiple large-
scale datasets.   
 
METHODS 
 
Data collection and peptide identification 
LC-MS/MS datasets used in these studies were collected on human melanoma and 
erythroleukemia cell lines and summarized in Table 3.2.  Samples were proteolyzed with trypsin 
as described (Resing et al, 2004; Old et al, 2009; Houel et al, 2010), and fractionated by 
reversed-phase HPLC coupled to an LTQ/Orbitrap mass spectrometer (parent scan 475-1600 
m/z).  DTA files representing MS/MS spectra were generated using BioWorks XCalibur v.3.0 
software and concatenated into MGF files using in-house software.  DTA files were searched by 
Sequest (Eng et al, 1994) specifying carbamidomethylated cysteine and up to two missed trypsin 
cleavages.  Parent ion tolerance was set to 1.2 Da or 50 ppm (specified in Table 3.2) and 
fragment ion tolerance to 0.8 Da.  MGF files were searched using Mascot v.2.2 (Matrix Science, 
Perkins et al, 1999) using the same parameters, and Mascot results were parsed using the Mascot 
parser (http://www.matrixscience.com/msparser.html).    Decoy versions of databases were 
constructed by reversing each protein sequence from normal databases, which were then 
searched separately or as a target-decoy database (Elias et al, 2007; Blanco et al, 2009).  
Peptides accepted when scores were above thresholds corresponding to 1% false discovery rate 
(FDR=FP/(FP+TP)).  Peptides were also filtered for physicochemical properties, including 
peptide size, likely missed cleavages (Yen et al, 2006), and mass accuracy (observed minus 
predicted between -5 ppm and +10 ppm).  Peptides were also supported by similarity scoring 
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Table 3.2  Datasets used in these studies.  Data collection was carried out by LC-MS/MS on 
three samples of proteins from human cell lines.  
 
 
 
Dataset Application DTAs Peptides Data analysis 
Dataset 1   
WM115 cell line 
Searched against IPI 
v.3.27 separated 
target and decoy 
databases by Mascot 
and Sequest, and 
validated by MAE.  
Parent ion tolerance 
1.2 Da, 8 amino acid 
minimum length.  
Rejected when > 10 
ppm or < -5 ppm 
than predicted.   
  Dataset 1A 
  198 rawfiles 
Examine extent of 
problems introduced by 
protein inference 
929,171  
372,642 
(26,225 non-
redundant,  
1,784 bridge) 
  Dataset 1B 
  99 rawfiles 
Compare pooled vs. 
aggregate dataset results 462,445  
181,460  
(21,414 non-
redundant, 
1,321 bridge) 
  Dataset 1C 
  9 rawfiles 
 
Compare protein 
identification software 41,659 
15,929 
(3,939 non-
redundant, 
155 bridge) 
  Dataset 1D 
  1 rawfile 
Compare protein 
identification software 5,489 
1,867  
(1,314 non-
redundant, 
63 bridge) 
Dataset 2 
K562 cell line Searched against IPI v.3.27 separated 
target and decoy 
databases using 
Mascot.  Parent ion 
tolerance 50 ppm, 9 
amino acid minimum 
length.   
  Replicate 1 
  (1 rawfile) 
Compare replicate runs 
for protein overlap 
16,983  
See Table 1   Replicate 2   (1 rawfile) 17,349  
  Replicate 3 
  (1 rawfile) 16,638  
Dataset 3 
K562 cell line 
Searched against IPI 
v.3.55 combined 
target and decoy 
databases by Mascot. 
Parent ion tolerance 
1.2 Da, 9 amino acid 
minimum length. 
Lower depth 
(2 rawfiles) 
Depth of sampling 
experiment 
29,907  
See Table 2 
Higher depth 
(25 rawfiles) 252,205  
Simulated  
lower depth 
(chosen from 
25 rawfiles) 
24,338 
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 between observed MS/MS and spectra simulated from peptide fragmentation models (Zhang 
2004, 2005) implemented by Manual Analysis Emulator (MAE) (Sun et al, 2007).  Sample 
preparation was done by Dr. Kutralanathan Renganathan and data was collected by Dr. Stephane 
Houel. 
 
IsoformResolver protein inference software  
IsoformResolver is a Perl program which uses as input one or more files containing 
validated peptide spectrum matches, and generates a protein profile displaying all identified and 
inferred proteins (Fig. 3.2).  For protein information, IsoformResolver accepts any FASTA or 
EMBL DAT formatted protein databases.  Prior to IsoformResolver execution, these protein 
databases are reformatted into a peptide-centric database, consisting of map files which associate 
peptides with proteins from which they can be proteolytically derived.  This is done once per 
protein database and requires specifying a protease, number of allowable missed cleavages, and a 
minimum peptide length.  During IsoformResolver execution, validated peptide spectrum 
matches are input, using the file format shown in Fig. 3.3.  Peptides not found in the peptide-
centric database, such as semi-proteolytic and non-enzymatic peptides, are searched for within 
the protein-centric database, and matched to the proteins from which they derive and to the MSD 
and ISD protein groups to which the proteins belong.  Peptides, even semi- and non-proteolytic, 
are included in all sections of IsoformResolver output and included in spectral counting.  
Peptide-centric database files have been constructed and tested for use with many proteases 
including ArgC, LysC, Trypsin, AspN, and can be constructed for any protease with cleavage 
specificity.  In addition, we have constructed and tested peptide-centric database files with 
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IsoformResolver Workflow
Protein database
  (FASTA or DAT)
in silico digest
Peptide-centric database
    Peptides
    Proteins
    ISD protein groups
MS  /MS   spectra2 3
  Peptide identification
e.g. Mascot and/or Sequest
Peptide validation
 e.g. MSPlus, mass
    accuracy filters
IsoformResolver protein profiler
    Construct MSD protein groups
    Identify minimal list proteins
    Output protein and peptide results, in the
      context of MSD and ISD protein groups
    Apportion spectral counts
    Output summary protein and peptide
      information
Figure 3.2  IsoformResolver workflow.  IsoformResolver inputs a list of experimentally 
observed peptides identified by a search program, as well as a precalculated peptide-centric 
database which includes non-redundant peptides, matching proteins, and ISD protein groups.  
From these input files, IsoformResolver constructs MSD protein groups, identifies primary 
and secondary proteins, and apportions spectral counts.
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Figure 3.3  IsoformResolver input file format.   The IsoformResolver software requires an 
input directory with files in a comma-separated values (CSV) file format with one header line, 
and one row per MS/MS record. Columns in each input .csv file must include the following: 
• File: an identifier for each MS/MS file.  This filename must be an identifier that is unique 
across all data files which are profiled at the same time.   
• Sample: the LC-MS/MS (aka sample or rawfile) from which the MS/MS or MSn file was 
extracted.  This value must be a subset of the value in the File column. 
• Charge: 1, 2, 3, or higher. 
• Golden: A validated peptide sequence which the user believes to be the correct 
identification for the MS/MS named in the File field.  This field may be empty (for an 
ambiguous identification) or contain an “X” (for a clearly rejected identification), in 
which case the entire line is ignored during IsoformResolver protein assembly. 
• Confidence: A string indicating the basis for validation of the peptide.  For example, 
values we often use include S for an identification by Sequest, M1 for an identification by 
Mascot, S-M1 for a peptide identified by both Sequest and Mascot, and MAE 
confidences.  Other confidences may be provided by the user. 
• MrExp: The observed mass of the peptide sequenced by MS/MS, derived from the parent 
ion mass.  
• CalcMass1: The calculated mass of the peptide, including modifications. 
• Mowse1: The Mascot score for the peptide identification.  This value is optional, but if 
present, is carried through to the protein profile output.  Other columns optionally 
supported include XCORR (Sequest score) and M1SIM (MAE score). 
• VarMods1: The variable modifications proposed by the search engine. 
• Intensity: Peptide ion intensity, measured from the parent ion.  Optional, but often helpful 
to view in the output.   Stddev (standard deviation value per MS/MS) is also accepted 
when intensity information isn’t available.  
Any row with ‘#’ in the first column is interpreted by the script as a comment and ignored unless 
followed by specific keywords.  For instance, the use of the keyword “Peptide Tolerance 
(Units)” shown in the figure above directs IsoformResolver to parse the values in this line as part 
of peptide isoform detection. 
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 combined ArgC + LysC + trypsin cleavages.  ISD reformatted datafiles can be constructed from 
any protein database.  The impact of the peptide-centric database will be higher as the number of 
shared peptides increases.  Thus, while ISD protein groups show some benefit using UniProt 
Sprot, which has a relatively low number of shared peptides, the impact is higher using 
Sprot/Trembl/Splice variants, a database with an even greater percentage of shared peptides than 
IPI.   
IsoformResolver utilizes two types of protein groups – in silico-derived (ISD) protein 
groups and MS/MS-derived (MSD) protein groups.  ISD groups are constructed using all 
peptides derived from in silico proteolysis of a protein database.  Using the peptide to protein 
mapping from the peptide-centric database, proteins are then clustered together whenever they 
have a peptide in common. Resultant ISD groups are assigned group identifiers and the mapping 
of proteins to these identifiers are stored in a text file for rapid access during IsoformResolver 
execution.  MSD protein groups are constructed in an identical way, but using different sets of 
input peptides, consisting of sequences identified from the MS/MS and validated by thresholds 
or other means. The list of all possible proteins for the observed peptides is obtained by matching 
peptides to the pre-calculated peptide-to-protein mapping from the reformatted protein database.   
These proteins are clustered whenever they have an observed peptide in common, and the 
resultant protein groups are then assigned an MSD group identifier.  MSD groups thus contain 
only peptides and proteins which were observed in the MS/MS experiment, while ISD groups 
contain peptides and proteins from the entire protein database, even when they were not 
observed. 
Protein inference is performed on each MSD protein group separately, considering each 
peptide equally plausible by default, although IsoformResolver can also accept peptide weights 
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using scores or probabilities.  Proteins are designated as primary through an iterative process, in 
which a greedy algorithm is used to select the protein which accounts for the largest number of 
peptides within a MSD group (or the highest combined score or probability), the protein which 
accounts for the largest number of remaining peptides that do not match the first protein, and so 
on until no peptides remain.  All other proteins (which lack distinguishing peptide evidence) are 
designated as secondary.  Indistinguishable proteins are primary proteins which are identified by 
shared peptides that cannot distinguish between the proteins and are counted as a single protein 
in the minimal list, although all protein identifiers are reported. 
In addition to the mapping files described above, the peptide-centric database consists of 
an annotation file which contains information on the relatedness of proteins within each ISD 
group.  Functional relatedness are evaluated: (i) by gene annotation, based on genes (from Entrez 
Gene, HGNC, Ensembl, VEGA, or H-InvDB), gene clusters (UniGene) or gene location 
(chromosomal start location and sense/antisense direction), (ii) by protein family, based on 
InterPro, Pfam, PROSITE, GENE3D, SUPERFAMILY, PANTHER, ProDOM, PRINTS, and 
TIGRFAMs databases, and (iii) by GO and other annotations found in the DAT format (e.g., 
RZPD, UTRdb, SMART, CCDS, CleanEx).  Each ISD group has a unique identifier, and is 
annotated to indicate the percentage of proteins in the group with the same gene, protein family, 
GO, or other annotation.   
 
Other protein inference programs 
Comparisons of IsoformResolver to five other protein inference programs used the 
following versions of software.  Analyses with ProteinProphet (Nesvizhskii et al, 2003) used 
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Transproteomic Pipeline (TPP) v.3.3.0 (9/25/2007), and v4.3 JETSTREAM rev 0, Build 
200908071234 (MinGW) (http://tools.proteomecenter.org/TPP.php), and were performed using 
the Mascot option, with peptide probability cutoff 0.95 and protein probability cutoff 0.50.  
Analyses with Scaffold v.01_07_00 (described in Searle et al, 2008, and generously provided by 
Proteome Software) used the combined Mascot and Sequest option, with peptide and protein 
probability cutoffs of 0.95 and 0.50, respectively.  Analysis with Panoramics v.1 (05/2007, 
described in Feng et al, 2007), used the Windows executable provided by the USDA Agricultural 
Research Service, performed on Mascot search results using protein probability threshold 0.80.  
IDPicker v.2.0 (described in Zhang et al, 2007 and Ma et al, 2009, 
http://fenchurch.mc.vanderbilt.edu/lab/software.php) used peptide and protein probability cutoffs 
equal to 0.99.  The same Sequest and Mascot results files were used in all analyses, except for 
IDPicker where datasets were searched using a combined target/decoy database.  Analyses with 
Phenyx Public Server and PhenyxOnline v.2.5 (described in Colinge et al, 2004, and generously 
made accessible by GeneBio) used the default threshold cutoff (Z-score=5, p=0.0001, and AC 
score=6).   
To compare output between programs, peptides from each program were converted into a 
common input format, a compare protein profile was created from all peptides generated by the 
six programs, and the output was annotated with proteins identified by each program.  Using 
IsoformResolver MSD and ISD protein groups, related proteins from each of the profiles were 
clustered together, simplifying the evaluation in cases where proteins were missed by a profiler 
or protein variants were identified, and allowing for an easy enumeration of primary and 
secondary proteins. 
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RESULTS 
 
IsoformResolver:  Protein groups and report structure 
 IsoformResolver pre-calculates a mapping of all proteins to a list of nonredundant 
peptides within a given database (Fig. 3.2), which identifies all proteins that share peptide 
sequences.  It then generates a protein profile displaying all identified and inferred proteins from 
one or more files of observed peptides.  The peptide-centric algorithm allows two types of 
protein groups to be generated.  In silico-derived (ISD) protein groups are constructed from a 
protein database, by compiling all peptides derived from in silico proteolysis (Fig. 3.4a).  
MS/MS-derived (MSD) protein groups are constructed in an identical way but using input 
peptides identified experimentally from MS/MS datasets (Fig. 3.4b).  Proteins are then assigned 
to the same group whenever they have a peptide in common.  For example, in Fig. 3.4a, 
proteins_A, _B, _C and _D share peptides and are therefore within the same ISD group.  
However, proteins_A and _B and proteins_C and _D belong to two MSD groups because not all 
peptides shared between these proteins are observed.  Because only some of all possible peptides 
can be detected by MS/MS, MSD protein groups are strict subsets of ISD protein groups.   
 IsoformResolver creates a comma separated values output file which consists of three 
sections (Fig. 3.5, Fig. 3.6).  Section 1 displays proteins and peptides within MSD groups, which 
are in turn listed together within ISD groups.  The output catalogues two types of proteins: those 
that pass Occam’s razor test of being among the smallest number which account for the peptide 
evidence (“primary” proteins), and those which do not (“secondary” proteins).  Thus, proteins 
which account for the greatest number of peptides within an MSD group, or else have 
distinguishing peptide evidence, are primary; all others are secondary.  This nomenclature  
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a.   ISD groups are constructed from all peptides derived from an in silico digest
peptide_a
peptide_b
peptide_c
peptide_d
peptide_w
peptide_x
peptide_y
peptide_z
Peptide to protein mapping ISD protein groups 
ISD_1: protein_A, protein_B, 
            protein_C, protein_D
ISD_2: protein_E, protein_F
Peptide-centric database
in silico digest
of all protein
sequences in 
a protein database
protein_A
protein_A, protein_B
protein_A, protein_B
protein_B
protein_C, protein_D
protein_A, protein_C,
protein_D
protein_E
protein_E, protein_F
c b d
xw
w x
a  b c x
Protein_B
Protein_C
Protein_D
Protein_E
Protein_A
b.  MSD groups are constructed from observed peptides and are subsets of ISD groups
Peptides from
MS/MS spectra
Match observed peptides to 
peptide-centric database
Construct 
MSD groups
MSD to ISD 
mapping
MSD_1:
  protein_A, 
  protein_B
MSD_2:
  protein_C, 
  protein_D
peptide_a
peptide_b
peptide_c
peptide_d
peptide_w
peptide_y
peptide_z
peptide_a
peptide_b
peptide_c
peptide_d
peptide_w
peptide_x
peptide_y
peptide_z
protein_A
protein_A, protein_B
protein_A, protein_B
protein_B
protein_C, protein_D
protein_A, protein_C,
protein_D
protein_E
protein_E, protein_F
   MSD_2
     protein_C, 
     protein_D
     
ISD_1:
   MSD_1
     protein_A, 
     protein_B
MSD_3:
  protein_E,
  protein_F
ISD_2:
   MSD_3
     protein_E,
     protein_F
Protein_F z
y z
Figure 3.4  IsoformResolver constructs two kinds of protein groups based on in silico 
derived and on observed peptides.  a. The peptide-centric database enables construction of in 
silico derived (ISD) protein groups, where each ISD group includes proteins that share peptides 
in common.  ISD groups provide a more stable identifier for proteomics results.  
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Figure 3.4  (continued) b. Experimentally observed peptides are matched to peptide sequences in 
the peptide-centric database, and proteins are clustered into MS/MS derived (MSD) protein 
groups when they share observed peptides.  MSD groups are subsets of ISD groups, and are 
listed in the output together.  Note that peptide_x was not observed experimentally, creating two 
separate MSD groups within a common ISD group.
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  IsoformResolver Output Format 
Expt_2Expt_1
Expt_2Expt_1
protein_A1
protein_B2
Section 3:
Summary of spectral counts
 
Section 2: 
Summary of peptide and protein counts
Section 1:
Peptides and proteins display 
peptide_a1 0 12
peptide_b1_2 1 2
1_2 protein_A_protein_B 4 8
MSD_2, ISD_1
peptide_c   3   61_2
2 peptide_d   8   5
MSD_2, ISD_1 
protein_C3*
protein_D3*
peptide_w3* 12 12
3* protein_C, protein_D 12 12
7 peptides found, 4 proteins in minimal list
1 protein_A 0   12
ID
MSD_3, ISD_2 
protein_E4
peptide_z4_a  3 2
4 protein_E   8   4
2 protein_B 58
peptide_y4  5 2
protein_Fa
Figure 3.5  IsoformResolver output.  IsoformResolver output is a comma separated values 
spreadsheet file consisting of three main sections.  Section 1 lists all possible proteins present in 
a dataset, organized by MSD and ISD groups.  Proteins inferred as primary are assigned integral 
numeric identifiers (e.g., 1, 2...), while secondary proteins are assigned alphabetic identifiers 
(e.g., a, b...).  Peptides are mapped to proteins, using concatenated identifiers (e.g., 4_a) when 
peptides are shared between more than one protein.  Bridge peptides are readily identified as 
those which map to two or more primary proteins (e.g., 1_2).  Indistinguishable proteins are 
identified by asterisks (e.g., 3*).  MSD groups are listed adjacently when they occur within the 
same ISD group, and are otherwise sorted in descending order by numbers of peptides.  Multiple 
lists of observed peptides can be displayed in a compare profile mode (e.g., Expt_1, Expt_2), 
allowing easy comparison of proteins and spectral counts between different LC-MS/MS datasets.  
Section 2 summarizes information on the number of peptides and proteins in the minimal list.  
Section 3 displays concise information for all proteins in the minimal list and, on bridge peptide 
regions (on separate lines, marked with concatenated identifiers, e.g., 1_2).  Spectral counts for 
proteins and bridge peptide regions are listed for each experiment.
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Experiment_1   Experiment_2 
MSD group ISD group ISD group descriptor 
Protein ID Protein accession Prot MW % Protein descriptor Gene 
Protein iD Peptide sequence Pep MW Confidence XC Mow Obs MW Stddev # XC Mow Obs MW Stddev #
MSD 1976 ISD8-12137 3 1 HGNC= CHEK1_100.0_100.0; InterPro= Kinase_like._100.0_100.0;  
2316 IPI00023664.3 3 54420 14.5 SERINE/THREONINE-PROTEIN KINASE CHK1. CHEK1
2316 HIQSNLDFSPVN… 2302.095 Seq,Mas 5.2 80.8 2302.098 11 2
2316 LVQGISFSQPTC.. 3893.906 Seq,Mas 3.5 40.9 3893.922 46 2 3.7 34.3 3893.917 68 2
2316 SCMNQVTISTTDR 1512.678 Seq,Mas 3.6 51 1512.679 11 3
MSD 917 ISD8-1383 9 7 HGNC= HDAC2_100.0_42.9; GENE3D= His_deacetylse_100.0_100.0;  
1207
IPI00289601.10 5 65538 
16.8 HISTONE DEACETYLASE 2. 
HDAC21208
IPI00013774.1 3 55103 
12 HISTONE DEACETYLASE 1. 
HDAC1
a IPI00514649.1 24545 10 HISTONE DEACETYLASE 1. HDAC1
b IPI00555868.1 27008 15.1 HISTONE DEACETYLASE 2 VARIANT (FRAGMENT). HDAC2
1207
DGIDDESYGQIFK… 2025.017 
Seq,Mas 
4.5 47.8 2025.017 9 3.7 41 2025.018 5
1207
VMEMYQPSAVVL… 2513.147 
Seq, Mas 
5.2 95.3 2513.147 101208
YYAVNFPMR 1160.556 
Seq, Mas 
2.3 17.7 1160.56 
2
1207_1208_a YGEYFPGTGDLR 1374.632 
Seq,Mas 
3.2 60.3 1374.631 
2
1208_b 
LHISPSNMTNQNTP...
2234.022 
Seq,Mas 
5.4 86.2 2234.021 5.2 85.6 2234.022 101208_b 
TFNLPLLMLGGG… 1822.988 
Seq,Mas 
97.8 1822.988 5 4.9 107.9 1822.99 3
1208
DGIDDESYEAIFK… 2043.958 MAE 12.9 2043.959 
2
26.6 2043.957 
2
1208
LHISPSNMTNQNTN…
2233.055 5.6 113.6 2233.055 127.8 2233.055 16
1207_a YYAVNYPLR 1158.594 1.7 16.3 1158.594 1
MSD 917.01 ISD8-1383 2 7 HGNC= HDAC2_100.0_42.9; GENE3D= His_deacetylse_100.0_100.0;  
2745* IPI00006187.1 2 48848 12.4 ISOFORM 1 OF HISTONE DEACETYLASE 3. HDAC3
2745* IPI00217965.1 49111 12.4 ISOFORM 2 OF HISTONE DEACETYLASE 3. HDAC3
2745* HLFQPVINQVVD… 3749.787 Seq,Mas 4.9 59.4 3749.814 15 1
2745* YGNYFFPGTGD… 2316.987 Seq,Mas 2.6 16.3 2316.997 25 1
 
[20] [20]
[1]
[2]
[5]
[6]
[6]
[4]
[7] [8]
[19][18]
[17]
[16][15][14][13]
[12][11]
[9]
a.  IsoformResolver output, Section 1:  MSD and ISD protein groups
[10]
[3]
[14]
Seq,Mas 
Seq,Mas 4.6 
771
415
618
34
1940
45
129
16
18 5.7 
2199
373
2768
77
887
78
149
68
Figure 3.6 IsoformResolver protein profile output.  IsoformResolver creates an output file which concisely displays information 
about the peptides, proteins, MSD and ISD protein groups.  In Section 1, peptides and all possible proteins from which the peptides 
b.  IsoformResolver output, Section 2:  Summary of peptide and protein counts
c.  IsoformResolver output, Section 3:  Summary of spectral counts
Input ﬁles referenced 929171 dta ﬁles;  928490 not counting  charge decoys
We found a total of 372642 golden peptides  and 26225 unique  golden peptides and 40199 unique golden peptide ions.
After  peptide  isoform  removal  we had 26225 unique  golden peptides  left.
We qualiﬁed  3668 proteins  and 3328 MSD protein  groups and 3050 ISD protein  groups.
This comes to 25.55% single peptide  proteins.
Breakdown  of protein  per number of peptides:
#  peptides  in  protein count
1 937
2 438
3 355
4 241
5 218
6 161
Distribution of minimum set proteins across sample sets:
Expt_1 Expt_2 Prot ID   Prot accession Gene ISD group  # Peps # App Peps   # App SC   MW  Protein descriptor Indistinguishables
  
30    
  
 
  
    
26 34 1206 IPI00031768.1 HOOK3 ISD8-5356 9 9 60 83126 HOOK HOMOLOG 3
21 18 1207 IPI00013774.1 HDAC1 ISD8-1383 3 3.4 39.8 55103 HISTONE DEACETYLASE 1
2 0 1207_1208 1HDAC2 ISD8-1383 1 HGNC=HDAC2_100.0_42.9; GENE3D= hIS_DEACETYLSE_100.0_100.0; GO function   IPI00013774.1_IPI..
40 40 1212 IPI00217949.12 UBE2S ISD8-9004 9 9 80 23845 INTERFERON REGULATORY FACTOR 3
63 78 1210 IPI00443909.1 TMEM4 ISD8-2294 9 9 141 20652 ISOFORM 1 OF MIR-INTERACTING SAPOSIN-LIKE PROTEIN PRECURSOR
30 1208 IPI00289601.10 HDAC2 ISD8-1383 5 5.6 HISTONE DEACETYLASE 26553861.2
97 68 1209* IPI00018804.3 TRIP10 ISD8-2599 9 9 165 62592 ISOFORM 2 OF CDC42-INTERACTING PROTEIN 4 IPI00168849.3-IPI
12 15 1211* IPI00302688.7 ECHDC1 ISD8-896 9 9 27 33698 ISOFORM 1 OF SENOYL-COA HYDRATASE DOMAIN-CONTAING PROT IPI00479537.1-IPI
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Figure 3.6 (continued) could be derived are displayed within MSD groups, clearly indicating the inferred primary and secondary 
proteins.  A simple example is shown in Panel a below in MSD group 1976 ([1]) which lists three peptides, each matching a single 
primary protein (IPI00023664.3), labeled by an identifier (2316) which tracks proteins in the minimal list.  In contrast, MSD group 
917 ([2]) has nine peptides which match four proteins, two of which are primary (labeled 1207, 1208) and two (labeled a, b) which 
lack independent peptide evidence and are therefore classified as secondary.  Each peptide is also labeled with an identifier which 
reports the proteins to which they map ([3]).  Identifiers for shared peptides combine two or more protein identifiers, for example,  
Figure 3.6 (continued)  TFNLPLLMLGGG… ([4]) maps both to primary protein ‘1208’ (IPI00289601.10) and secondary protein ‘b’ 
(IPI00555868.1).  MSD group 917.01 ([5]) shows two proteins that are indistinguishable because they are each accounted for by the 
same set of peptides.  Identifiers of indistinguishable primary proteins are labeled with asterisks.  
 Although the peptide evidence may separate proteins into multiple MSD groups (e.g., 917 [2] and 917.01 [5]), such proteins 
are linked by gene family and belong to the same ISD group ([6]), even if the shared peptide sequences were not captured by 
MS/MS.  (The .01 suffix in MSD group identifier 917.01 is used to associate it with MSD identifier 917.)  IsoformResolver facili-
tates detection of these cases, by placing MSD groups belonging to the same ISD group adjacent to each other.  The program also 
displays the number of peptides which report each protein and MSD group ([7]), the number of proteins per ISD group ([8]), the 
mass of each protein ([9]), and the percentage protein sequence coverage by observed peptides ([10]).
 Information from the input files are displayed, including calculated peptide mass ([11]), closest observed mass ([12]), criteria 
used for validation (“Confidence”, [13]), highest search program scores ([14]), and standard deviation of fragment ion spectral 
quality ([15]).  Total spectral counts ([16]) as well as spectral counts for each charge state are reported (not shown).  Annotations are 
provided for each protein and ISD group, including the ISD group descriptor ([17]), protein descriptor ([18]), gene symbol ([19]), 
and GO and other cross references (not shown).  Multiple experiments, each containing one or more LC/MS runs, can be compared 
(“compare profiles”), reporting results from each experiment in separate sets of columns ([20]).  When a compare profile is 
requested, two additional files are generated – one which reports the numbers and names of proteins in the minimal list, and the other 
which reports the number of identified peptides in each experiment – which can be used as input for a Venn diagram display.
 The detailed report of Section 1 is followed by a summary of results in Sections 2 and 3.  Section 2 (Panel b) consists of a 
brief paragraph with the number of spectra, peptides, proteins, and protein groups, as well as the number of proteins supported by 
different numbers of peptides.  Section 3 (Panel c) summarizes proteins inferred to be in the minimal list in the same order as Section 
1, showing spectral counts and protein annotations (e.g., gene, ISD group, protein molecular weight, descriptor).  When IsoformRe-
solver is used to compare multiple experiments (“compare profile”), spectral counts for each experiment (e.g., Expt_1 and Expt_2) 
are listed side by side, allowing easy assessment of quantitative changes.  Indistinguishable proteins are marked with an asterisk, and 
accession numbers of representative and other proteins are separated out.  The number of peptides for each protein are indicated (# 
Peps), as are the number of peptides shared between two or more primary proteins (“bridge peptides”) which are reported on a 
separate line.  Bridge peptides and their spectral counts are apportioned between proteins based on spectral counts of non-bridge 
peptides, and the sum of non-redundant peptides and bridge peptides apportioned for each protein are reported (# App Peps).  The 
sum of non-bridge and apportioned bridge peptide spectral counts equal total spectral counts (# App SC) (28).  In the example shown 
here, the two spectral counts corresponding to bridge peptides 1207_1208 are apportioned to protein 1207 (0.8 SC) and 1208 (1.2 
SC), while the single bridge peptide is apportioned to 1207 (0.4 peptides) and 1208 (0.6 peptides).  The format of Section 3 is useful 
for further automation in spectral count analyses.
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simplifies, but is nevertheless compatible with the six protein inference categories previously 
described (Nesvizhskii et al, 2005; Yang et al, 2004).  Thus, primary proteins include those that 
are distinct, differentiable, indistinguishable, and proteins identified by shared peptides only 
when inferred in the minimal list.  Secondary proteins include subset, subsumable, and proteins 
identified by shared peptides only when not inferred in the minimal list (Nesvizhskii et al, 2005).  
Primary protein identifiers are integral numbers (e.g., 1,2,...) while secondary proteins have 
alphabetical identifiers (e.g., a,b,...), and common identifiers indicate connectivities between 
peptides and proteins.  For example, in Fig. 3.5, peptides_a, _b, and _c which match 
protein_A(identifier 1), will contain “1” in their identifiers.  Peptides_b, _c which match both 
protein_A(identifier 1) and protein_B(identifier 2), contain both “1” and “2” in their identifiers.  
Primary proteins which are indistinguishable are marked with an asterisk, e.g., peptide_x 
matches protein_C and protein_D, each with the identifier “3*”. 
 IsoformResolver lists MSD groups in descending order of peptide counts, reporting the 
observed mass and mass error for each MS/MS, and the number of observed charge forms and 
highest scores for each peptide, in accordance with reporting guidelines (Bradshaw et al, 2006; 
Taylor et al, 2006).  Results from multiple experiments, each containing one or more LC/MS 
runs, are displayed in separate columns and easily compared using a “compare profile” feature 
(see below).  Section 2 consists of a paragraph summarizing the number of spectra, peptides, 
proteins, and protein groups, as well as the number of proteins supported by different numbers of 
peptides.  Section 3 summarizes proteins inferred to be in the minimal list in the same order as 
Section 1, and is in a format which is useful for further automation in spectral count analyses 
(Old et al, 2009; Old et al, 2005; Hulsen et al, 2008).   
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MSD groups provide a complete and non-redundant protein display 
  Protein inference can be complicated when peptides are shared between multiple protein 
entries.  For example, proteins which are indistinguishable based on the peptide evidence (e.g., 
proteins_C and _D in Fig. 3.5) complicate the protein report, because the number of proteins in 
the minimal list (where only one is counted) differs from the number of primary proteins (where 
both are counted).  Reporting all indistinguishable proteins (protein_C and protein_D) inflates 
the protein count over the minimal list.  Selecting one representative protein (protein_C or 
protein_D) reports the minimum count accurately, but chooses proteins arbitrarily.  Treating a set 
of indistinguishable proteins as one entity with a concatenated name (e.g., protein_C_D) reports 
the correct number and retains information about the protein identities, but leads to variations in 
naming between datasets.  Each method reports different protein lists, and each compromises 
accuracy, especially when comparing results from two or more protein profiles.  
  Also important are cases where peptides are shared between proteins that are 
distinguishable by the presence of other peptides.  We call these cases “bridge peptides”,1 which 
are shared between primary proteins, and are more problematic than peptides which are shared 
between primary and secondary proteins.  This is because when bridge peptides are encountered 
by protein-centric inference programs, they are either eliminated from all but one group, or else 
duplicated and assigned redundantly to different protein groups.  An example is shown in the 
report of two primary proteins, where bridge peptides are replicated and comprise 70% of the 
peptides for each protein (Fig. 3.7a).  Because each protein is listed separately in the output, the 
replicated peptides may lead to overconfidence in the protein identifications.  
                                                            
1 Our use of the term “bridge peptides” is similar but not identical to the term “razor peptides” (Cox and Mann, 
2008).  The latter refer to peptides which are, by Occam’s principle, assigned to the non-overlapping protein group 
with the greatest number of peptides.  By contrast, bridge peptides are assigned to protein groups which allow 
overlapping proteins, in order to retain information that the peptide is shared. 
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Figure 3.7  Methods of assigning bridge peptides used by different protein inference 
programs.  Protein-centric profiling methods replicate or arbitrarily assign bridge peptides to 
proteins, whereas IsoformResolver reports bridge peptides in the context of their MSD protein 
groups and ISD protein groups, thus displaying related proteins adjacently in the output.
a.  TPP ProteinProphet.  The output replicates bridge peptides between different proteins, and 
assigns weights according to distribution.  Bridge peptides are those with weight < 1.0, assigned 
to proteins which are often displayed in different areas of the profile.  Replication of peptides in 
the output may suggest higher confidence in inferred proteins than warranted.
In this example, peptides listed with weight = 0.50 were bridge peptides, assigned to high 
confidence proteins IPI00030783.1 and IPI00103415.1 (STAT5A and STAT5B).  Each of the 
two protein identifications were supported by only 2 or 3 unique peptides, although 9 and 10 
peptides were listed in each case. 
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In this example, although they are related to STAT5, the proteins IPI00030782.1 and 
IPI00743541.1 (STAT6) are displayed in a different location in the protein profile output. The 
peptide in IPI00743541.1 is also contained within IPI00030782.1, so it is considered a secondary 
(subset) protein and assigned a weight of 0.0.
b. IsoformResolver.  Peptides, proteins, and MSD protein groups which belong to the same ISD 
protein group are displayed adjacently.  Here STAT5 and STAT6 are listed together in the 
output, despite the fact that none of the observed peptides were common to both. 
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  Bridge peptides and indistinguishable proteins are a significant problem in protein 
profiling.  For example, in Dataset 1A (Table 3.2), 15% of the 3,667 minimal list proteins were 
linked to others through bridge peptides, 40% were indistinguishable, and only 25% were 
distinct.  Of the 26,225 non-redundant peptides, 67% matched two or more proteins, 7% were 
bridge peptides, and only 33% matched a single protein entry.  Thus, underlying the ambiguity in 
protein identifications is the fact that the shared and bridge peptides are a considerable fraction 
of total peptides and affect a high percentage of proteins.   
  These problems are addressed by IsoformResolver’s report format, which lists proteins 
with shared peptides together, within the context of MSD protein groups.  Because primary 
proteins are displayed adjacently when they share peptides, the need to duplicate bridge peptides 
and redundantly assign them to different proteins is eliminated (e.g., Fig. 3.7b).  By displaying 
all possible proteins, MSD groups allow a user to immediately view the support for inferred 
proteins as well as alternative but equally likely candidates (Fig. 3.6).   The nomenclature used 
for the MSD identifiers allows the different classifications of distinguishable, indistinguishable, 
subset, and subsumed proteins to be readily assessed.   
 
ISD protein groups mitigate volatility caused by protein inference 
   Problems also arise when protein identifications are easily altered by minor changes in 
observed peptides, which we refer to as “volatility”.  Volatility reflects a non-robust quality of 
protein inference.  Fig. 3.8 shows an example of assigning peptides to proteins using a greedy 
algorithm, where two proteins are inferred as primary (IPI00181997.7 & IPI00479677.3), and 
five proteins are secondary (IPI00376351.2, IPI00383202.1, IPI00744506.1, IPI00785128.2,  
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VYFVFH HWL NNE TQT ISD IPI00181997.7 METHYLTRANSFERASE LIKE 2B
IPI00479677.3     METTL2B PROTEINHWL NNE TQT ISD VYFGSL
IPI00376351.2 ISOFORM 1 OF METHYLTRANSFERASE-
LIKE PROTEIN 2
VFH HWL NNE ISD VYFGSL
IPI00383202.1  HSPC267 (FRAGMENT)VFH HWL NNE TQT
IPI00744506.1  24 KDA PROTEIN VFH HWL NNE
IPI00785128.2   ISOFORM 2 OF METHYLTRANSFERASE
-LIKE PROTEIN 2
ISD VYFGSL
IPI00797783.1 14 KDA PROTEIN VYF
     Ambiguity in assigning primary proteins
VFH = VFHHNAWDNVEWSEEQAAAAER; HWL = HWLFTEFPELAPSQNQNHLK; NNE = NNEDGPGLIMEEQHK;
TQT = TQTPPVEENVTQK; ISD = ISDLEICADEFPGSSATYR; GSL = GSLDIIILIFVLSAIVPDK; VYF = VYFFTQEELDTLFTTAGLEK
 IPI00181997.7 and IPI00479677.3 inferred, but other equally likely inferences are possible  
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Figure 3.8  Challenges to protein inference include volatility in choosing primary proteins.   
An illustration of how protein inference introduces ambiguity in assigning primary proteins.  The 
MSD group includes seven proteins, from which IsoformResolver infers two primary proteins,
IPI00181997.7 and IPI00479677.3.  Given equal likelihood for peptides VFH..., TQT..., and GSL..., 
selection of the two inferred proteins is arbitrary, because the primary proteins could also have 
been assigned as IPI00181997.7 & IPI00376351.2, or IPI00479677.3 & IPI00376351.2.  
IPI00797783.1).  However, in two equally plausible alternative solutions, IPI00181997.7 & 
IPI00376351.2 or IPI00376351.2 & IPI00479677.3 could be assigned as the primary proteins.  
Here, small changes in observed peptides will affect which proteins are deemed primary.  For 
example, if peptide GSL… had not been observed, then IPI00181997.7 would have been inferred 
as the only primary protein accounting for all peptides, and IPI00479677.3 & IPI00376351.2 
would have been called secondary.  No method of protein inference obviates this problem, 
including those which are probability-based, or those which ignore proteins supported by a single 
peptide.    
 
Protein repeatability between replicate datasets 
  In order to quantify the effects of protein inference on volatility, we examined the 
repeatability of proteins identified in different datasets, collected at similar depth or varying 
depth of sampling.  First, we quantified the degree to which proteins were repeated between 
three technical replicate datasets (Table 3.2, Dataset 2), where peptides identified in any dataset 
varied due to random sampling by LC-MS/MS.  On average each dataset yielded 2,922 ± 83 non-
redundant peptides (Table 3.3a), 71% of which were found in at least two datasets and 48% 
which were identical across all three datasets.  We then examined all, primary, concatenated, and 
representative proteins, evaluating their overlap between replicates.  As expected, the overlap 
between replicates was generally higher for proteins than peptides, because each protein was 
represented by 2.8 peptides, on average.  However, we found that the degree of overlap varied 
with each reporting method (Table 3.3a), due to their differences in how they dealt with 
indistinguishable proteins.   
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Table 3.3  Protein inference reduces protein repeatability between replicates.  a. Proteins 
identified by one or more peptides showed low overlap between three replicate datasets, due to 
the effects of protein inference.  Comparing proteins at the level of ISD protein groups 
counteracts this effect, and more accurately captures differences between the replicates.  b. 
Requiring a minimum of two charge invariant peptides per protein does not mitigate the protein 
variation.  c. Pooling the replicate datasets together results in fewer proteins in the minimal list.   
 
  
Non-
redundant 
peptides 
Protein reporting method 
  All 
possible 
proteins 
Primary 
proteins 
Concatenated  
proteins 
Representative 
proteins 
ISD protein 
groups 
a. Proteins identified by ≥ 1 peptide 
Replicate 1 2931 3204 2207 1015 1015 896 
Replicate 2 2997 3331 2284 1059 1059 933 
Replicate 3 2839 3231 2229 1026 1026 902 
Total 3989 3972 2936 1418 1298 1109 
Present in 
2 or more 
replicates 
71% 82% 74% 70% 78% 81% 
Present in all 3 
replicates 48% 64% 55% 48% 60% 65% 
b. Proteins identified by ≥ 2 peptides 
Replicate 1 2512 2177 1184 596 596 516 
Replicate 2 2533 2244 1197 595 595 513 
Replicate 3 2384 2127 1120 571 571 494 
Total  3390 2675 1519 796 741 626 
Present in  
2 or more 
replicates 
71% 82% 75% 71% 78% 81% 
Present in all 3 
replicates 48% 63% 55% 50% 59% 62% 
c. Proteins identified by ≥ 2 peptides from pooled replicate datasets 
Total 3479 2791 1507 760 760 656 
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  The overlap was highest when all possible proteins were compared (82% between two or 
more replicates, 64% between three replicates, Table 3.3a), because none were removed by 
inference.  In contrast, primary proteins, which listed indistinguishable proteins as separate 
entities and removed secondary proteins, showed decreased overlap between two replicates 
(74%) or three replicates (55%), and tended to select for splice variants and proteins that shared 
many peptides.  Concatenated protein identifiers reduced overlap even further (70% between two 
replicates; 48% between three replicates).  Here, indistinguishable proteins were named by 
concatenated identifiers, which often overlooked proteins present in common between datasets 
(e.g., an identifier ProteinA_ProteinB would fail to match ProteinB_ProteinC in a different 
dataset, although ProteinB was common to both).  Representative proteins increased their 
overlap between replicates, because proteins with the lowest accession number were chosen from 
among indistinguishable proteins, while information about other possible proteins was discarded.   
  Thus, methods which enumerated the most likely proteins (primary and concatenated) 
paradoxically led to the lowest protein repeatability.  Similar trends were observed with proteins 
identified by two or more peptides (Table 3.3b), indicating that the effect was not caused by 
peptide sampling variations or low confidence protein identifications.  We hypothesized that the 
effects were instead due to problems introduced by protein inference.   
 To test this, we constructed a protein profile using a dataset which pooled the three 
replicate datasets together (using a two peptide minimum), then annotated the results by those 
proteins inferred when each dataset was analyzed separately.  The minimal list for the pooled 
dataset contained 760 proteins, of which 75 proteins were supported by peptides present in only 
one or two of the replicates (Table 3.3c, Fig. 3.9a).  Thus 685 (90%) of all of proteins were found 
in common between replicates, far higher than the degree of overlap observed when proteins  
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c.   Variations due to parsimony differences
GL= GLGLDESGLAK; QA=QAASGLVGQENAR ; TA= TALALAIAQELGSK; TI= TISHVIIGLK; 
GT= GTEDITSPHGIPLDLLDR; AQ= AQTEGINISEEALNHLGEIGTK; EH = EHVEEISELFYDAK; 
ISOFORM 1 OF RUVB-LIKE 1IPI00021187.4
Replicate #1 Replicate #2 Replicate #3
SIMILAR TO RUVB-LIKE 1IPI00787897.1
ISOFORM 2 OF RUVB-LIKE 1IPI00788942.1
20 KDA PROTEINIPI00796459.1
17 KDA PROTEINIPI00798367.1
GL
GL
GL
GL
QA
QA
QA
QA
GT
GT
GT
GT
GL
GL
GL
GL
QA
QA
QA
QA
TA
TA
TA
TA
TI
TI
TI GT
GT
GT
GT
AQ
AQ
AQ GL
GL
GL
GL
QA
QA
QA
QA
AQ
AQ
AQ EH
GT
GT
GT
GT
Replicate #1: indistinguishable proteins IPI00021187.4, IPI00787897.1 and IPI00788942.1
Replicate #2: indistinguishable proteins IPI00021187.4 and IPI00787897.1
Replicate #3: distinguishable protein IPI00021187.4 
Proteins inferred:
SND
Replicate #1
SSP
SNDSSP
Replicate #2
SSP
SNDSSP
Replicate #3
b.   Variations due to two peptide minimum rule
SND = SNDSGIQQSSDDGR; SSP = SSPSTGSLDSGNESK
CENTAURIN-BETA2
17 KDA PROTEIN
IPI00014264.5
IPI00795932.1
Replicate #1: none (below the two peptide minimum)
Replicate #2: IPI00014264.5
Replicate #3: IPI00014264.5
Proteins inferred:
a.   Proteins varying or in common between three replicate datasets
Proteins varying between
replicates, due to parsimony 
differences (110)
Both peptides and proteins varying
between replicates (75)
Proteins common to three
replicates - distinct (89)
Proteins common to three
replicates - inferred (288)
Proteins varying between
replicates, due to two
peptide minimum rule (198)
Figure 3.9  Protein repeatability is affected by protein reporting methods and volatility.  a. 
Three pooled replicate datasets analyzed separately showed varying levels of agreement 
between identified proteins.  Of 760 proteins identified when replicate datasets were analyzed 
together, 685 (all but 75) were inferred from peptides present in all 3 replicates, signifying high 
peptide overlap between datasets.  Of these, only 377 (55%) proteins were present in all three 
replicates, revealing low protein overlap.  b. Examples of protein variations between replicates 
introduced by protein inference.  Replicate 1 in Dataset 2 shows only one peptide and is there-
fore not matched to a protein, while Replicates 2 and 3 infer IPI00014264.5 from two peptides.  
c. Three of seven peptides are found in all three replicates, but peptides in Replicate 1 cannot 
distinguish between IPI00021187.4, IPI00787897.1 & IPI00788942.1, and peptides in Replicate 
2 cannot distinguish IPI00021187.4 & IPI00787897.1.  In contrast, peptide EH... identifies 
IPI00021187.4 as the sole primary protein in Replicate 3. 
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were inferred from the three datasets independently, regardless of reporting method.  
Nevertheless, only 377 (55%) of the 685 proteins were inferred in all three replicates (89 distinct 
proteins, 288 in the same MSD groups), while 308 (45%) proteins differed between replicates.  
Therefore, the low repeatability across replicate sets was mainly due to variability in the proteins 
inferred from peptides present in all three sets.  In 198 of the 308 cases, the same proteins would 
have been identified in each dataset, but were removed because they were identified by fewer 
than two peptides (e.g., illustrated in Fig. 3.9b).  In the remaining 110 (16%) cases, differences 
between datasets were due to different protein identifications, and thus caused by parsimony.   
 Cases where proteins varied due to parsimony reflected volatility due to small changes in 
additional distinguishable peptides that were present in some, but not all replicates.  For 
example, in Fig. 3.9c, the presence of peptide EH... in Replicate 3 but not Replicates 1 and 2, led 
to inference of only one primary protein in Replicate 3, whereas three indistinguishable proteins 
were inferred in Replicate 1 and two indistinguishable proteins were inferred in Replicate 2.  
Overall, the inferred proteins showed greater differences between replicates than the peptides.  
These results showed that protein variations are an intrinsic feature of shotgun proteomics, not 
only due to variations in peptide sampling, but also because variable protein identifications are 
exacerbated by inference. 
  We next examined the replicate datasets using ISD protein groups.  When each of the 
three replicate datasets were analyzed separately, 1,109 or 626 ISD groups were respectively 
identified after requiring ≥ 1 or ≥ 2 peptides/protein (Tables 3.3a,b).  The overlap in ISD groups 
between 2 and 3 replicate datasets were 81% and 62-65% respectively, comparable to the 
overlap between all possible proteins, and significantly higher than the overlap between inferred 
proteins, regardless of reporting method.  Thus, ISD groups allow greater overlap to compare 
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proteins between datasets, and therefore offers a more stable view of the protein profile. 
 
Protein repeatability between datasets collected at different sampling depth 
  Next we examined effects of protein inference on volatility by comparing datasets 
collected at different depths of sampling, comparing datasets of cell lysate proteins analyzed in 
duplicate 1D-LC-MS/MS runs (29,907 MS/MS) vs. proteins separated by SDS-PAGE followed 
by in-gel digestion (252,205 MS/MS) (Table 3.2, Dataset 3).  Prior studies had shown that 
proteins identified in datasets at lower sampling depth overlap nearly completely with those in 
datasets collected at higher depth (Resing et al, 2004).  Thus as expected, the overlap was high, 
where 91% of peptides and 98% of proteins identified in the lower sampling depth dataset were 
also identified in the higher depth dataset (Table 3.4a).  However, the overlap between primary 
proteins was only 75%.   
  In order to confirm that this variability was due to inference and not to differences in 
peptides between the peptides contained in each dataset, we simulated a lower depth dataset by 
truncating MS/MS spectra with lowest intensity from the higher depth Dataset 3.  The MS/MS 
removed were adjusted to yield a remaining number of peptides similar to that of the lower depth 
experimental dataset (Table 3.4b).  Because peptides in the truncated dataset were a complete 
subset of those in the high depth dataset, any protein variations would reveal effects due only to 
inference.  The results showed that even when the peptides in the low depth dataset overlapped 
those in the high depth dataset completely, protein inference decreased the overlap between 
primary proteins by 21%.   
  By contrast, ISD groups showed 98% overlap between datasets collected at lower and  
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Table 3.4  Protein inference methods underestimate overlap between proteins obtained 
from datasets with lower vs. higher depth of sampling.  a. Unfractionated lysates are sampled 
at a lower depth, while fractionated lysates allowed for higher sampling depth.  b. Lower depth 
of sampling is simulated by removing > 90% of the lowest intensity MS/MS from the higher 
depth dataset.  Even when the peptide overlap between lower and higher depth datasets is 100%, 
different proteins were inferred. 
 
  
MS/MS 
Spectra 
Non-
redundant 
peptides 
Protein reporting method 
  All 
proteins 
Primary 
proteins 
Representative 
proteins 
ISD 
protein 
groups 
a.  Comparison of lower depth (unfractionated) vs. higher depth (fractionated) datasets 
Lower depth 
dataset 29,907 3660 3631 2260 941 836 
Higher depth 
dataset 252,205 11,112 8502 5064 2402 2098 
Overlap (as % 
of lower depth 
dataset) 
N.A. 91% 98% 75% 91% 98% 
  
b.  Comparison of simulated lower depth vs. higher depth datasets 
Simulated lower 
depth dataset 24,338 3663 3895 2448 1052 935 
Higher depth 
dataset 252,205 11,112 8502 5064 2402 2098 
Overlap (as % 
of lower depth 
dataset) 
N.A. 100% 100% 79% 94% 100% 
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higher sampling depth, and retained 100% overlap between the simulated and higher depth 
datasets.  Thus, the mapping of proteins and peptides to invariant ISD groups added stability to 
the protein report, bypassing problems in reproducibility, and thereby counteracting volatility 
caused by protein inference. 
 
Compare profile feature optimizes information retrieval from multiple experiments 
  We found that protein inference varied when datasets were joined in different ways.  
Often, proteomics experiments involve comparisons between LC-MS/MS runs (e.g., control vs. 
treated, differing protocols, chromatographically separated proteins).  The many datasets 
produced can be analyzed either carrying out protein inference on each dataset separately and 
then combining the results to create an aggregate set (“aggregate” analysis), or by pooling 
peptides from all datasets together before protein inference (“pooled” analysis) (Fig. 3.10a).   
  In order to compare the two approaches, datasets were collected on cell lysate proteins 
that were first separated into 33 fractions by strong anion exchange (SAX) chromatography, 
followed by proteolysis and LC-MS/MS (Table 3.2, Dataset 1B).  In a first test, proteins were 
assembled from datasets of each fraction analyzed separately by IsoformResolver, which were 
then joined into an aggregate profile of 7,699 primary (distinct + distinguishable + total 
indistinguishable) proteins and 4,582 minimal list (distinct + distinguishable + minimal 
indistinguishable) proteins, where the counting excluded redundant cases.  In a second test, 
peptides from each SAX fraction were combined into one pooled dataset and then assembled into 
proteins using IsoformResolver, yielding 5,854 primary and 3,270 minimal list proteins.  Thus, 
the number of minimal list proteins inferred in the pooled profile was 40% lower than those  
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21,414 non-redundant 
peptides yielded:
a.  Aggregate vs. Pooled Analysis
Aggregate Analysis
Expt 1 peptides
Expt 2 peptides
Expt N peptides
combine
Expt 1 protein list 
Expt 2 protein list 
Expt N protein list 
protein list 7,699 primary proteins 
4,582 minimal list proteins
. .
 . 
.
Pooled Analysis
Expt 1 peptides
Expt 2 peptides
Expt N peptides
5,854 primary proteins 
3,270 minimal list proteinspeptides
pool
protein list
. .
 . 
.
Pooled Analysis 
protein list
Expt 1 peptides and proteins 
Expt 2 peptides and proteins 
Expt N peptides and proteins 
5,854 primary proteins 
3,270 minimal list proteins
b.  IsoformResolver − Compare Profile
display by fraction
. .
 . 
.
Figure 3.10  Protein inference is affected by joining multiple datasets in different ways.  a. 
In an aggregate analysis, peptides from LC-MS/MS datasets of different fractions from a chro-
matographically resolved sample are first analyzed by inference, then the proteins are combined.  
In a pooled analysis, peptides from different fractions are combined prior to protein inference.  
Pooling peptides and then performing inference yields the simplest solution with the smallest 
number of proteins, as shown at the right (Dataset 1B), but loses important information when 
analyzing fractions separately.  b. In a compare profile, IsoformResolver combines the strengths 
of pooled and aggregate analyses, by pooling the datasets to identify the minimal list proteins, 
and then displaying spectral counts for each individual dataset.  
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inferred in the aggregate profile.  The protein overlap was nearly complete, as only one primary 
protein observed in the pooled analysis was excluded from the aggregate analysis.  Therefore, 
with multiple LC-MS/MS runs, pooling the peptide information before assembly yielded a more 
conservative protein count. 
  How protein inference underlies this effect is illustrated in an example where 6 observed 
peptides mapped to 6 possible proteins (Fig. 3.11).  In the pooled analysis, two primary proteins 
(IPI00444788.1 & IPI00025340.3) accounted for all peptides (Fig. 3.11a).  However, in the 
aggregate analysis, the number of peptides in each fraction varied, and together inferred six 
primary proteins, five of which were distributed in three indistinguishable sets (Fig. 3.11b).  For 
example, peptides in fraction #22 identified four indistinguishable proteins (IPI00444788.1, 
IPI00445123.1, IPI00456744.1 and IPI00743804.1), while peptides appearing in fraction #23 
identified two indistinguishable proteins (IPI00444788.1 and IPI00456744.1).  Thus, even when 
the same peptides were represented, carrying out protein inference on separate datasets inflated 
the protein counts compared to pooling the datasets prior to inference.  Such differences were 
caused by lower numbers of peptides in each fraction in the aggregate analysis, leading to 
increased numbers of indistinguishable proteins.  In the pooled analysis, more proteins were 
converted to distinguishable or secondary proteins, reducing the indistinguishable proteins and 
minimizing the number of primary proteins. 
  Despite this advantage, pooling datasets discarded important information about the 
representation of different proteins across samples.  For example, when chromatographically 
separating proteins, it is often useful to know how different proteins vary in elution, and here, it 
would be advantageous to analyze each dataset separately.  Therefore, IsoformResolver provides 
the option of displaying a “compare profile” in Section 3 (Fig. 3.10b), in which primary proteins  
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 a.  Pooled Analysis
c.  Compare Profile 
b.  Aggregate Analysis
KLP LSE SLS SPP LEE
TPG LEE
SPPLSE SLS
SPPKLP LSE SLS
KLP LSE SLS
SPPLSE SLS
CDNA FLJ44925 FIS. CLONE BRAMY3014613. 
HIGHLY SIMILAR TO SJ3BP1.IPI00444788.1
PYRIDOXAL PHOSPHATE PHOSPHATASE.IPI00025340.3
CDNA FLJ44592 FIS. CLONE BLADE2002310. 
SIMILAR TO SH3BP1 (FRAGMENT).IPI00445123.1
ISOFORM 1 OF SH3 DOMAIN-BINDING PROTEIN 1IPI00456744.1
ISOFORM 2 OF SH3 DOMAIN-BINDING PROTEIN 1IPI00456745.3
67 KDA PROTEIN.IPI00743804.1
KLP=KLPLMALSTTMAESFK; LSE=LSEEELPAILK; SLS=SLSSLDTALAELR; TPG=TPGTGSLAAAVETASGR; SPP=SPPETAAPVEDMAR; 
LEE=LEEAQAYLAAGQHDLVPHYYVESIADLTEGLED
Protein ID Accession Protein  descriptor Gene
763 IPI00444788.1 CDNA  FLJ44925  FIS. CLONE BRAMY3014613.  HIGHLY SIMILAR  TO PDXP
764 IPI00025340.3 PYRIDOXAL  PHOSPHATE PHOSPHATASE. PDXP
a IPI00445123.1 CDNA  FLJ44592  FIS. CLONE BLADE2002310.  HIGHLY SIMILAR  TO SH3BP1
b IPI00456744.1 ISOFORM  1 OF SH3 DOMAIN BINDING  PROTEIN 1. SH3BP1
c IPI00456745.3 ISOFORM  2 OF SH3 DOMAIN BINDING  PROTEIN 1. SH3BP1
d IPI00743804.1 67  KDA  PROTEIN. PDXP
  Peptide  sequence … fr#15 fr#16 fr#17 … fr#22 fr#23 fr#24 …
763_764 LEEAQAYLAAGQHDLVPH 2 1
763_a_b_c_d LSEEELPAILK 2 1
763_a_b_c_d SLSSLDTALAELR 2
763_a_b_d SPPETAAPVEDMAR 1 2
763_b_c KLPLMALSTTMAESFK 1
764 TPGTGSLAAAVETASGR 3 2 1
YYVESIADLTEGLED
HOMO  SAPIENSSH3 DOMAIN  BINDING  PROTEIN 1.
( )HOMO  SAPIENS SH3 DOMAIN  BINDING  PROTEIN 1 FRAGMENT).
 Peptides Proteins inferred
Fraction KLP LSE SLS TPG SPP LEE
    x x IPI00025340
    x x IPI00025340
    x IPI00025340
  x   x
 x x   x
   x    IPI00444788 IPI00445123 IPI00456744 IPI00456745IPI00743804 
fr# 15
fr# 16
fr# 17
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fr# 24 , , , ,
IPI00444788 IPI00445123 IPI00456744 IPI00743804, , ,
IPI00444788 IPI00456744,
-
-
-
Protein ID
Expt 1
Expt 2
Expt N
peptides
pool
protein list
Expt 1
Expt 2
Expt N
peptides
combine
proteins in Expt 1
peptides
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proteins in Expt 2
proteins in Expt N
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proteins in Expt N
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Figure 3.11  Compare profiles use aspects of pooled and aggregate analysis.  
Figure 3.11  (continued)  In a pooled analysis, peptides from different fractions are combined 
prior to protein inference.  Pooling peptides and then performing inference yields the simplest 
solution with the smallest number of proteins, as shown at the right (Dataset 1B), but loses 
important information when analyzing fractions separately.  b. In an aggregate analysis, peptides 
from LC-MS/MS datasets of different fractions from a chromatographically resolved sample are
first analyzed by inference, then the proteins are combined.  c. In a compare profile, 
IsoformResolver combines the strengths of pooled and aggregate analyses, by pooling the datasets 
to identify the minimal list proteins, and then displaying spectral counts for each individual dataset.
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are inferred and spectral counts apportioned using the pooled datasets, while spectral counts are 
displayed per individual dataset.   
  An example of a compare profile is shown in Fig. 3.11c, where the pooled analysis 
inferred two primary proteins, and displaying each fraction separately in the output clearly 
showed that the two proteins resolved chromatographically.  Peptides in fractions #15-17 best 
matched protein_764, while peptides in fractions #22-24 best matched protein_763 or secondary 
protein_b.  In fact, in fractions #22-24, support for protein_b over protein_763 was suggested by 
the absence of peptide LEE... against the presence of peptides LSE..., SLS..., SPP... and KLP....  
This illustrates the advantage of combining the peptide evidence with information about 
chromatographic resolution, allowing the user to evaluate cases which might otherwise have 
been overlooked.  By calculating the most conservative estimate of minimal list proteins, and 
displaying related proteins in logical groupings, IsoformResolver allows spectral count variations 
between individual datasets to be readily evaluated.  Thus, the compare profile feature of 
IsoformResolver combines the strengths of pooled and aggregate analyses, by providing a 
conservative calculation of proteins from a pooled analysis and an informative display of results 
in each experiment. 
 
IsoformResolver simplifies the spectral count analysis of bridge peptides 
  An important approach for label-free quantification of proteins is spectral counting, 
which sums the total number of MS/MS corresponding to any peptide in a given protein (Old et 
al, 2005).  However, assigning spectral counts to proteins is complicated when bridge peptides 
are shared between two or more proteins in the minimal list (Zhang et al, 2010; Jin et al, 2008).  
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This can skew information on relative abundances of proteins.  For example, in Fig. 3.12a, 2 
peptides (EAG..., NHP...) uniquely infer two indistinguishable proteins (GNPDA2) with 9 
spectral counts, and 5 peptides (AAG..., DHP..., FFD..., LII..., and LVD...) uniquely infer one 
protein (GNPDA1) with 37 spectral counts.  Four bridge peptides (AIE..., EVM..., TFN..., 
VPT...) represent an additional 45 spectral counts, and how these are apportioned can greatly 
influence the estimated relative abundance of GNPDA1 and GNPDA2.  IsoformResolver 
apportions spectral counts from bridge peptides proportionally to the spectral counts of non-
shared peptides for distinguishable proteins.  In this example, 20% of spectral counts from bridge 
peptides were apportioned to GNPDA2 and 80% were apportioned to GNPDA1 (Fig. 3.12b).  
Similar calculations are used to apportion non-redundant peptides.  Apportioned spectral counts 
for bridge and non-redundant peptides are then summarized in Section 3 of the IsoformResolver 
output (Fig. 3.5, Fig. 3.6).  We report spectral counts for distinguishable and bridge peptides 
separately, as the primary evidence for each protein.  Apportionment of spectral counts 
according the number of distinguishable peptides is also included which can be useful for 
comparing proteins containing bridge peptides with those that don’t.   
  Fig. 3.12c shows examples which break down spectral counts according to SAX 
fractions, and illustrate how spectral counts for non-bridge vs. bridge peptides can provide 
information about the reliability of protein identifications and the presence of related proteins.  
Case [i] shows a simple example, where bridge peptides track two proteins (1009*, 1010) in each 
of fractions #19-22, and support the presence of each protein.  Case [ii] shows bridge peptides 
which match two primary proteins (1065, 1066*) but track only one protein (1065).  In Case [iii], 
some bridge peptides appear in fractions #33-39 but track neither primary protein (363 or 364), 
suggesting that they instead correspond to another protein.  Because IsoformResolver reports  
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c.   Spectral count tables for fractionated datasets
Prot ID Accession Protein descriptor Gene
1009* IPI00550894.4 GLUCOSAMINE-6-PHOSPHATE ISOMERASE SB52 GNPDA2
1009* IPI00744859.1 GLUCOSAMINE-6-PHOSPHATE DEAMINASE 2 (FRAGMENT) GNPDA2
1010 IPI00009305.1 GLUCOSAMINE-6-PHOSPHATE ISOMERASE GNPDA1
Prot ID Peptide sequence Highest XCORR Highest Mowse Spectral Counts
1009* EAGGIDLFVGGIGPDGHIAFNEPGSSLVSR 4.5 99.1 3
1009* NHPESYHSYMWNNFFK 2.8 30.5 6
1009*_1010 AIEEGVNHMWTVSAFQQHPR 6.2 96.3 22
1009*_1010 EVMILITGAHK 3.2 50.7 2
1009*_1010 TFNMDEYVGLPR 3.9 82 14
1009*_1010 VPTMALTVGVGTVMDAR 4.6 117.2 7
1010 AAGGIELFVGGIGPDGHIAFNEPGSSLVSR 5.6 94.6 10
1010 DHPESYHSFMWNNFFK 5.4 99.1 8
1010 FFDGELTK 2.1 52 2
1010 LIILEHYSQASEWAAK 5.4 70 13
1010 LVDPLYSIK 2.7 35.6 4
b.   Apportionment of bridge peptide spectral counts
  
Case [i]
Case [iv]
Case [ii]
a.  MSD protein group (GNPDA1, GNPDA2)
} 9
}45
}37
  Protein ID Accession Gene ISD group  
1009* IPI00550894.4 GNPDA2 ISD8 -4884
1009*_1010  IPI00550894.4_IPI00009305.1 GNPDA2 ISD8 -4884
1010 IPI00009305.1 GNPDA1 ISD8 -4884
17.8
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SHMT2
ISD8 -207
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13
1
6
13.6
6.4
108.2
59.8
103
8
57
  Protein ID Accession Gene ISD group
121* IPI00003964.3 USP9X
121*_122*       IPI00003964.3_IPI00012094.1 USP9Y
122* IPI00012094.1 USP9Y
ISD8 -1819
ISD8 -1819
ISD8 -1819
152.1
1.9
App SC App Pep Pep 
18
SC
64
72
1
2.8
8.2
35     36     37     38
Fractions
0
3
0
17
12
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37
40
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27
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11
Case [v]
  Protein ID Accession Gene ISD group
1470* IPI00258833.1 SNX6
1290 IPI00295209.5 SNX5
ISD8 -1020
ISD8 -1020
Total SC
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38
27     28     29     30     31     32
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7
5
2 3
23
4 0
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0
20
App Pep Pep 
4
8
4
8
Case [iii]
  Protein ID Accession Gene ISD group
248 IPI00641829.5 BAT1
248_249       IPI00641829.5_IPI00644431.1 DDX39
249 IPI00644431.1 DDX39
ISD8 -184
ISD8 -184
ISD8 -184
147.6
52.4
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9
SC
74
107
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17.1
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Figure 3.12  Apportionment of bridge peptides for spectral counting.  a. An example 
shows 11 peptides observed in datasets of 33 fractions, mapped to three glucosamine-6-
phosphate isomerase/deaminase proteins (GNPDA1, GNPDA2).  Four peptides bridge both 
sets of primary proteins (IPI00009305.1 and the indistinguishable set of IPI00550894.4 & 
IPI00744859.1).  
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Figure 3.12.  (continued) b. The spectral count summary shows that bridge peptides account 
for nearly half of the spectral counts.  Spectral counts for the bridge regions are apportioned to 
each primary protein, proportional to the spectral counts for their distinguishing peptides.  c. 
Using a compare profile to report spectral counts across multiple datasets facilitates evaluation 
of primary proteins and apportionment of bridge peptides.  Case [i] Bridge peptides track each 
of two primary proteins across fractions.   Case [ii] Bridge peptides track with and are more 
accurately apportioned to IPI00002519.1, with minor overlap with IPI00002520.1.   Case [iii] 
Bridge peptides provide evidence for a protein that likely differs from Bat1 and Ddx39.  Case 
[iv] Bridge peptides track IPI0003964.3 and IPI00012094.1, but are more accurately appor-
tioned to IPI0003964.3, given low spectral count evidence for IPI00012094.1.  Case [v] No 
bridge peptides were observed in the dataset, although IPI00258833.1 & IPI0295209.5 are 
related proteins.  The fact that these proteins are related would have been missed, had they not 
been listed within the same ISD protein group.
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detailed information about all proteins and their spectral counts, such cases can be readily 
assessed and overlooked proteins identified.   
  A unique feature of IsoformResolver is that it clusters the display of proteins based on 
shared peptides, allowing proteins related by bridge peptides and belonging to the same MSD 
and ISD groups to be listed adjacently.  This solves problems caused by listing proteins 
separately, which may lead to overconfidence in protein identifications.  For example, Fig. 3.12c, 
Case [iv] shows two paralogous proteins from different genes which differ widely in spectral 
counts (81 for 121*, 1 for 122*).  Redundantly assigning the 18 bridge peptides to both proteins 
might create false confidence for the presence of protein 122*, especially if the proteins were 
reported in different regions of the output.  By displaying these proteins adjacently in the output, 
potential false positive peptide assignments (e.g., with disproportionately few spectral counts) 
and the apportionment of bridge peptides are readily evaluated.  In addition, clustering proteins 
by ISD groups allows related proteins to be easily identified.  For example, in Case [v], proteins 
1470* and 1290 are paralogs that share amino acid sequences, but no bridge peptides were 
observed and the peptides for proteins 1470* and 1290 were non-overlapping.  Here, protein-
centric methods would have placed each protein in separate groups, and the fact that these genes 
are related would have been missed.  The ability of IsoformResolver to display ISD groups 
adjacently allowed these related gene products to be listed together, facilitating evaluation of 
their relative abundance by spectral counting. 
 
Proteins in ISD groups are functionally related and vary with shared peptide length 
 We evaluated whether ISD groups might contain proteins which share biological function 
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as well as peptide sequence.  Functional relatedness was evaluated in multiprotein ISD groups 
(i.e., with two or more proteins), scoring agreement between IPI UniProt (DAT) and GO 
database annotations, and requiring one or more annotation to be shared in common among all 
proteins within an ISD group.  We assessed first whether proteins within each group were 
derived from common genes; second, whether they were members of a common protein family, 
although not derived from a common gene; and third, whether they were functionally related by 
GO or other annotations, although not a common protein family.   
 Of the 10,651 multiprotein ISD groups generated from shared peptides of 8 amino acids 
or longer, 7,136 (67%) contained protein members all derived from a common gene (e.g., splice 
variants, processed protein forms), 1,683 more (16%) contained members all belonging to a 
common protein family, and 538 more (5%) contained protein members sharing GO or another 
cross-reference annotations (Fig. 3.13a).  Another 929 (9%) contained members with incomplete 
annotations, however the proteins that were annotated showed complete agreement in gene, 
protein family, or other annotations.  Thus in 97% of ISD groups, all protein members that could 
be evaluated were functionally related.  In the remaining 3%, proteins often appeared related.  
For example, one group contained proteins with similar gene names (CNNM1, CNNM2, 
CNNM3, and CNNM4, corresponding to cyclins M1-M4), even though their annotations were 
non-overlapping.  Because gene names do not always report function, this group was not scored, 
although its members were clearly related.   
 We also examined the frequency with which proteins between different ISD groups were 
unrelated.  Here we scored “exclusivity”, when a group was the only one which corresponded to 
a particular gene, protein family, or other cross-reference identifier.  Among the 7,136 ISD 
groups whose protein members unanimously specified a single gene annotation, 7,041 (99%)  
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Figure 3.13  ISD protein groups define functionally related proteins.  a. Proteins show 
strong functional relatedness within multiprotein ISD groups (defined by a minimum shared 
peptide length of 8 amino acids).  In 67% (7,136 of 10,630) ISD groups where all proteins are 
annotated, all proteins within the group were related based on gene database annotation and 
agreement on a gene identifier.  In 16% (1,684) of cases, all proteins within the group were 
related based on protein family annotation, and consensus for a single identifier.  In 5% (538) of 
cases, all proteins were related based on GO or other database annotations.  In ISD groups 
where the proteins were incompletely annotated, 9% (929) showed complete agreement in gene, 
protein family, GO or other annotations for those proteins which were annotated.  b. As the 
minimum length of the shared peptides are set to increasing values, the number of ISD protein 
groups increases while the average number of proteins per ISD protein group decreases.  c. 
Consensus and functional relatedness between proteins within each ISD group increases as the 
length of shared peptides increases.
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were exclusive.  Not surprisingly, protein family annotations did not show the same degree of 
exclusivity.  Among 5,868 groups whose proteins unanimously specified a common protein 
family annotation (4,185 also specifying a common gene), only 1,410 cases were exclusive.  The 
results show that proteins that share even few peptides in common are related functionally, and 
that for the most part, ISD groupings capture all proteins which are related, while excluding 
proteins which are unrelated.  
 This behavior changed with the length of shared peptides.  Protein groups constructed 
from shared peptides with minimum length 5, 6, or 7 amino acids produced fewer protein groups, 
each with higher average numbers of proteins (Fig. 3.13b).  On the other hand, as peptide length 
and the number of groups increased, the relatedness of proteins within each group also increased 
(Fig. 3.13c).  Considering only gene annotations, increased peptide length led to increased 
consensus, while exclusivity remained constant (data not shown).  A minimum length of 5 amino 
acids yielded large ISD groups, averaging 98 protein entries, whose proteins exhibited functional 
relatedness within 84% of groups.  A minimum length of 12 amino acids yielded more ISD 
groups, with little change in functional relatedness compared to 8 amino acids.  Overall, 8 amino 
acids was the optimal minimum length for grouping proteins with common function.  This was 
the minimum length previously determined for filtering out false positives during peptide 
identification (Resing et al, 2004; Elias et al 2007).  We conclude that 8 amino acids provide an 
optimal minimum peptide length for protein grouping as well as peptide identification.   
 
Comparison of protein profiling and inference software 
 We compared IsoformResolver to other programs used for protein inference (IDPicker, 
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Panoramics, Phenyx, Scaffold, TPP ProteinProphet).  The programs varied with respect to 
input/output format, ease of use, and other features (summarized in Table 3.5).  Here, we focused 
on their differences with respect to protein inference, protein grouping, how they dealt with 
indistinguishable proteins, their ability to handle large datasets, and comparison of results 
between different datasets.    
 
Protein inference   
 We first compared software with respect to protein inference on a single LC-MS/MS run 
(Table 3.2, Dataset 1D).  The numbers of peptides and proteins reported by each program were 
comparable and default parameters were used in each case, with settings chosen to yield 
comparable numbers of identified peptides.   One complication was that Phenyx, Scaffold, and 
ProteinProphet integrate peptide identification algorithms into the software, each using different 
underlying methods to choose peptides, assess false assignments, and evaluate low scoring 
MS/MS spectra.  This introduced variations in identified peptides, which complicated the 
comparison of protein identifications.  Therefore, IsoformResolver was used to specify ISD 
groups from the peptides identified by each program.  In this way, we could assess proteins 
identified by each program that were within the same ISD group, allowing differences in protein 
inference rather than differences in peptides to be evaluated.   
 Each program yielded proteins corresponding to 255-295 ISD groups.  Of the 238 groups 
common to all six programs, 60 contained proteins that were distinct and unambiguously 
identified by all.  In order to minimize differences due to peptide variations, 112 of the remaining 
178 ISD groups were selected because all programs mapped identical proteins to the peptides in  
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Table 3.5  Comparison of protein inference programs.   
 
Factor Isoform Resolver IDPicker Panoramics Phenyx Scaffold 
TPP 
Protein 
Prophet 
Cost  Free  Free  Free  
Three 
versions, one 
is free  
Fee required  Free  
Search 
methods 
supported  
Mascot, 
Sequest, 
X!Tandem, 
X!Hunter  
MyriMatch, 
X!Tandem, 
Sequest, 
Mascot  
Mascot  
OLAF,  
Mascot, 
Sequest, 
Scaffold, 
X!Tandem  
Sequest, 
Mascot, 
X!Tandem, 
Phenyx  
Sequest, 
Mascot, 
SpectraST, 
X!Tandem  
Program 
description  
Command 
line  HTML  HTML  
HTML  or 
downloaded 
GUI program  
Downloaded 
GUI program  
HTML or 
command 
line  
Ease of use  Moderate  Moderate  Very easy  Easy to moderate  Easy  Moderate  
Determining 
accuracy, 
validation 
Allows 
filtering by 
physico-
chemical 
properties  
By probability No tuning parameters 
Various 
probability and 
proprietary 
scores  
By 
probability  
By 
probability  
Bridge 
peptide 
handling  
Uses protein 
groups and 
avoids 
replication  
Uses protein 
groups and 
avoids 
replication 
Replicates  
bridge 
peptides  
Replicates 
bridge 
peptides  
Replicates 
bridge 
peptides  
Replicates 
bridge 
peptides  
Protein 
reporting  
Primary, 
representative 
and 
secondary 
proteins  
Representative 
only (not all 
primary and 
no secondary 
proteins) 
Primary only 
(no 
representative 
or secondary 
proteins)  
Representative  
and secondary 
proteins (not 
all primary)  
Primary only 
(no 
representative 
or secondary 
proteins) 
Primary and 
secondary 
proteins  
(no repre-
sentative) 
Protein 
databases  
DAT or 
FASTA 
format; 
converts into 
peptide-
centric format  
Requires 
target decoy 
database in 
FASTA 
format  
FASTA 
format  
FASTA 
format; limited 
in the free 
version  
FASTA 
format  
FASTA 
format  
Output 
display  Spreadsheet HTML HTML  
HTML or 
spreadsheet  
HTML or 
spreadsheet 
XML or 
spreadsheet 
Compare 
profiles? 
Yes, for any 
grouping 
Yes, for any 
grouping, even 
hierarchical 
No 
Limited to 
small datasets 
in the free 
version  
Yes, by 
sample  
No, 
although 
Protein-
Prophet in 
CPAS does  
Throughput 
capabilities  
Good with 
large datasets 
Limited with 
large datasets 
One rawfile at 
a time 
Limited in the 
free version  
Good with 
large datasets 
Limited with 
large 
datasets  
Quantifi-
cation? Yes Yes No Yes  Yes  Yes  
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these groups (termed “meta-peptides” by Zhang et al, 2007).  We inspected and compared 
proteins inferred for these 112 ISD groups.  
 Certain programs showed greater similarities in their protein identifications.  Programs 
that reported all indistinguishable proteins as primary (TPP ProteinProphet, Panoramics, 
Scaffold, and IsoformResolver in its default mode) showed greater similarities in protein 
identification with each other, compared to programs which selected a single, representative 
protein from among each indistinguishable set (IsoformResolver in its representative protein 
selecting mode, Phenyx, and IDPicker).   We identified five different cases.  In 20 of 112 ISD 
groups (Case 1), the same proteins were identified by all 6 programs (Fig. 3.14, Table 3.6).  In 34 
ISD groups (Case 2), identical proteins were inferred by programs which selected and displayed 
all primary proteins, and by programs which displayed only representative proteins, although the 
proteins differed between the two program types.  In 53 ISD groups (Case 3), proteins were 
identical among programs that displayed primary proteins, but non-identical among programs 
that selected representative proteins.  In 3 ISD groups (Case 4), the proteins were non-identical 
among programs displaying primary proteins, but identical among those selecting representative 
proteins.  The remaining 2 ISD groups (Case 5) showed no agreement in proteins identified 
between the two kinds of programs.  Thus, agreement was generally found between programs 
which selected primary proteins, while programs which selected representative proteins often 
disagreed with each other, and sometimes chose proteins that none of the other programs 
inferred.  Similarly, analysis of the Sigma-Aldrich UPS1 sample of purified human proteins, 
where true and false protein identifications could be determined, showed that programs reporting 
primary proteins yielded more true assignments than programs reporting representative proteins 
(data not shown).  We conclude that reporting primary proteins yields greater agreement after  
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Case 1 Case 2 Case 3 Case 4
Case 5
All programs
 agree
Agreement within primary
selecting or representative 
protein selecting programs,
 but not between them
Agreement within primary protein 
selecting programs only
Agreement within 
representative 
protein selecting 
programs only
No overall agreement 
between programs
1
2
3
4
5
6
Protein Entries:
Inference programs:
Primary protein
selecting
Representative
 protein selecting
TPP Pan Sca IRP IRR Phe IDP
Figure 3.14  Protein inference differences are mainly due to whether programs report 
primary or representative proteins.  Six protein inference programs (TPP ProteinProphet, 
Panoramics, Scaffold, IsoformResolver, Phenyx, and IDPicker) were used to analyze a dataset.  
112 ISD protein groups with common peptides are shown here.  Color shadings distinguish 
programs which report primary proteins (TPP ProteinProphet, Panoramics, Scaffold, IsoformRe-
solver in its default mode), versus programs which report a single representative protein from 
among indistinguishable proteins (IsoformResolver in its representative selecting mode, Phenyx, 
and IDPicker).  
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Figure 3.14  (continued) Top panel: Close-up of Case 5 illustrating the organization of each 
case.  In this example between 1 and 6 proteins were reported for this ISD protein group, and 
boxes indicate proteins inferred by each program.  Bottom panel: all 112 ISD protein groups.  In 
Case 1 (20 of 112 ISD groups), identical proteins were inferred by all programs.  In Case 2 (34 
groups), proteins agreed between primary selecting programs and between representative select-
ing programs, although the two types of programs disagreed. In Case 3 (53 groups), primary 
selecting inference programs agreed with each other, but programs which select representative 
proteins did not. In Case 4 (3 groups), only representative selecting programs agreed.  In Case 5 
(2 groups) there was no overall agreement in either set of programs.
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Table 3.6  Examples of ISD groups found in common by six protein inference programs.  The 
five examples illustrate cases shown in Fig. 9.  Proteins inferred by each program are shown in the 
columns on the left, while spectral counts reported by each program are shown in columns on the 
right.  The programs tested were TPP ProteinProphet (TPP); Panoramics (Pan); Scaffold (Sca); 
IsoformResolver, in the default, primary protein selecting mode (IRP); IsoformResolver in the 
representative protein selecting mode (IRR); Phenyx (Phe); and IDPicker (IDP).  For more detail, 
all 112 annotated ISD protein groups can be viewed in Suppl. Worksheet_3.xlsx. 
 
Case 1. All programs identify the same protein.  Not all programs identified all peptides, but all 
programs identified the same protein in the group (IPI0025019.3). 
 
Proteins inferred by each program  Protein Spectral Counts 
TPP Pan Sca IRP IRR Phe IDP   TPP Pan Sca IR Phe IDP 
√ √ √ √ √ √ √ 1 IPI00025019.3  PROTEASOME SUBUNIT BETA TYPE 1 PRECURSOR. Gene=PSMB1 
       a IPI00556291.1  PROTEASOME BETA 1 SUBUNIT VARIANT (FRAGMENT). No gene annotation. 
       1 AGGSASAMLQPLLDNQVGFK 1 1 1 1 1 1 
       1 NMQNVEHVPLSLDR 2 2 2 2 2 2 
       1_a AMTTGAIAAMLSTILYSR 1 1 1 1 1 1 
       1_a GAVYSFDPVGSYQR     1  
       1_a RFFPYYVYNIIGGLDEEGKGAVYSFDPVGSYQR 1 2 1 2   
 
 
Case 2. Disagreement between programs which select primary protein vs. representative 
proteins.  The programs that select and report primary proteins (TPP ProteinProphet, 
Panoramics, Scaffold, IsoformResolver) all selected the same three primary proteins, and the 
programs that select representative proteins (IsoformResolver in representative protein selection 
mode, Phenyx, IDPicker) selected the same representative protein.  However, none of the 
peptides provided distinguishing evidence for any specific isoform of Drebrin-like protein. The 
primary protein selecting programs retained this ambiguity while the representative selecting 
programs selected one of the three arbitrarily. 
  
Proteins inferred by each program  Protein Spectral Counts 
TPP  Pan  Sca  IRP  IRR  Phe  IDP      TPP Pan Sca  IR  Phe IDP
√  √  √  √  √  √  √  2* IPI00101968.3    ISOFORM 3 OF DREBRIN-LIKE PROTEIN.  Gene=DBNL 
√  √  √  √        2* IPI00396437.3    ISOFORM 2 OF DREBRIN-LIKE PROTEIN.  Gene=DBNL 
√  √  √  √        2* IPI00456925.3    ISOFORM 1 OF DREBRIN-LIKE PROTEIN.  Gene=DBNL 
              2* AEEDVEPECIMEK 1 1 1 1 1 1 
              2* FQDVGPQAPVGSVYQK 1 1 1 1 1 1 
              2* GYGPDGHFGMFPANYVELIE 1 1 1 1  1 
              2* VAGTGEGGLEEMVEELNSGK 1 1 1 1 1 1 
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Case 3. Disagreement between programs which select representative proteins.  Each program 
identified the same peptide, and the same primary proteins were selected by TPP ProteinProphet, 
Panoramics, Scaffold, and IsoformResolver.  However, there was no agreement between 
representative protein selecting programs (IsoformResolver in representative protein selection 
mode, Phenyx, IDPicker) as to which of the three indistinguishable proteins should be reported.   
 
Proteins inferred by each program  Protein Spectral Counts 
TPP Pan Sca IRP IRR Phe IDP   TPP Pan Sca IR Phe IDP 
√ √ √ √ √  √ 3* IPI00384745.3    HSR1 PROTEIN. No gene annotation. 
√ √ √ √  √  3* IPI00396387.3    GUANINE NUCLEOTIDE BINDING PROTEIN-LIKE 1.  Gene= GNL1 
√ √ √ √    3* IPI00797329.1    GUANINE NUCLEOTIDE BINDING PROTEIN-LIKE 1.  No gene annotation. 
       3* EQVLQPVSAELLELDIR 1 1 1 1 1 1 
 
 
Case 4.  Disagreement among programs which select primary proteins.  Each program 
identified the same peptide, and the same representative proteins were selected by 
IsoformResolver in representative protein selection mode, Phenyx, and IDPicker.  However, 
programs which select primary proteins (TPP ProteinProphet, Panoramics, Scaffold, and 
IsoformResolver) disagreed with each other.   
 
Proteins inferred by each program  Protein Spectral Counts 
TPP Pan Sca IRP IRR Phe IDP   TPP Pan Sca IR Phe IDP 
√ √ √ √ √ √ √ 4* IPI00220834.8    ATP-DEPENDENT DNA HELICASE 2 SUBUNIT 2.  Gene=XRCC5 
 √  √    4* IPI00792121.1    PROTEIN.  Gene=XRCC5 
 √  √    4* IPI00795088.1    HYPOTHETICAL PROTEIN XRCC5.  Gene=XRCC5 
       4* YAPTEAQLNAVDALIDSMSLAK 1 1 1 1 1 1 
 
 
Case 5.  Disagreement among programs which select primary and representative proteins.  
Each of the 6 programs identified the same peptide, but programs within each group failed to reach 
agreement about which protein to infer.    
 
Proteins inferred by each program  Protein Spectral Counts 
TPP Pan Sca IRP IRR Phe IDP   TPP Pan Sca IR Phe IDP 
√ √ √ √ √  √ 5* IPI00339320.5    ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 15.  Gene=ANKRD15 
√ √  √    5* IPI00479846.1    ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 15.  Gene=ANKRD15 
√ √  √    5* IPI00551051.4    ANKYRIN REPEAT DOMAIN 15.  Gene=ANKRD15 
√ √ √ √  √  5* IPI00646764.2    ANKYRIN REPEAT DOMAIN PROTEIN 15 ISOFORM B.  Gene=ANKRD15 
       5* AGYTPIMLAALAAVEAEK 1 1 1 1 1 1 
 
 
protein inference, whereas representative proteins, while convenient for simplifying output, loses 
important information. 
 
Protein display   
 An important difference between these programs was how they displayed bridge 
peptides.  Phenyx, Panoramics, Scaffold, and ProteinProphet replicated bridge peptides, listing 
them redundantly with proteins that shared them.  IDPicker dealt with bridge peptides by 
assigning them to only one protein and discarding them from others.  When ProteinProphet and 
IsoformResolver profiles were compared (Table 3.2, Dataset 1C), 777 MSD groups were found 
in common by both programs.  ProteinProphet displayed secondary (subset) proteins within its 
protein groups (e.g., as in Fig. S3.7a), but separated protein groups which shared bridge peptides.  
By contrast, IsoformResolver listed each peptide together within their MSD group, therefore 
bridge peptides were neither overrepresented nor underrepresented (Fig. 3.7b), and reported the 
MSD groups adjacently in the output.  By separating protein groups that shared bridge peptides, 
17 of the 777 MSD groups in IsoformResolver were displayed as 34 protein groups in 
ProteinProphet, where members of each pair of related protein groups were separated far from 
each other in the output.  This illustrates the advantage of a display which positions related 
proteins adjacently, in a manner which avoids peptide replication and redundancy.  
 
Compare profiles 
 Finally we examined the ability of each program to compare results from two or more 
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datasets.   IsoformResolver, Scaffold, Phenyx, and IDPicker were each able to display 
differences between multiple datasets within a single protein inference profile.  Scaffold and 
Phenyx only allowed comparison of individual LC-MS/MS runs, while IsoformResolver and 
IDPicker allowed for any number of LC-MS/MS datasets (Table 3.5).     
  We also examined the ability of each program to compare results from separate protein 
inference analyses, e.g., datasets analyzed at different times and then compared retrospectively.  
All programs allowed primary proteins to be manually compared between separate analyses, 
however, differences in protein inference and shortcomings of protein reporting led to 
overestimates of variation between analyses. This was alleviated by reporting protein groups, as 
allowed by IsoformResolver and IDPicker.  However, IDPicker identified protein groups 
sequentially per profile, preventing their comparison against protein groups from other protein 
profiles.  Only IsoformResolver had a stable (ISD) numbering scheme which allowed uniform 
comparisons between different experiments.   
 
CONCLUSIONS 
 
  In this study, we describe IsoformResolver in detail for the first time.  We demonstrate 
that protein inference exacerbates volatility in protein identifications, such that small changes in 
peptides lead to greater changes in the inferred proteins.  We show that protein inference causes 
significant protein variation introduced by LC-MS/MS sampling in technical replicates, and even 
when peptides are completely overlapping between full datasets and simulated subsets.  When 
many datasets are compared, protein repeatability is improved by pooling datasets at the peptide 
level and performing inference once, instead of performing inference on each experiment and 
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aggregating the results.  However, the pooled analysis loses important information gained by 
analyzing each experiment individually. 
  Underlying the problem of protein volatility is the question of how to select between 
indistinguishable proteins, inferred as present but not distinguishable from other equally possible 
candidates.  Indistinguishable proteins must be counted singly and yet must be linked to multiple 
protein identifiers, because reporting all proteins in an indistinguishable set overestimates their 
presence, but reporting only one of several proteins loses valuable information.  No single 
method of reporting protein identifiers – listing all proteins, primary proteins, concatenated 
identifiers, or representative proteins – completely solves the problem of underrepresenting or 
overrepresenting proteins in the sample due to protein inference.   
  Another important question is how to treat peptides that bridge multiple primary proteins.  
The results can be misleading when protein inference programs either assign the bridge peptides 
to only one protein arbitrarily, or else replicate the peptides and match them redundantly to 
multiple proteins, which may underestimate or overestimate the peptide evidence for a protein.  
We find that in complex protein databases like the human proteome, the number of bridge 
peptides increases as more peptides are identified with higher depth (e.g., see Dataset 1 in Table 
3.2). 
  IsoformResolver addresses all of these problems by reporting proteins and peptides in the 
context of MSD and ISD groups, developed using a peptide-centric strategy which lists each 
peptide once, and matching each observed peptide to all proteins that share its sequence.  In this 
way, primary, secondary, and indistinguishable proteins can be immediately assessed by the 
presence or absence of distinguishing peptides, and are clearly marked in the output.  Displaying 
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proteins in the context of MSD groups avoids the problems of listing peptides redundantly or 
arbitrarily assigning them to one primary protein.  Displaying primary, indistinguishable, and 
secondary proteins adjacently avoids loss of information about their relatedness, and allows the 
experimentalist, not the software, to decide which proteins are most likely present.  
  By displaying MSD groups adjacently and linked by ISD groups, all proteins linked by 
shared peptides can be listed together, even when the peptides are not observed experimentally.  
We show that proteins within ISD groups are usually derived from the same gene or products of 
gene duplication, exhibiting functional relationships which reflect their underlying sequence 
identity.  Importantly, experimentally observed peptides and proteins can be mapped to protein 
identifiers which are invariant for a given database, lending stability to the protein profiles by 
allowing comparisons to be made between experiments analyzed at different times and using 
different software.  ISD groups also allow IsoformResolver to facilitate comparison between 
datasets by spectral counting, by allowing related proteins to be listed adjacently. 
 In summary, protein inference remains a challenging problem, but the approach used by 
IsoformResolver, of converting a protein database into a peptide-centric format in which all non-
redundant peptides are pre-mapped to proteins, and all proteins are mapped to ISD groups, helps 
counteract many ambiguities introduced by the inference problem.  In addition, when large 
datasets are involved, or many datasets must be compared, the algorithms employed by 
IsoformResolver allow greatly increased speed in execution time compared to other software.  
Presenting protein and peptide results in the context of MSD and ISD groups is a logical, complete 
and concise way to display proteomics information, which solves problems in comparing datasets 
of high complexity from shotgun proteomics.  
  
 
CHAPTER IV 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
DISCUSSION 
 
In this thesis I have described algorithms I have developed which confidently identify 
peptides and quantify proteins from shotgun proteomics experiments.  MSPlus uses 
physicochemical filtering and consensus to produce a list of believable peptide spectrum matches 
with a low percentage of false positive identifications.  IsoformResolver uses a peptide-centric 
paradigm that efficiently generates a list of highest confidence proteins without omitting other 
possibilities.  It can be run in two modes:  one suitable for analysis of a single cell state in which 
the relative abundance of proteins can be assessed, and another suitable for analysis of two or 
more cell states which can be used for identifying biomarker candidates.   These programs have 
been used for several years in our mass spectrometry facility and have resulted in significant 
findings from our lab and others (Ruth et al, 2006; Yen et al, 2006; Old et al, 2009).  In addition, 
the novel aspects of these algorithms have influenced other programs used in proteomics 
analyses.   
With IsoformResolver in hand, there are many larger questions which we can now 
investigate. In the remainder of this thesis I explore three of these:  What is the size of the human 
proteome, and how close can we get to observing it entirely?  What do we know about the 
protein abundances of particular protein classes, and how can we use that information to learn 
about pathway regulation?   How do proteomics results compare to microarray analyses, and can 
proteomics studies do as well as transcriptomics, in identifying biomarkers that specify diseases 
or cellular states? 
 
The proteome size and the impact of depth of sampling 
The number of proteins that are expressed in a single human cell type is unknown.  In the 
early days of proteomics, our lab and others reported proteins numbering in the hundreds and 
low thousands.  With development of higher resolution chromatography methods, and as mass 
spectrometers improved in terms of speed and mass resolution, the numbers of reported proteins 
steadily increased, to the point that profiles with close to 10,000 proteins are now commonly 
reported.  This raises the question of how close our protocol is to being capable of observing all 
of the proteins in a cell, and how we will know when we have reached that point.  We also want 
to know whether it is possible to estimate the number of proteins in a human proteome, given 
results from experiments carried out at varying depths of sampling.  These are important 
questions that remain for the future.   
Here, I summarize some very preliminary observations in order to show how the MSPlus 
and IsoformResolver software tools I have developed can begin to answer some of these 
problems.   First, I carried out studies asking how many proteins can be identified at varying 
depths of sampling.  Our expectation was that protein profiling carried out at high depth of 
sampling, where many proteins can be identified, would include all proteins also seen at lower 
depth of sampling.  We tested this by constructing a compare profile from peptides generated 
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from the same human cell lysate, which was then sub-fractionated to varying degrees. At each 
sampling depth, Dr. Stephane Houel in our lab ran two technical replicates in order to minimize 
stochastic differences.  Peptides were then identified using Mascot and MSPlus, with peptide 
false discovery rate <1%.  Using IsoformResolver, I obtained spectral counts for each of three 
protocols, which were named FASP2, FASP6 and FASP24.  The names refer to the filter-
assisted sample preparation (FASP) method which was used to proteolyze proteins and extract 
peptides from a cell lysate of WM239A melanoma cells, and the 2, 6, and 24 steps used during 
the first dimension peptide separation by RP-C18 chromatography, which was then followed by 
gradient separation on a second dimension RP-C18 column.  It has been shown that 2-
dimensional LC systems can yield orthogonal separations when the first dimension is performed 
by RP at high pH and the second dimension by RP at low pH (Gilar et al, 2005).   
I measured the spectral counts for proteins in each experiment from the IsoformResolver 
compare profile, and then normalized for protein length by dividing by the number of peptides 
expected to be observed using our protocol (i.e., fully tryptic peptides allowing up to two missed 
cleavages, and excluding peptides with 8 or fewer amino acids).  The numbers of observable 
peptides for different proteins in the protein database ranged between 1 and 4499.  Spectral 
counts normalized in this way correct for the probability of observing peptides from each 
protein, and thus provide estimates of relative abundances between different proteins.  I then 
multiplied the normalized spectral counts by a scalar, so that the minimum value among all 
proteins equaled 1, and plotted histograms of proteins vs. normalized spectral counts on a log10 
scale. 
Figure 4.1 shows high overlap between proteins identified in experiments at lower 
sampling depth and those identified at higher sampling depth.  Nearly all proteins identified in 
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the FASP2 experiment were also detected in FASP6 and FASP24 experiments, which would be 
expected because the same sample was used in each experiment.  Only 37 (out of 3,752) proteins 
were unique to FASP2 and not found in FASP6 or FASP24.  Those proteins which failed to 
reproduce in the higher depth experiments most likely reflect false positive identifications, 
allowing the protein false discovery rate to be estimated as less than 1%.   
 
Figure 4.1  Protein overlap from experiments with varying degrees of 
fractionation.  There were 3752, 5789, and 8895 minimum set proteins inferred 
for the FASP2, FASP6, and FASP24 datasets, respectively, when these datasets 
were analyzed together.  
   
 
I next plotted histograms of spectral counts.  Plotting spectral counts without 
normalization showed that most proteins in each of the three datasets were inferred from 10 or 
fewer peptides (Figure 4.2a).  Proteins from the FASP24 experiment showed proportionally more 
spectral counts, as expected from the higher sampling.  Proteins from FASP24 also showed 
higher numbers of proteins with higher normalized spectral counts than those in FASP6 and 
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FASP2 (Figure 4.2b).  However, in this representation, the proteins detected in common among 
all three datasets appear redundantly in the graph.  Therefore we added another correction, in 
which the total spectral counts for all proteins in each experiment were first normalized to each 
other, before being used to normalize spectral counts for individual proteins.  This had the effect 
of shifting the proteins in the FASP2 to overlap with the higher values seen in the FASP6 and 
FASP24 histograms (Figure 4.2c).  Normalization in this manner demonstrates that the proteins 
captured in the FASP2 experiment are biased towards the highest abundance proteins, as 
expected. 
Turning the distribution in Figure 4.2c by 90º provides a tier structure view of the effects 
of sampling depth which may be more intuitive.  Figure 4.3 shows the relative abundances of 
proteins found in FASP2 and FASP24, to each other as well as within each tier.  Table 4.1 shows 
the percentages of proteins in each tier of FASP2, and the tier in which the same protein is found 
in FASP24.  For instance, of the proteins found in tier 3 of FASP2, 516 (58%), 338 (38%), and 
15 (2%) are detected in FASP24, in tiers 2, 3, and 4, respectively, while 17 (2%) are not found in 
FASP24.  In other words, proteins appearing in lower tiers of low sampling depth experiment 
will be found in higher tiers of high sampling depth experiments.  
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Figure 4.2  Distributions of normalized spectral counts from experiments with 
varying degrees of fractionation.  a. Spectral counts as reported by IsoformResolver. 
FASP2, FASP6, and FASP24 have 2, 6, and 24 degrees of fractionation and increasing 
depth of sampling, respectively.  b. Spectral counts are divided by the number of 
peptides for the proteins they derive from, scaled by 5000, and the log10 value plotted.  
This representation shows the FASP2 proteins have lower overall abundance than those 
detected at lower depths of sampling.  c. Here spectral counts were also normalized 
between experiments, so that like proteins will appear in the same relative abundance 
bins across experiments. This representation shows that the shallow depth of sampling 
only recovers higher abundance proteins.  
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 FASP24 Tiers 
% Found % Not found FASP2 Tiers 1 2 3 4 5 
1 44 56 0 0 0 100 0 
2 1 91 7 0 0 99 1 
3 0 58 38 2 0 98 2 
4 0 0 75 13 0 88 13 
 
 
 
Table 4.1  Protein locations vary by tier between low- and high-
depth sampling.  This table shows the percentages of proteins from 
FASP2 and which FASP24 tier they are found in.  
Figure 4.3  Protein abundance tiers comparing low and high depth sampling.  
Normalized protein abundances are shown with log10 differences between tiers.
In LC-MS/MS, peptides are sampled among many others in a complex mixture.  Thus, 
the data collection are often modeled using sampling statistics, such as those employed in 
population biology methods.  Use of capture-recapture models (Kozial et al, 2006) have been 
applied to estimate the total number of proteins present in a sample, given the sampling overlap 
observed in replicate proteomics datasets.   
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Projected number of proteins = # Proteins in replicate #1 × # Proteins in replicate #2  
                                                                                               # Overlapping proteins 
 
We applied this calculation in our datasets, collected in duplicate at varying depths of sampling, 
and in each case estimated the total number of proteins (Table 4.2): 
 
  
 
 # Proteins, replicate 1 
# Proteins, 
replicate 2 
# Overlapping 
proteins 
Total 
proteins 
predicted 
FASP2 3,485 3,470 3,099 3,902 
FASP6 5,455 5,394 5,021 5,860 
FASP12 6,937 6,952 6,514 7,403 
FASP24 8,329 8,368 7,803 8,932 
Table 4.2  Predicted numbers of proteins using capture-recapture 
calculations.  Replicate analyses were done for each of four experiments 
carried out at varying sampling depth.  We observed no agreement on the 
total proteins predicted using capture-recapture calculations on replicate 
datasets.  
 
 
In spite of current limitations in modeling, we observed hints that we are close to a 
complete sampling of proteins.  For instance, the total numbers of proteins identified in FASP2, 
FASP6, FASP12 and FASP24 experiments were 3,745, 5,784, 7,362, and 8,895, respectively, 
which begins to level off as shown in Figure 4.4.  I also observed lower percentages of single 
peptide proteins in experiments performed at higher sampling depths.  For instance, I calculated 
40% single peptide proteins in the FASP2 datasets, vs. 20% single peptide proteins in FASP24 
datasets.  The percentage of protein coverage was also increased when experiments were 
performed at high sampling depth as expected, but more importantly, began to level off.  This 
implies that we are close to sampling all proteins which are observable in the highest tiers. 
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Figure 4.4  The number of proteins reported from 
depth of sampling experiments is asymptotic. 
 
Protein classes show varying abundances 
IsoformResolver provides rich annotation data that can be used to provide information 
about the relative distributions of different protein classes and functions.  Of the many cross-
references IsoformResolver provides in its protein profiles, GO annotations (Gene Ontology 
Consortium, 2000) are probably the most widely used in the proteomics field.  I wanted to see 
whether different protein classes, as circumscribed by GO function terms, showed different 
abundances as reported by protein profiling.  To test this I used a custom reduced GO code set, 
modified from the Protein Information Resource GO Slim set 
(www.geneontology.org/GO.slims.shtml).  By traversing the GO hierarchy from protein GO 
annotations in the protein profile, I was able to associate the proteins with higher level functional 
categories.  I then assigned each protein’s spectral counts to its functional classes, and when a 
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protein had more than one associated class, spectral counts were assigned to each class, under the 
assumption that the protein had multiple distinct functions. Using IsoformResolver output from 
the FASP24 dataset, I found that certain protein classes, such as structural proteins, were skewed 
towards high abundances, while other protein classes, such as protein kinases, were skewed 
towards low abundances (Figure 4.5).  In order to validate the GO Slim assignments, I examined 
the distribution of the 147 protein kinases that were found within the FASP24 protein profile 
(according to the 518 human protein kinases described by Manning et al, 2002).  This 
distribution agreed well with the protein kinases identified by GO annotations.   
 Figure 4.5 Distributions of normalized and binned spectral counts for 
proteins mapped to three GO Slim molecular function categories. 
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My preliminary results show that protein classes cluster around different median 
abundances with varying width.  This implies that proteins with certain functions stratify by 
abundance within cells.  This type of analysis provides information about how cell states 
correlate with protein abundances, in a manner orthogonal to direct measurements.  This could 
be used, for instance, to map protein abundance information onto cellular pathways, and ask 
whether pathways are static, or if they are dynamic and how they vary with cell type and cell 
state.  In addition, information about relative abundances of protein classes could, in conjunction 
with post-translational modifications such as phosphorylation, be used to trace pathway 
branchpoints, in order to infer which branches of pathways are most highly activated.  In this 
way, relative protein abundance information from shotgun proteomics could be used to guide 
experiments which test how different cell states modulate pathway activation.   
For example, carbons entering the glycolytic metabolic pathway in the form of hexose 
monosaccharides eventually are processed to different metabolites branching off from glycolysis.  
These include ribose synthesized by the pentose phosphate pathway, CO2 generated by the TCA 
cycle, lactate synthesized from pyruvate, amino acids synthesized from pyruvate, oxaloacetate, 
and α-ketoglutarate, fatty acids synthesized from acetyl CoA, and nucleotides synthesized from 
amino acids, CO2 and ribose.  By examining the distributions of enzymes in each of these 
pathways from proteomics spectral count information, and examining the width of each 
distribution, the relative flux through each branchpoint might be inferred and changes in flux 
predicted in response to changes in cellular state.  The analysis will also help reveal the 
importance of metabolic enzyme isoforms and how pathways are modulated between cell states 
by isoform switching. 
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 Similar analyses might inform signaling pathways, beginning with transmembrane 
receptors (e.g., growth factor or G protein coupled receptors), followed by heterotrimeric G 
proteins or small GTPase effectors (e.g., Ras), protein kinase cascades (e.g., MAP kinase 
pathways), and transcription function substrates (e.g., Egr/AP1/SRF).  While specific pathways 
have been modeled to predict signal amplification from receptors to transcriptional responses, 
how the different tiers of a signaling pathway are perturbed with respect to abundance is still 
poorly documented.  Already, Figure 4.5 shows differences that may be unanticipated.  For 
example, proteins annotated as transcription factors appear to be more abundant than protein 
kinases.  This is unexpected, given that many protein kinases are estimated at 106 copies per cell, 
whereas highly abundant transcription factors are usually considered to be 104 copies per cell.   
A more careful validation is needed to determine whether this difference is real, or related to 
proteins mistakenly annotated as transcription factors by GO.  To the extent that the observation 
is valid, it implies that the ratio of kinases to their substrates in cells may not be as high as 
formerly presumed.   
 
Can proteomics be used to identify members which distinguish cell states? 
Microarray analysis has been used successfully to identify biomarkers (Dhanasekaran et 
al, 2001; van de Vijver et al, 2002; Wang et al 2005).  In contrast, the ability of proteomics to 
identify biomarkers has been slower, due to the inherent difficulty in identifying and quantifying 
proteins, which show far more chemical variability than nucleic acids.  Intuitively, proteomics 
should provide more insight than microarray assays because proteins are the primary controllers 
of cell regulation, and their abundances are often not well correlated with corresponding mRNA 
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levels.  In addition, microarray assays cannot capture information about post-translational 
processing events.  However, the ability to observe and quantify all proteins in a cell by mass 
spectrometry is more limited than the ability to observe mRNA by nucleic acid hybridization.  I 
examined characteristics of proteomics and microarray data to ask whether the lower depth of 
sampling in proteomics limited its usefulness compared to microarray assays. 
I first compared proteomics and microarray data collected on the same WM239A human 
melanoma cell line.  For proteomics analysis I examined the FASP24 replicates with normalized 
spectral counts, described earlier in this chapter. For the microarray analysis I examined 
duplicate Affymetrix datasets (Human U133A GeneChips) which were analyzed with 
Bioconductor mas5 software (Argast et al, 2009; Croy et al, unpublished), considering only 
probesets marked as ‘present’ in at least one of the two replicates. When there were multiple 
proteins per gene, their spectral counts were summed, and when there were multiple microarray 
probesets per gene, the probesets with the largest intensity values were selected.  In total, I found 
8,473 and 8,524 genes from the microarray and proteomics data, respectively.  Of these, only 
3,711 genes were common to both lists, a low number that may be caused in part by information 
loss when mapping from probeset and protein identifiers to genes.  I examined the 3,711 genes in 
common and scaled the normalized spectral counts in order to match the median intensity 
measurements in the microarray data, and then plotted log2 values of the genes in common, as 
shown in Figure 4.6. 
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Figure 4.6.  Distributions of mRNA and protein data sets with 
genes in common.  Normalized protein spectral counts were scaled to 
match the median value of mRNA intensity in antilog form. 
 
 
I then asked whether there was any correlation between protein and mRNA intensity, by 
plotting the normalized intensities for the genes in common, and concluded that the correlation 
was present, but poor (Figure 4.7). I then marked the location of the 101 protein kinases 
(Manning et al, 2002) and the 99 protein phosphatases (http://phosphatase.net/database.php). 
These appeared at lower abundances but with similar correlation between protein and mRNA. 
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Figure 4.7.  Correlation between mRNA and protein intensities.  
Intensities for 3,711 genes in common are shown in blue, and 
intensities for 101 kinases and 99 phosphatases are shown in red. 
 
 
I then examined datasets of experiments where cell states could be compared under 
conditions of constitutive MAP kinase pathway activation (control, untreated cells) and MAP 
kinase pathway inactivation (cells treated with the MKK1/2 inhibitor, U0126, for 24 hours).  
Rank analysis (Breitling et al, 2004) on the microarray data resulted in two ranked lists of genes, 
one showing increased expression in response to U0126, and the other showing decreased 
expression.  I then asked whether the highest differentially regulated genes identified by Rank 
Analysis were in any way correlated with their relative intensity.  As shown in Figure 4.8, this 
was not the case.  The genes that best discriminated control vs. U0126 treated cells showed 
similar distribution with respect to relative intensity as all genes in the dataset. 
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Figure 4.8.  Intensity distribution of highest ranked differentially regulated 
genes.   
 
I wondered whether these rankings would change when I only considered only those 
probesets with highest intensity.  Figure 4.9 shows that the probeset rankings changed very little 
when computed on the 50% most intense data vs. all of the probesets.  Therefore, the probesets 
which best discriminated control vs. U0126 were still the best discriminators when using only the 
highest intensity probesets. 
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  Figure 4.9.  Comparison of rankings from microarray analysis 
considering all vs. only the most intense genes. 
  
I also examined a proteomics dataset of WM239A cells, treated with and without U0126 
for 24 hours.  For this analysis I used extracts prepared by Dr. Thomas Lee from cells that were 
metabolically labeled with stable isotope labeled amino acids (SILAC). Proteins were harvested, 
extracted and proteolyzed and analyzed by LC-MS/MS, and the experiment was repeated, 
switching the labeling in order to correct for systematic bias.  There was little correlation 
between rankings from proteomics and microarray datasets, despite the fact that relative 
intensities of proteins and mRNA correlated reasonably well.  Thus, the best discriminators in 
the protein dataset did not necessarily correspond well to the best discriminators in the 
microarray dataset.  Further analysis is needed in order to understand the reason for the lack of 
correlation, however currently it appears that Rank Analysis may not be a robust method to 
identify biomarkers from proteomics datasets. 
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Finally I examined a very large microarray dataset from which biomarkers had been 
found and validated, in order to ask whether genes which determine disease classes included 
those with higher intensities that would be more likely to be found in proteomics datasets.  I 
found a study which identified a 76 gene signature that predicted the likelihood of relapse among 
lymph node negative breast cancer patients (Wang et al, 2005).  This gene signature has since 
been commercialized as a diagnostic screen.  In this study, the gene signature was constructed to 
correlate with ER+ and ER- patient samples separately, using training sets and supervised class 
prediction approaches.  A relapse score, based on weighted log2 based expression values, was 
then validated using patient data not included in the training set, producing receiver-operator 
characteristic (ROC) curves with sensitivity 93% and specificity 48%.  The study did not divulge 
which patient samples were applied to the training vs. the testing sets, thus it was not possible to 
replicate the construction of the 76-gene signature.  However, microarray expression values for 
all 286 patient samples were made available and using this, I could replicate the ROC curves to 
sensitivity 91% and specificity 54% as shown in Figure 4.10.   
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Figure 4.10.  ROC curve showing the predictive power of a 76-probeset 
signature.  TP = relapse scores at or above threshold from patients who 
relapsed; FN = relapse scores below threshold from patients who relapsed; 
TN = relapse scores below threshold from patients who didn’t relapse; FP = 
relapse scores at or above threshold from patients who didn’t relapse.  
 
 
Although the signature set was not biased towards high intensity probesets (data not 
shown), I wondered what effect it would have on the predictive value to recalculate the relapse 
score, considering only those probesets with the average highest intensity values across all 
patient samples.  As shown in Figure 4.11, I found that the lower depth datasets were able to 
recapitulate the same high sensitivity levels as found in the original gene signature, but with 
some decrease in specificity.  From this I concluded that even at a shallower depth of sampling, 
patients who suffered relapse were still identifiable, but at the cost of increasingly higher levels 
of false positive predictions. 
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In conclusion, proteomics studies are approaching the level of completeness of 
microarray studies in terms of the numbers of genes reported, but protein coverage is still low for 
low abundance proteins.  Still, correlations between mRNA and proteins are weak enough to 
justify the goal of mining proteomics data, in order to find biomarker candidates that may be 
missed by microarray analyses.   
 I examined the impact of depth of sampling in two ways:  first, by comparing the results 
of Rank Analysis on complete and truncated two-state microarray datasets, and second, by 
asking how the predictive value of a relapse score changed when only high intensity probeset 
expression values were considered.  In both experiments I found that it did not matter if only the 
high abundance expression values were considered.  From this I conclude that a low or 
incomplete depth of sampling may be sufficient to discovery and use of biomarkers. 
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In this thesis, I have presented novel computational methods for peptide identification 
and protein inference, and discussed some larger questions about the capabilities and limits of 
proteomics.  At the time I started this research, proteomics users were finding that only low 
percentages of spectra were being identified, and questioning the correctness of those 
identifications.  In Resing et al 2004 (reprinted in Chapter 2), we proposed a simple but powerful 
solution to this problem by using physicochemical filters and multiple peptide identification 
programs as implemented in MSPlus, solutions that are now fully accepted.  More recently, it has 
been recognized that proteomics results suffer from a lack of repeatability both within and 
between different labs, a problem inextricably linked to the sampling nature of shotgun 
proteomics.  In Meyer-Arendt et al 2011 (reprinted in Chapter 3), I show how peptide-centric 
protein groups are a logical and effective way to address this volatility.  By publishing this work 
and making the IsoformResolver software publicly available, I hope that this will influence the 
community as much as MSPlus has.   
In the final chapter of this thesis I examine how we might make the best use of MSPlus 
and IsoformResolver output.  I show how protein spectral count data can be presented in 
abundance tiers, and describe how the highest abundance tiers are filled completely, while lower 
abundance tiers are only filled with extensive fractionation.  Extrapolating from increasingly in-
depth proteomics experiments, it appears that we are close to completely sampling the proteome.  
As we approach this major milestone, we need to be ready to use our quantitative data to gain 
insight into cell function.  As described, one way this can be done is to use protein abundances 
for individual proteins as well as for protein classes to infer the pathways that are activated for a 
given cell state, data which could be used to model cell function.   Finally, I explore whether 
there are particular intensities for established biomarker genes identified from microarray data.  
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As no such constraints were found, I conclude that proteomics experiments, supplemented by 
appropriate statistical validation, show great potential for leading to the discovery of important 
biomarkers, and remain a very promising high-throughput method. 
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APPENDIX A:  Manual analysis of examples in Table 2.2 illustrating "distraction" 
  
Four DTA files from Table 2.2 show Example 1 (A, B), Example 2 (C, D), Example 3 (E, F, G, H), 
Example 4 (I, J, K, L), along with manual analysis for each alternative peptide assignment.  Indicated are sequence 
specific fragment ions (a, b, and y ions, and their dehydrated/deammoniated forms), as well as internal fragment ions 
produced by two cleavages (a and b forms, and dehydrated/deammoniated forms).  Fragment ions that report each 
peptide sequence are diagrammed on the sequence, indicating sequence-specific y or a/b fragment ions ions (└ or 
┐) 
and internal fragment ions (horizontal lines).  Different charge states are indicated on separate lines, where 
applicable.  Predicted masses were calculated using ProteinProspector (http://Prospector.ucsf.edu), indicating mass 
differences between observed and predicted in parentheses when >0.6 Da.  Asterisks indicate ions of significant S/N 
that could not be assigned to the identified sequence.  
 
Example 1:   
(A) Sequence tested: AIGTEPDSDVLSEIMHSFAK (validated).  Positive indications: the high intensity 
y18+2 ion is consistent with efficient cleavage at the second peptide bond; the high intensity y15+2 ion is consistent 
with N-terminal cleavage at Pro; although fragmentation overall is poor, the observed cleavages are largely from 
adjacent peptide bonds, and are consistent with efficient cleavage in the EPDSD region as expected; despite low 
intensity of ions above m/z = 1000 Da, a surprising number are interpretable; no significant mass inaccuracies; all 
major ions were identified.  Negative indications: none.  (B) Sequence tested: TTIGAAGLPGRDGLPGPPGPPGPP 
(distracted).  Positive indications: none.  Negative indications: assigned cleavages are rather randomly distributed 
over the peptide; major cleavages are inconsistent with expected cleavage at Pro or Asp residues in the sequence; 
three medium and one high intensity ion are unidentified; large mass inaccuracy for three ions.   
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Example 2: 
(C) Sequence tested: EGLELPEDEEEK (validated).  This is a nice example of the tendency towards 
internal fragmentation in distracted ions.  Positive indications: all ions are accounted for with reasonable accuracy; 
cleavages are consistent with expected chemistry, with efficient cleavage N-terminal to Pro and N-terminal to Leu at 
the adjacent peptide bond; several internal fragment ions are observed, all derived from one cleavage N-terminal to 
Pro and a second cleavage through an acidic region; the parent easily dehydrates twice, consistent with the acidic 
nature of the sequence, and the biggest fragment ion also has the same double dehydration.  Negative indications:  
one moderate sized fragment ion is unaccounted for (747.2 Da).  (D) Sequence tested: EGIELLLNEGSEL 
(distracted).  This sequence is identical to that of the validated peptide at the N-terminal five amino acids, and thus 
shows high intensity y ions identical to those in Panel C; however, the validated sequence is preferred, because it is 
a tryptic peptide, and because it accounts for more ions with higher mass accuracy.  Positive indications: a well 
defined sequence of high intensity y ions report cleavage in the acidic, I/L rich region of the sequence.  Negative 
indications: for this sequence, two high and two moderate intensity fragment ions are unaccounted for and ten 
assignments have large mass inaccuracies. 
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Example 3:     
(E) Sequence tested: GDAMIMEETGK (validated).  Positive indications: All high and moderate intensity 
ions are accounted for, with no significant mass inaccuracy; the highest intensity ion reports cleavage C-terminal to 
Asp and the next two highest intensity ions report cleavage on either side M, at IM and ME; the presence of Thr and 
three acidic residues in a small peptide accounts for the tendency for multiple dehydration.  Negative indications: 
two low intensity ions are unaccounted for (some multiple dehydrations are not labeled for clarity).  (F) Sequence 
tested: YPILFLTQGK (distracted).  Positive indications: a continuous set of several high intensity y ions, missing 
only the expected one that is C-terminal to Pro.  Negative indications: the highest intensity ion, four moderate 
intensity ions, and three low intensity ions are unaccounted for; nine ions show large mass inaccuracies; no obvious 
reason for multiple dehydration.  (G) Sequence tested: AVYVEMLQIL (distracted).  Positive indications: the 
highest intensity ion reports cleavage at the second peptide bond.  Negative indications: both ends are nontryptic; 
the charging of y ions is problematic; two moderate intensity ions and two low intensity ions are unaccounted for; 11 
ions have large mass inaccuracies; no obvious reason for multiple dehydration.  (H) Sequenced tested: 
GIMAIEMVEGE (distracted).  Positive indications: the y ion series is consistent with chemistry; overall acidity 
consistent with multiple dehydration.  Negative indications: the y ions have large mass inaccuracies that randomly 
vary up and down vary with no consistent trend; two high and two moderate intensity ions are unaccounted for; 
lacking the Thr usually associated with multiple dehydration. 
Example 4:   
(I) Sequence tested: DLSLEEIQK (validated).  This is a difficult spectrum to interpret due to the weak 
signal and several internal fragment ions; however the peptide was sequenced two other times in the dataset, which 
produced better spectra with higher scores, and comparison of all three spectra was used in interpretation of minor 
peaks, which strictly speaking are not distinguishable from the noise in this spectrum.  However, even without the 
additional spectra, the validated sequence is clearly better than the alternatives, which failed to account for 1 to 5 of 
the major ions and have significant mass inaccuracies.  Positive indications: all major ions are accounted for with 
good mass accuracy; the highest intensity ion is from cleavage C-terminal to Asp; several internal fragment ions 
show cleavages consistent with expected properties of multiple internal fragment ions; fragment ions tend to line up 
from the same site on one side, at a peptide bond that is expected to be labile (this is not required, particularly when 
fragment ions are dipeptides, but it is a strong plus when it is present).  Negative indications: none, other than poor 
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spectra.  (J) Sequence tested: IDCEAPLKK (distracted).  Positive indications: cleavages at adjacent residues.  
Negative indications: six high and two moderate intensity ions are unidentified (there are many weaker ions that are 
not identified, but their S/N is poor and they are not justified as negative indicators); three assignments have high 
mass inaccuracies.  (K) Sequence tested: NSQVKELKQ (distracted).  Positive indications: clustering of cleavages 
at C-terminus.  Negative indications: unusual protease specify required to produce this peptide; few y ions observed, 
for no obvious reason; one major ion unaccounted for; four ions have large mass inaccuracies.  (L) Sequence tested: 
ALASQSAGITGV (distracted).  Positive indications: none.  Negative indications: highest intensity ion, three high 
and one moderate intensity ion unaccounted for; one large mass inaccuracy; from peptide composition, would 
expect a nice series of b ions, which are not present. 
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Example 4:   
(I) Sequence tested: DLSLEEIQK (validated).  This is a difficult spectrum to interpret due to the weak 
signal and several internal fragment ions; however the peptide was sequenced two other times in the dataset, which 
produced better spectra with higher scores, and comparison of all three spectra was used in interpretation of minor 
peaks, which strictly speaking are not distinguishable from the noise in this spectrum.  However, even without the 
additional spectra, the validated sequence is clearly better than the alternatives, which failed to account for 1 to 5 of 
the major ions and have significant mass inaccuracies.  Positive indications: all major ions are accounted for with 
good mass accuracy; the highest intensity ion is from cleavage C-terminal to Asp; several internal fragment ions 
show cleavages consistent with expected properties of multiple internal fragment ions; fragment ions tend to line up 
from the same site on one side, at a peptide bond that is expected to be labile (this is not required, particularly when 
fragment ions are dipeptides, but it is a strong plus when it is present).  Negative indications: none, other than poor 
spectra.  (J) Sequence tested: IDCEAPLKK (distracted).  Positive indications: cleavages at adjacent residues.  
Negative indications: six high and two moderate intensity ions are unidentified (there are many weaker ions that are 
not identified, but their S/N is poor and they are not justified as negative indicators); three assignments have high 
mass inaccuracies.  (K) Sequence tested: NSQVKELKQ (distracted).  Positive indications: clustering of cleavages 
at C-terminus.  Negative indications: unusual protease specify required to produce this peptide; few y ions observed, 
for no obvious reason; one major ion unaccounted for; four ions have large mass inaccuracies.  (L) Sequence tested: 
ALASQSAGITGV (distracted).  Positive indications: none.  Negative indications: highest intensity ion, three high 
and one moderate intensity ion unaccounted for; one large mass inaccuracy; from peptide composition, would 
expect a nice series of b ions, which are not present. 
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APPENDIX B:  Distribution of MS/MS spectral ion intensities in the distracted group vs. 
the MSPlus-validated group  
 
 Distributions show relatively small differences in spectral intensity between distracted and MSPlus-
validated assignments, indicating that low intensity spectra are not an important cause of distraction.  Percent of 
DTA files with varying fragment ion intensities is shown for the MSPlus-validated and distracted ions (identified by 
CLASP) from Sample 1.  Intensity of MS/MS fragment ions is represented as the standard deviation of the 
intensities of the ions reported in the DTA file, not counting the parent ion, in units of cpm.  MS/MS spectra with 
many high intensity fragment ions show high standard deviations, while weak spectra primarily report the standard 
deviation of the noise.  An intense, but poorly fragmenting, parent ion producing only a few fragment ions will 
generally have a lower standard deviation, because the many noise ions in the DTA file will overwhelm the 
contribution of the few fragment ions.  Neither Sequest nor Mascot ever successfully identifies spectra with standard 
deviations less than 860 cpm (in surveying 49,715 DTA files), although manual analysis can sometimes identify the 
peptide down to 600 cpm.  Below this point, it is not possible to distinguish signal from noise. 
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